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ABSTRACT OF DISSERTATION

SURFACE-INITIATED POLYMERIZATION FOR THE RAPID SORTING OF
RARE CANCER CELLS
Cancer metastasis directly accounts for an estimated 90% of all cancer related
deaths and is correlated with the presence of malignant tumor cells in systemic
circulation. This observed relationship has prompted efforts to develop a fluid biopsy,
with the goal of detecting these rare cells in patient peripheral blood as surrogate markers
for metastatic disease as a partial replacement or supplement to invasive tissue biopsies.
Numerous platforms have been designed, yet these have generally failed to support a
reliable fluid biopsy assay due to poor performance parameters such as low throughput,
low purity of enriched antigen positive cells, and insufficiently low detection thresholds
to detect poor expressed surface markers of target cell populations. This work describes
the development of a rapid cell sorting technology called Antigen Specific Lysis (ASL)
based on photo-crosslinked polymer film encapsulation to isolate tumor cells in
suspension.
In the first study, we characterize the chemical and structural properties of the
surface-initiated polymer films formed directly on mammalian cell surfaces. Coated cell
populations are shown to remain highly viable after coating formation. Biomolecular
transport is examined though film coatings on cellular substrates using fluorescent, timeresolved confocal microscopy and diffusivity estimates are generated for these materials.
In the next study, a lysis-based cell isolation platform is described in which marker
positive cells can be specifically coated in a heterogeneous cell suspension. Anionic
surfactants lyse virtually 100% of uncoated cells while fully encapsulated cells remain
protected, and are then easily collected by centrifugation. We report that purified cells are
released from polymeric coatings to yield viable and functional populations. We monitor
cell response throughout the isolation process by multiple techniques, and report cell
viability >80% after the sorting process. Lastly, we examine the response of process yield
on the level of photoinitiator loading on target cell populations. Streptavidinfluorochrome loading was quantitatively assessed on a panel of markers, both epithelial
and mesenchymal, on representative model breast and lung cancer cells. We report that
ASL is fundamentally capable of achieving 50-60% yield which is promising for fluid
biopsy applications. Finally, both EpCAM and metastatic targeting strategies are then
compared to covalently biotinylated samples to inform future robust targeting strategies.
KEYWORDS: cancer, cell sorting, photopolymerization, thin films, surface coatings, cell
encapsulation
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Chapter 1: Introduction
Tumor metastasis plays a central role in the often fatal nature of cancer, and
directly accounts for an estimated 90% of all cancer related deaths [3, 4]. Although the
exact signaling cues and underlying mechanisms that drive the metastatic process remain
an area of intense research, the link between metastasis and the presence of circulating
tumor cells (CTCs) in peripheral blood has long been observed. Many have reported that
the detection of high numbers of CTCs in cancer patients is correlated with poorer
prognosis, particularly in breast, prostate and colorectal cancer types [5-9].
These findings have prompted much effort in developing technologies to detect,
isolate, and characterize these CTCs in patient peripheral blood samples for clinical use
as a “fluid biopsy”, with the hope of establishing a reliable prognostic indicator. Ideally,
this isolation modality could be implemented in a treatment regimen as a supplement or
partial replacement for a traditional tissue biopsy. This would allow almost continual
supervision of progression and response to treatment, while minimizing the trauma and
bodily stress of a tissue biopsy. For decades, strategies have focused on simple
enumeration of the rare epithelial-like cell in the bloodstream, and have shown limited
success as a reliable, predictive assay. Critically, the poor performance in both sensitivity
and specificity of CTC isolation strategies has prevented their incorporation into standard
therapy practices and has not led to measurable improvements in clinical outcomes [10].
This has been due, in part, to the reliance of these isolation technologies on detecting
cells based on the definitive epithelial marker, EpCAM, and the assumption that the
tumor cell phenotype is static and unalterable [11-13]. Emerging evidence suggests there
exists vastly complex biochemical signaling between tumor cells and their evolving

1

microenvironment that provoke and sustain metastasis [14]. This heterotypic signaling
causes a certain subset of tumor primary cells to shed their epithelial phenotype and gain
more stem-like properties that allow them to be particularly well suited for the
subsequent phases of metastasis – migration, invasion, intravasation, circulation, and
extravasation [1].
This process, known as epithelial-mesenchymal-transition (EMT), has been
shown to causes a reversible and dynamic shift in the tumor cell phenotype as epithelial
markers are downregulated, suggesting that CTC detection strategies based on
recognition of epithelial markers may not “see” a large proportion of these highly
metastatic stem-like CTCs [4, 15, 16]. We submit that mesenchymal cells represent
significant false negative events in current detection approaches, contributing to poor
assay sensitivity, specificity, and ultimately utility. Further, while this phenomenon has
been well described in vitro and at the tumor primary, little is known about the marker
expression profile of a CTC during transit in the bloodstream largely because currently
available CTC isolation technologies are incapable of isolating these populations with the
purity and quantity needed for analysis.
This dissertation focuses on the development of polymer thin film cell coatings to
rapidly sort marker-positive cancer cells via lysis based negative depletion of all markernegative cells. Here, we demonstrate that primary antibodies bind specifically to cancer
cell surface markers, which through subsequent biotin/avidin interactions then direct the
site-specific binding of visible-spectrum photoinitiator species. Irradiation in the presence
of monomer and coinitiator is shown to crosslink a nanothin film around marker-positive
cells that specifically protects and stabilizes these cells during surfactant lysis. Chapter 2
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presents a more detailed background of cancer biology relevant to circulating tumor cells,
and an overview of the current technologies designed to isolate and detect these rare
cells. In Chapter 3, a background of the polymer materials is introduced as well as the
specific photochemistry reactions utilized in this work. In chapters 4 through 7, the main
projects of this work are presented. First, the chemical, structural, and selective
permeability properties of our thin film materials on cell substrates are investigated. Next,
a UV-photodegradable functionality is designed to allow for release of target cells after
isolation, and sorting from heterogeneous cell suspensions confirms the specificity of our
method. Due to the variability often seen in cancer phenotypes, we then offer a
quantitative and comparative analysis of a panel of markers implicated in metastasis.
Commonly studied breast and lung cancer lines are examined to provide reference and
guidance as to the quantity, and moreover density, of cancer markers available for
targeting. Lastly, we relate photoinitiator binding density to the yield of cells delivered
and determine a loading threshold for isolation.

3

1.1 Specific Objectives
The overall objective of this work was to design and implement surface-initiated polymer
coatings for protective isolation during lysis-based negative depletion. The specific
objectives of the four experimental chapters presented in this dissertation are shown
below:
1. Characterization of Molecular Transport in Ultrathin Hydrogel Coatings on
Cellular Substrates for Engineered Selective Permeability
a. Demonstrate successful and specific cell surface film coating
b. Analyze and describe the chemical and structural properties of polymer
coatings
c. Investigate the cell toxicity effects of coating formation
d. Develop Fickian model and determine macromolecular diffusivity within
PEGDA film coatings
2. Design and Development of Protective Polymer Coatings for Rapid High-Purity
Cancer Cell Isolation
a. Synthesize UV-degradable macromers and confirm structure
b. Demonstrate marker specific cell sorting in binary mixtures
c. Determine sorted cell purity after ASL sorting
d. Determine cell viability and capacity for proliferation of sorted
populations
3. Quantitative Investigation of Surface Receptor Expression Density For The
Isolation of Tumor Cells
a. Identify cancer-associated markers implicated in metastasis for analysis
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b. Describe non-small lung cancer and breast cancer cell morphology and
calculate diameter.
c. Determine specific fluorescent probe loading for all marker targeting
scenarios on cancer lines and normal human peripheral blood cells
d. Calculate loading densities for all marker targeting scenarios
4. The Role of Surface Receptor Density in Surface-Initiated Polymerizations for
Cancer Cell Isolation
a. Determine effect on isolated cell yield of incrementally varied
photoinitiator loading on A549 cells covalently tagged with sulfo-NHSbiotin
b. Compare isolation yield of covalent biotinylation to populations targeted
via primary antibodies binding epithelial and stem markers
c. Investigate gelation response in analogous protein microarrays
d. Determine lower threshold photoinitiator loading density required for
protective coating isolation
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Chapter 2: Relationship of CTC Isolation Technologies to Metastatic Cancer
Biology
2.1 Introduction
Recent evidence suggests a subpopulation of primary tumor cells acquire stemlike properties that permit the dissemination from the primary into the surrounding
stroma and sets the stage for metastatic spread. In contrast, current CTC isolation
methodologies are based on detecting cells based on the antigenic profiles found in the
original primary, which are largely epithelial. This disconnect highlights the need for a
greater appreciation of the biological drivers of metastasis in designing CTC detection
technologies. This chapter focuses on metastatic cancer biology that determines CTC
phenotype and provides perspective in light of the currently available CTC isolation
technologies.
2.2 Role of Epithelial-Mesenchymal Transitions in Metastatic Cancer
Numerous studies have reported epithelial-mesenchymal transitions are a
facilitator and driver of metastatic activity [17]. Recently, several underlying signaling
networks have been revealed to be extremely intricate, and eventually generate a
heterogeneous composition of cell phenotypes in the stromal environment and at distant
metastases. Further, EMT is highly active at both the primary invasive front and during
blood bourne metastasis where intervening treatment is perhaps most crucial for disease
management [1, 18]. These findings have highlighted the need for greater appreciation of
the biology in designing cell isolation methodology.
During tumor formation in a primary carcinoma, oncogenic changes in epithelial
cells lead to excessive proliferation, as well as angiogenesis and cell recruitment to fuel
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rapid growth [19]. During this initial stage of tumorigenesis, the malignant cells are
thought to retain much of their epithelial characteristics, including cell-cell junctions,
apical-basal polarity, and lack of motility [14]. However, as recruitment cytokines
emanate from the primary, the stromal environment begins to evolve and diversify with
the accumulation of support cells such as mesenchymal stem cells, endothelial
progenitors, and macrophages [20, 21]. This complex signaling landscape is believed to
play a prominent role in sparking aggressive and robust EMT programs in a certain
subset of primary cells that drive the subsequent stages of cancer progression [22].
Growth factors exchanged at the tumor-stroma interface such as PDGF, EGF, HGF, and
TGF-β have been shown to initiate pathways that induce transcription factors implicated
in EMT [1, 23, 24]. Notably, induction of Snail, Slug, ZEB1/2, Twist, and the Wnt/βcatenin pathway previously associated with wound healing and embryogenesis models
have all more recently been implicated in this cancer progression process [25, 26].
Epithelial surface proteins, particularly those involved in attachment to ECM are celljunctions, are downregulated such E-cadherin, αβ-integrins, and EpCAM [27]. The
marker E-cadherin especially has been widely studied in this context, and the functional
loss of this epithelial marker has become a hallmark of the EMT program. Accompanying
the repression of attachment proteins, mesenchymal traits begin to appear such as
restructuring of the cytoskeleton to favor a more motile and invasive cell, as well as
enhanced resistance to apoptosis, and loss of polarity [28]. Other stem-like molecular
features also appear such as matrix metalloprotease and N-cadherin expression that
allows for degradation of ECM and basement membranes and increased capacity for
migration necessary to enter the vasculature [27].
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Not surprisingly, evidence shows these stem-like tumor cells are highly enriched
at the invasive front of many primary carcinomas as depicted in Figure 2.1. Further,
these cells may even lead the way for intravasation of many other tumor cell phenotypes
arising from the same primary that otherwise may not have had the required invasive
attributes to accomplish the feat on their own [26, 29].
While we hypothesize that the mesenchymal transitioned tumor cells are the most
relevant and potent for disease progression, this could perhaps reconcile the observed link
between the detection of epithelial-like cells in circulation of metastatic patients and poor
prognosis in several current CTC isolation technologies. Largely, once tumor cells spill
into the bloodstream, little is known about the exact mechanisms that determine their
phenotype while in free circulation. Some evidence supports that a CTC is never truly
autonomous, but EMT signaling in the primary does stabilize the mesenchymal state for
transit such that it constitutively remains until signals favoring an epithelial phenotype
reverses the cell back to a more epithelial state, ostensibly at a secondary and distant site
(i.e. metastatic focus) [15, 30]. Further complicating the characterization of these stemlike CTCs, the Stott group recently managed to collect a small number of CTCs from
several metastatic breast cancer patients, and immunostained for both epithelial and
mesenchymal markers. The results suggest these cells as highly variable from patient to
patient, and even shows variable phenotypes within the same peripheral blood sample
[31]. Many cells expressed significant levels of both epithelial and mesenchymal
markers, suggesting an EMT phenotype in reality falls more on a continuum between the
two extremes. Collectively, these findings relating EMT to surface expression on CTCs
point toward the need for an isolation methodology capable of yielding viable and
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functional cells for further analysis to elucidate the mechanisms that shift or sustain CTC
phenotypes.
2.3 Current CTC Isolation Technologies
Given the significant progress made in revealing the underlying biological drivers
governing metastasis, the isolation technology community has been compelled to reassess
the fundamental bases and performance characteristics that will be needed to deliver a
reliable CTC sorting approach [32-35]. While some groups have had moderate success is
isolating CTCs based on physical properties such as size and membrane rigidity [36], the
most promising approaches by far have isolated CTCs based on recognition of surface
antigens. However, translating these for clinical use has remained challenging due to poor
sensitivity and biological specificity, largely because they target epithelial antigens.
Moreover, many assay protocols require fixation and often take an entire day of
processing, which precludes further functional analysis of these multipotent EMT cells
[9]. In the following sections, the current most common isolation methodologies will be
detailed, with context given to the particular challenges of metastatic tumor cell targeting.
2.3.1 Magnetic-Activated Cell Sorting
Magnetically-activated cell sorting, or MACS, relies on tagging antigen-positive
populations with magnetic particles by standard immunolabeling protocols [37].
Antibodies are conjugated to magnetic particles and incubated with a cell mixture where
they bind to a particular surface marker of interest [38]. Magnetic sorting can achieve its
highest throughput in a semi-batch mode, where after immunolabeling a cell mixture is
passed through a magnetized disposable column. The sensitized antigen positive cells are
retained by the column with varying affinity while all other cell populations not
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sensitized by immunomagnetic labeling pass through the column readily and are
discarded. The magnetic field is removed, and through subsequent rinsing steps the
antigen-positive cells are removed and collected from the column [39]. The main
advantages of MACS is in its high throughput capabilities and little sterilization
requirements because the column is typically single-use. In evaluating the efficacy of
MACS in circulating tumor cell detection applications, even advanced MACS systems
only achieve ~50-75% purity [34] , which is insufficient given the extreme rarity at which
CTCs exist in circulation (~1 per million).
2.3.2 Fluorescence-Activated Cell Sorting
Fluorescence-activated cell sorting (FACS) has existed as a concept for cell
analysis for several decades and is based on labeling antigen-positive cells with
fluorophores conjugated to antibodies. Flow cytometry is used to measure the cell
fluorescence due to antibody binding, size, and granularity, and thresholding is imposed
to collect target cells based on marker expression [40]. Purities attained by FACS are
often greater than 99%, but because microfluidics are used to hydrodynamically focus
individual cells during sorting, this high purity comes at the cost of extremely slow
sorting rates [41, 42]. Additionally, FACS has the capability of analyzing several
fluorescent signals simultaneously with multiple-laser configurations, representing a key
advantage in analyzing complex protein interactions. Flow sorters are also prohibitively
costly (~$500,000) to many laboratories, and require lengthy sterilization procedures to
flush contaminates from fluidic lines, and peristaltic pumps need to be routinely
calibrated to ensure measurement accuracy. In all, due to its reliance on microfluidics,
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FACS inherently cannot provide rapid and cost effective sorting for large-scale CTC
detection and isolation.
2.3.3 CellSearch System
To date, only one CTC isolation technology is clinically validated by the FDA
called CellSearch, designed by Veridex (Raritan, NJ), which involves enrichment with
immunomagnetic beads against EpCAM followed by immunofluorescent labeling and
analysis to further confirm the epithelial phenotype (DAPI+, CK+, CD45-) of the
enriched population. Staining with DAPI ensures the detected event is a nucleated cell,
while staining for cytoplasmic cytokeratins is a secondary measure for an epithelial cell.
Finally, positive detection also requires the cell event to be negative for the leukocytecommon antigen CD45. Using this definition of a CTC, it was established that a count of
≥5 of cells per 7.5ml peripheral blood that met the thresholding criteria correlated with a
statistically significant drop in prognosis in breast, prostate, and colon cancers [8, 9].
CellSearch systems have been the most commonly employed CTC isolation and
enumeration methods, however have not incorporated into standard treatment regimens
because of widely reported low sensitivity resulting in considerable false negatives in
metastatic patients as well as low purity of isolated cells. As detailed above, it is
suspected that the poor performance of CellSearch is due to variability in antigen
expression from EMT processes, such that the most metastatic cells have little to no
epithelial expression and therefore go unnoticed as false negatives when employing the
CellSearch platform [4, 12]. Further, the FDA validated CellSearch protocol requires
fixation and permeabilization of the cell samples, which presumably improves
consistency and reproducibility, yet does not yield viable and functional cells post-
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processing. We hypothesize that the isolation of biologically functional CTCs for
downstream characterizations is critical for linking the observed EMT processes with the
ultimate fate of a CTC, and for developing a fluid biopsy approach with greater
prognostic capacity.
2.3.4 Microfluidic Approaches
More recently, groups have worked toward designing CTC isolation methods
capable of delivering viable cells that use microfluidic channels to separate and capture
CTCs [35]. For metastatic breast cancer, cell suspensions are flowed into microfluidic
devices containing reservoirs that feature arrays of micro-posts covalently functionalized
with antibodies cocktails – typically a combination of EpCAM, HER2, and EGFR [4345]. These antigen-selective methods have exhibited moderate purity and capture
efficiency. Later generations of these devices have begun to appreciate the dynamic and
seemingly unpredictable nature of CTC phenotypes, and take a more unbiased and
agnostic approach to enrichment by negatively depleting CD45+ cells by magnetic
separation in microfluidic channels to yield cells unmolested by sorting methodology
[46]. While these creative approaches have yielded intriguing results that will
undoubtedly instruct future generations of isolation technology, they suffer critically
from low throughput at approximately 3 mL processed per hour [45]. Microfluidic
channels inherently introduce high levels of shear forces that prevent the increase of fluid
flow rates to practical levels, and require the need for careful optimization so fluid shear
does not exceed the electrostatic force of antibody capture. These constraints ultimately
result in an assay that would require a day or more to isolate a population of CTCs
sufficient for immediate characterization.
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2.4 Conclusions and Perspectives
Here, the biology of cancer metastasis has been discussed, as well as the
limitations of current CTC isolation approaches. In the context of sorting rare stem-like
populations, these cells purportedly exist in a dedifferentiated state that can respond to a
multitude of lineage-specific, directing stimuli [47]. Therefore, we submit that not only
does a CTC sorting method need to yield functional cells, perform with high specificity
and purity, but also be a high-throughput and rapid technique to successfully isolate these
stem-like populations for analysis.
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Figure 2.1: Schematic depicting invasion of mesenchymal-transitioned cells leaving the
primary tumor site. From Kalluri & Weinberg (2009) [1].
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Chapter 3: Hydrogel Polymerization Approaches to Cellular Encapsulation and
Surface Modification
3.1 Introduction
In the past several decades, the use of synthetically derived polymeric materials
has revolutionized the field of medicine, particularly for targeted therapy and tissue
regeneration. Hydrogel polymers allow remarkable versatility; they can be tailored to
possess a wide array of functional characteristics that make them well suited as a medium
in biomedical settings [48, 49]. This chapter will focus on the polymerization of
hydrogels as a scaffold for cell encapsulation. First, the chemical and structural
characteristics of hydrogels will be introduced in the context of cell encapsulation.
Microencapsulation strategies will be discussed with perspective on the effect of
encapsulation environment on permeability and mass transfer to the cell surface. Next,
photoinitiated free radical polymerization will be examined as a route to hydrogel
formation, with particular emphasis on the eosin Y photoinitiation system, which is used
throughout this dissertation. Lastly, we will examine surface initiated polymer-based
amplification as a method to form nanometer-scale hydrogel films specifically at sites of
protein expression.
3.2 Hydrogel Properties
Synthetic hydrogels have long been studied for the protection of biological
species in vivo [50]. Hydrogels for cell encapsulation are typically covalently crosslinked
[51]. The most definitive property of hydrogels is the ability to absorb water and swell
and remain stable and water-insoluble, often to several fold greater sizes that the
dehydrated states [52]. This swelling occurs due to hydrogen bonding and electrostatic
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interactions between water and the crosslinked structure, such that water is
thermodynamically favored to infiltrate the porous material. In applications in aqueous
cell media settings, oxygenated water and other small molecules can readily permeate to
and from the cell surface while the cell itself stays protected and occluded for large
molecular structures. This allows cells to remain encapsulated for long periods of time
while retaining high viability [53, 54].
One particularly advantageous capability is the polymerization of hydrogel
materials directly around cells from a monomeric precursor solution. This allows one to
carefully tune and tailor the properties of the eventual 3D material. Scaffold geometry
and material thickness is an important design consideration and can be modified
depending on the polymerization method employed. Mechanical properties can also be
tuned with the monomer chemical composition and concentration. Crosslinked hydrogels
consist of a porous mesh structure with void space between crosslinks, which allows for
significant movement and flexing under mechanical strain. Many groups have shown that
the mechanical performance of hydrogel is predictably controlled to mimic that of
biologically derived tissue depending on the monomer, crosslinking density, and
molecular weight between crosslinks (MWBC) [55-57]. Hydrogels can been designed to
resemble a variety of complex tissues at a wide range of length scales from extracellular
matrices, to individual cells, to whole organs [58, 59].
These parameters (monomer concentration, crosslinking density, MWBC, mesh
size) are also significant determinants of the permeability of hydrogel scaffolds. For
homogenously crosslinked hydrogels, smaller MWBC and mesh size or higher
crosslinking density will generally result in lower permeability [60-62]. Tailoring the

16

selective permeability of hydrogel encapsulation environments is critical for many
applications. Selectivity based on sized can prevent large macromolecules such as host
antibodies and immune cells from penetrating the hydrogel architecture while allowing
smaller growth factors to freely penetrate. Cruise et al. has shown in bulk crosslinked
PEG-diacrylate membranes that PEG-diacrylate with MWBC of 2kDa, vitamin B12 (1.2
kDa) was able to permeate the material while globular proteins such as myoglobin
(16.7kDa) and larger showed no detectable diffusion [60]. Membranes composed of
20kDa PEG-diacrylate, however, readily allowed both vitamin B12 and myoglobin,
showing the effect of MWBC on the membrane permeability. Reinhart et al. developed a
model for swollen polyvinyl alcohol hydrogels that relates solute diffusivity to these
structural parameters for several biomolecular permeants, which further suggests the
direct positive correlation between MWBC and diffusivity [63, 64]. Increasing the crosslinking density, by either increasing the monomeric concentration in solution, longer
polymerization reaction times, or increased reaction kinetics, can also reduce the
permeability of hydrogel membranes. More complete crosslinking (i.e. unreacted pendant
monomer ends) reduces the mobility and access of solutes as they navigate through the
material via passive diffusion.
3.3 Hydrogel Chemical Composition
Many monomer chemistries have been explored for hydrogel cell encapsulation
and are selected with consideration to each particular application [65]. Both naturallyderived and synthetic polymers have been investigated. Naturally-derived hydrogel
materials typically offer innate compatibility with the encapsulated cells of interest as
they are often derived from ECM scaffolds that would surround these cells
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physiologically. They include materials composed of collagen, gelatin, fibrin, and
chitosan typically covalently modified with vinyl moieties to allow for radical
polymerization [66]. While these materials have shown successful application in tissue
engineering to encapsulate chondrocytes [67], cardiomyocytes [68], and mesenchymal
stem cells [69] among many others, they are often impractical to utilize due to their
heterogeneous and complex nature. Gelation kinetics, mechanical performance, and
diffusivity are often difficult to predict and control for these materials. Alternatively,
synthetic monomeric compounds are typically more monodisperse and predictable and
offer high control over gelation rates and consistent mechanical performance. Synthetic
materials that have been utilized for cell encapsulation include polyethylene glycol
(PEG), polycaprolactone (PCL), polyvinyl alcohol (PVA), poly lactic acid (PLA), and
poly lactic-co-glycolic acid (PLGA) [70]. Of these, PEG has been by far the most widely
investigated material for encapsulation. PEG macromers are typically functionalized with
acrylate groups to enable radical polymerization in solution, and are typically water
soluble. PEG hydrogels also show high structural and chemical stability [71]. While the
ester bond within acrylate backbones of PEG hydrogels is susceptible to hydrolytic
degradation, this occurs at very slow rates. Further, PEG has been widely shown to be
biocompatible in vivo and exhibit low encapsulated cell toxicity [53]. Many acrylated
PEG macromers with excellent monodispersity are also commercially available,
providing a convenient medium with which to design and scale up many cell
encapsulation technologies with predictable gelation kinetics and mechanical properties.
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3.4 Microencapsulation and Hydrogel Geometry Effects on Mass Transfer
While macroscale cell-laden hydrogel scaffolds have advanced numerous
applications in tissue engineering and regenerative medicine , many researchers have
recognized the potential advantages of microengineered hydrogel architectures in certain
applications [51, 72-74]. Microencapsulation is the strategy to coat individual cells or
small groups of cells with porous scaffold material with thicknesses typically a few
hundred micron or less. Minimizing the coating thickness, and thus the diffusion length,
would improve the transport of low-molecular weight nutrients and cellular waste
components while still preventing large immune molecules from reaching the cell
surface. Because of the increased surface area to hydrogel volume ratio, the overall mass
flow rate can increase per cell. In the field of islet encapsulation for insulin therapy,
Canaple et al. showed an improvement in diffusion leading to increased long term
viability and cellular function for islets encapsulated in 400 μm thick coatings as
compared to 1000 μm [75]. Further, for coatings designed to be degradable
(enzymatically or photocleavage), the volume of material to be degraded is minimized.
Several

methodologies

have

been

investigated

for

hydrogel

cell

microencapsulation. Mumaw et al. encapsulated small groups of mesenchymal stem cells
in PEG-diacrylate (10kDa) by oil-aqueous phase microemulsion and subsequent UVrange photopolymerization for bone grafting therapy [76]. Microcapsules were
approximately 100 μm in diameter, and showed high long term viability and cell
proliferation. Photolithographic techniques can also be useful in forming microstructures
with high spatial resolution. Koh et al. showed PEG microstructures could be patterned
down to 50 μm containing as few as one 3T3 murine fibroblast per structure [77]. Flow
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microfluidics and combined lithographic techniques have also been explored that can
generate well defined and gradient microencapsulation geometric shape on the order of
tens to hundreds of microns in thickness [78, 79]. Cruise et al. showed the capability of
encapsulating individual porcine islets with visible-light photopolymerization of PEGdiacrylate coatings after soaking cells in eosin Y (type II photoinitiator) solution [54, 80].
This technique allowed for thicknesses down to a few hundred microns, and showed long
term cell survival and insulin secretion in vivo after xenograft transplantation.
3.5 Approaches to Photoinitiated Polymerization of Hydrogels
One of the most commonly employed methods of forming hydrogels for cell
encapsulation is through radical photopolymerization. This method offers many practical
advantages

for

hydrogel

formation

over

other

types

of

polymerization.

Photopolymerization allows for rapid and predictable gelation from an aqueous monomer
precursor solution at room temperature, often at buffered, pH balanced conditions [81,
82]. Initiating light can typically be delivered uniformly throughout hydrogel systems
creating highly homogenous materials. Further, by controlling where and when light is
exposed, one has excellent spatial and temporal control over the reaction, allowing for
complex material geometries or crosslinking gradients to be engineered into hydrogel
systems if desired. Both visible and UV spectrum range photoinitiated systems have been
described, where light sensitive compounds are excited to generate radicals to crosslink
the hydrogels from the precursor solution. Water-soluble monomer units are often vinyl
or acrylate functionalized, enabling this free radical polymerization process [70]. In the
following sections, two types of photoinitiator compounds (type-I and type-II) will be
introduced that have been utilized for hydrogel formation.
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3.5.1 Type-I Photoinitiators
Type-I photoinitiation involves the photoinduced cleavage of initiators to produce
free radical reaction products, which then propagate crosslinking of monomers in
solution. While these polymerizations are complex reactive processes, a typical
mechanism can be written for type-I photopolymerization as shown in Scheme 3.1.
During the initial phase of the polymerization, the reaction rate and double bond
conversion increase as radicals are generated at a rate such that reaction dominates the
process and monomer crosslinking propagates. Once the gel point is reached, diffusion
begins to control the process as radical mobility is decreased leading to termination of
radicals as nearby monomer ends react. These photocleavage type initiators are
commonly employed in dental resins and simple tissue engineering scaffolds, where rapid
gelation and homogenous crosslinking is desired [2]. Widely employed type-I
photoinitiators for polymerization include the acetophenone and hydroxyalkylphenones
chemical families, mostly sensitized with irradiation light below 400 nm [70]. One
particular concern for hydrogel cell encapsulation is water solubility and cell cytotoxicity.
Because these compounds are mostly comprised of alkyl groups and aromatic rings, they
typically display limited water solubility making implementation in cellular systems
difficult. Of type-I photoinitiators, lithium acylphosphinate (LAP), 2-hydroxy-1-[4(hydroxyethoxy)phenyl]-2-methyl-1-propanone

(Irgacure

2959),

2,2-dimethoxy-2-

phenylacetophenone (Irgacure 651), and 1-hydroxycyclohexyl-1-phenyl ketone (Irgacure
184) have commonly been employed for hydrogel formation [81, 83]. Williams et al.
formed cell-laden hydrogel systems with the listed Irgacure compounds in a comparative
toxicity study and showed that all were generally significantly cytotoxic, with Irgacure
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2959 showing moderate cell compatibility for a limited number of cell lines [84]. Another
practical concern is that these compounds are generally unable to achieve regeneration
after cleavage and must be used at relatively high concentrations, hindering their
application to coating individual cell surfaces by interfacial polymerization.
3.5.2 Type-II Photoinitiators
In type-II polymerization, often referred to as dye photosensitizer systems,
photosensitive compounds absorb irradiation light energy, enter an excited state and
abstract a hydrogen molecule from a nearby donor coinitiator which then initiates
crosslinking of monomer acrylic groups. Scheme 3.2 shows a typical reaction mechanism
for this process:
While this system requires a more complex two-component initiation step, the
propagation and termination steps occur similarly as to type-I systems. Common type-II
photoinitiators include benzophenone, camphorquinone, xanthene derivatives, and
thioxanthones [70, 85, 86]. For cell encapsulation, hydrogen donor coinitiators have
typically been tertiary amines. Several xanthene derivatives absorb in visible range,
affording the use of more cell compatibility lamp outputs than the typical UV range
lamps [83]. Of these, eosin Y and fluorescein have been commonly investigated as typeII initiators and absorb around 450-550 nm [87]. The eosin system in particular shows
sufficiently fast gelation and excellent cytocompatibility for cell encapsulation utilized in
tandem with tertiary amine coinitiators [80].
3.5.3 Eosin Y Photoinitiation System
As this dissertation utilizes primarily eosin Y as a type-II photoinitiator, this
section will expound on the previous work with this specific system. Eosin Y has been
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used with a tertiary amine coinitiator triethanolamine (TEA) to form crosslinked hydrogel
networks in aqueous media [88-90]. In our studies, an isothiocyanate group is coupled to
eosin to form eosin-5-isothiocyanate (EITC), which negligibly affects the absorbance
properties. A plot of extinction coefficient dependency on wavelength for EITC is shown
in Figure 3.1. In eosin/TEA systems, eosin is irradiated by visible green light typically in
the range of 500-550 nm, corresponding to the shown range of absorptivity. Eosin
molecules are excited to a triplet state, which is quenched by the tertiary amine TEA
which acts as a hydrogen donor. Proton transfer occurs, which yields a protonated eosin
radical and a neutral α-aminoalkyl radical. This amine radical then acts to initiate
polymerization of nearby carbon double bonds [87, 91].
Encinas et al. has demonstrated the rate of eosin/TEA system in the
polymerization of acrylamide in water is largely unaffected by pH changes in the range of
3 to 10 [87]. Further, this work showed the efficiency of photoinitiation at 20mM TEA of
approximately 45-55% of triplets quenched to form active amine radicals, which is well
correlated with trends in the initial polymerization rates of other xanthene dyes. Avens et
al. presented evidence of a cyclic photoinitiator regeneration mechanism that enables
eosin to overcome high concentrations of polymerization inhibitors in the reaction
environment, whereas the cleavage-type photoinitiator Irgacure-2959 was completely
inhibited in this setting [86]. These data suggested many dye photosensitizer systems
benefit from cyclic regeneration to achieve overall improved polymerization efficiency.
Kizilel et al. demonstrated the eosin/TEA system in surface-mediated polymerization,
where eosin molecules where covalently functionalized on glass substrates, and surface
grafted thin films of PEG-diacrylate were analyzed both chemically and visually by
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microscopy [85]. Here, as commonly employed with similar systems, 1-vinyl-2pyrrolidinone is included in the monomer formulation as a polymerization accelerator.
The performance and significant parameters of the surface-mediated eosin system was
also investigated by Avens et al. for both PEG-diacrylate and acrylamide formulations
[92]. At eosin functionalization densities greater than 200 molecules/μm2, the acrylamide
system generated films >600 μm and the PEG-diacrylate system generated films of
approximately 150 μm. It should be noted that acrylamides have shown to be highly toxic
in cell environments whereas PEG-diacrylate is generally non-toxic. This work also
showed the phenomenon of a lower photoinitiator surface density threshold for this
interfacial system, below which radical generation was no sufficient to crosslink any
detectable film.
3.6 Surface-Mediated vs. Bulk Polymerized Hydrogels
Differences arise between bulk and surface-mediated polymerization settings in
both design considerations and the eventual hydrogel structure. A bulk crosslinked
system refers to polymerizations in which photoinitiator is dissolved and distributed
indiscriminately throughout the precursor solution, and upon irradiation the
polymerization reaction proceeds uniformly throughout the gelling material irrespective
of location. In surface-mediated or interfacial polymerization, photoinitiator molecules
are adsorbed to a surface or interface, and remain localized at this surface throughout the
reaction. Type-II photosensitizers are often employed in applications for surfacemediated hydrogel systems and can leverage cyclic regeneration and achieve appreciable
polymerization efficiencies, whereas cleavage-type compounds can only generate an
amount of radicals on the same order as the initially adsorbed surface density of
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molecules. Competing diffusive-reactive phenomena play a large role in the overall
polymerization performance of surface-mediated systems, as coinitiator molecules in the
immediate vicinity of the photoreactive surface are radicalized [93]. These free radicals
are able to diffuse away from the reactive surface, so radical generation must be
sufficient to overcome diffusion of radicals to reach the gel point for a continuously
interlinked polymer network to form. While bulk crosslinked systems typically display
homogenous crosslinking density, this phenomenon in surface-mediated systems leads to
a gradient, with crosslinking density decreasing at increasing distance from the reactive
surface as shown in Figure 3.2. As the gel point is first reached near the photoinitiatorprimed surface, radical mobility falls significantly and leads to overall decreasing free
radical concentration a further outward distances, leading to the gradient in crosslinking
density. This is an important consideration in hydrogel structure design, particularly in
applications where permeability is a critical parameter as the hydrogel mesh size cannot
be assumed to be constant through the entire material.
3.7 Polymer-Based Amplification
The work in this dissertation leverages the efficiency of the eosin
photopolymerization system to generate polymer thin films specifically at sites of protein
recognition by adapting the recently described technology of polymer-based
amplification (PBA), as shown in Figure 3.3 [94]. PBA was developed as an inexpensive
diagnostic platform to generate an easily detectable signal prompted by recognition of
biomolecules at extremely low concentrations on printed microarrays. Other signal
amplification approaches such as tyramide-signal amplification are highly sensitive to
variations in enzyme activity and preparation conditions that often lead to inconsistent
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results and high nonspecific signal. In contrast, PBA has shown to generate predictable
signal responses with high signal-to-noise [95]. Specific antibodies or anti-sequence
oligonucleotides are contacted with microarrays printed with analyte solution.
Photoinitiators, typically eosin or fluorescein, are covalently labeled directly on these
molecules or on secondary

biorecognition molecules that bind to analyte.

Photopolymerization is then initiated in the presence of acrylic monomer and tertiary
amine coinitiator to generate a crosslinked polymer response at sites of analyte
presentation. PBA has been shown to generate polymer films in response to as low as
zeptomolar analyte concentrations in seconds to minutes [96]. Applications have been
developed that utilize initiating visible range light from broad spectrum mercury lamps,
collimated LEDs, and lasers. Monomer formulations studied for use in PBA include
acrylamide/bisacrylamide and polyethylene glycol diacrylate, both including 1-vinyl-2pyrrolidinone as an accelerator [92]. Because this reaction has been shown to be inhibited
by oxygen, printed chips or slides are typically purged with inert gas (nitrogen or argon)
during photopolymerization to remove oxygen from the reacting system. For
visualization of analyte recognition, polymer films are either colorimetrically stained
post-polymerization or loaded fluorescent imaging nanoparticles that are physically
entangled in the film crosslinking during initial photopolymerization. Notably, the signal
intensity of loaded fluorescent nanoparticles has been shown to trend linearly with film
thickness in PBA applications [97].
PBA has been adapted as a diagnostic platform to detect several types of analytes.
Hansen et al. (2007) showed a PEG diacrylate film response to detect a short
oligonucleotide sequences [98]. Hansen et al. (2009) then progressed DNA detection with
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the specific detection of KRAS sequence variants [99]. Antibody based detection has also
been investigated, where biotin-α-goat IgG is printed on glass array chips [95]. Eosinlabeled streptavidin then bonds to sites of biotin functionalization and initiates
fluorescent PBA with visible light and monomer. Here, fluorescent PBA is shown to
achieve 100-fold greater signal-to-noise than samples stained with traditional fluorescent
probe approaches. Fluorescent PBA has also been previously demonstrated for enhanced
histochemical staining on fixed mammalian cells [100]. Nuclear pore complex, vimentin,
and von-Willebrand factor proteins are targeted with primary antibodies in permeabilized
lung fibroblasts, which direct streptavidin-eosin binding and fluorescent PEG-diacrylate
film formation. PBA is shown to provide enhanced signal-to-noise immunostaining
compared to parallel stained samples with streptavidin-FITC and tyramide signal
amplification approaches.
3.8 Conclusions
Hydrogels offer a cell compatible material for covalent microencapsulation. By
dispersing cells in a monomer precursor solution, hydrogel can be formed by
photopolymerization in situ around individual cells. Further, by tuning the molecular
weight of monomeric units and crosslinking conditions, hydrogel materials can be
engineered to act as size selective, semi-permeable membranes that occlude large
biomolecules while allowing free passage of small compounds. Lastly, eosin-mediated
polymer-based amplification provides an efficient and convenient approach to forming
nanothin films specifically at sites of surface protein expression.
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I  2R•
R• + M  M•
Mn• + M  Mn+1•
Mn• + Mm•  P
Scheme 3.1: General mechanism for Type-1 (photocleavage) polymerization. Adapted
from Ifkovits & Burdick, 2007 [2].

I  I*
I* + R  I+• + R•
R• + M  M•
Mn• + M  Mn+1•
Mn• + Mm•  P
Scheme 3.2: General mechanism for Type-II photopolymerization.
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Figure 3.1: Plot of extinction coefficient dependency on wavelength of eosin
isothiocyanate in water. Calculated from UV-Vis absorbance spectra.
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Figure 3.2: Comparison of crosslinking density and mesh size for bulk and surfacemediated polymerization schemes.
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Figure 3.3: General schematic of fluorescent polymer-based amplification.
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Chapter 4: Characterization of Molecular Transport in Ultrathin Hydrogel
Coatings on Cellular Substrates for Engineered Selective Permeability
This work studies a surface-initiated, nanoscale hydrogel coating on mammalian
cells for tunable, size-selective permeability. Coatings composed of PEG diacrylate of
molecular weight 575 Da and 3500 Da were studied by tracking the transport of
fluorescently-labeled dextrans across the coatings. The molecular weight of dextran at
which the transport is blocked by these coatings are consistent with cutoff values in
analogous bulk PEG materials. Additionally, the diffusion constants of 4 kDa dextrans
across PEG 575 coatings was lower than across PEG 3500 coatings and these trends and
magnitudes agree with bulk scale models. Further, this study supports the adaptability of
this coating strategy for a lysis-based isolation methodology, where antigen presenting
cells are coated with ultra-thin films which impart protection during exposure to SDS
micelles. The data suggest these hydrogel coatings will be fundamentally capable of
excluding SDS micelles that are several orders of magnitude larger than the dextran
molecules shown to be excluded. The chapter presented here is adapted with minor
modifications from work previously published:
Jacob L. Lilly, Gabriela Romero, Wejie Xu, Hainsworth Y. Shin, Brad J. Berron.
Characterization of Molecular Transport in Ultrathin Hydrogel Coatings for
Cellular Immunoprotection. Biomacromolecules. 27;16(2):541-9, 2015.
4.1 Introduction
Synthetic hydrogels have long been studied for the protection of biological
species [53, 66]. Hydrogel architectures have been designed for use in applications
ranging from drug delivery particles and scaffolds to large tissue grafts for implantation
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[101-103]. For cell replacement therapies, exogenous cells have been encapsulated in
hydrogels to physically prevent the host’s antibodies from recognizing the foreign cells
while allowing the free transport of water and nutrients throughout the porous mesh [50,
70]. This strikes a careful balance between the transport of the unwanted high molecular
weight materials and the beneficial low molecular weight materials. The size selectivity
of the hydrogel is a property of the polymer mesh structure, where large molecular
weight materials do not penetrate appreciably into the hydrogel.
We

seek

to

encapsulate

mammalian

cells

in

suspension

by

the

photopolymerization of ultra-thin hydrogel films for designed semi-permeable barriers to
prevent large molecules from reaching the encapsulated cell surface. Our approach is
based on surface-mediated polymerization of nanoscale films (Figure 4.1), where
photoinitiator is grafted to the outside of a cell in extremely low concentrations [95]. In
these conditions, the photoinitiator content is reaction limiting, and the subsequent
growth of polymer is restricted to a thin film at the cell surface [104]. Upon introduction
of a monomer precursor solution containing triethanolamine (coinitiator), the initiatorprimed cells are exposed to green light, and a free-radical, interfacial polymerization
process results [85]. We expect this technique will be capable of completely coating cells
for size selective control of materials to the cell surface. Prior calculations on 100 µm and
1 mm thick analogues of these materials describe a mesh size of 2-5 nm which prohibits
IgG diffusion, yet readily permits diffusion of low MW materials [60, 105]. Critically,
the diffusion properties of these ultra-thin films on cells have yet to be measured.
This chapter directly studies the chemical, physical, and transport properties of
nanoscale hydrogel films on a cellular surface. For experimental simplicity, we examined
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coatings on the surface of Jurkat cells, an immortalized, robust, and easily cultured T
lymphoma cancer cell line. The chemistry of the coatings was directly analyzed with
Raman microscopy showing shifts consistent with the localization of PEG coatings on the
cell’s surface. The coatings were imaged by scanning electron microscopy, supporting a
surface morphology distinct from native cells and consistent with control samples of
surface-initiated polymer thin films.
While structure and chemical characterizations provide valuable insight to the
film properties, the most definitive measure of an encapsulation technique is the
capability to exclude large biomolecules from penetrating the coating while allowing the
free transport of low molecular weight nutrients to retain high viability. Extrapolation of
transport properties of a bulk hydrogel to thin film geometries is commonplace, yet
fundamentally assumes identical and uniform cross-linking in the film [60]. For the
surface-mediated, free radical polymerizations employed here, a gradient of double bond
conversion arises during the photoreaction yielding a film with non-uniform
microstructure [93]. To this end, we measured these transport properties directly on a
coated cellular substrate for measurement of film properties directly on biological
supports without any extrapolation of bulk transport properties. Our findings support the
current practice of extrapolating bulk hydrogel transport properties to nanoscale coatings,
where minimal differences were observed between our diffusion constants and those of
the analogous bulk materials. These findings support the potential use of ultra-thin
coatings, such as those presented here, for tunable, size-selective membranes effectively
halting transport of large molecular weight materials above the critical values observed in
bulk hydrogel systems.
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4.2. Materials and Methods
4.2.1 Materials
A Jurkat cell line (clone E6.1) was purchased from ATCC. RPMI-1640 with Lglutamine and Dulbecco’s Modified Eagle’s Medium were both purchased from Corning
Cellgro, and supplemented with fetal bovine serum (Gibco) and Streptomycin/Penicillin
solution (Thermo Scientific). Deionized and ultra-filtered water was purchased from
Fisher Scientific. Eosin-5-isothiocyanate, poly(ethylene glycol) diacrylate (Mn=575), 1vinyl-2-pyrrolidinone, poly-L-lysine (PLL), bovine serum albumin, HEPES-KOH buffer
solution, potassium acetate, magnesium acetate, and fluorescein isothiocyanate-dextran
(FD) with MW of 4, 10, and 20kDa were purchased from Sigma-Aldrich. Poly(ethylene
glycol) diacrylate was passed over a MEHQ removal column twice prior to use.
Phosphate buffered saline 10X solution, nile red carboxyl-terminated 20 nm Fluosphere
nanoparticles (NPs), and calcein AM were purchased from Life Technologies.
Biotinylated monoclonal mouse IgG anti-human CD45 was from BD Pharminogen,
monoclonal mouse IgG anti-human nuclear pore complex was from Covance,
biotinylated goat IgG anti-mouse IgG was purchased from Vector Labs. Lyophilized
streptavidin, biotinylated bovine serum albumin and 4',6-diamidino-2-phenylindole
(DAPI) were purchased from Thermo Scientific. Poly(ethylene glycol) diacrylate (Mn =
3500) was purchased from Jenkem Technology. Triethanolamine and Triton X-100 were
purchased from Acros. Paraformaldehyde (16%, EM grade) was purchased from Electron
Microscopy Sciences. Sucrose was obtained from MP Biomedical. Calcein/ethidium
homodimer-1 Cytotoxicity kit was purchased from Life Technologies.
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4.2.2 Preparation of Polymer Encapsulated Cells in Suspension
The T lymphoma Jurkat cell lineage was cultured in RPMI-1640 supplemented
with 10% fetal bovine serum (FBS) and 1% streptomycin/penicillin at 37 °C and 5%
CO2. The cell culture was maintained at approximately 0.5-1x106 cells/ml. A sample of
1.5 x 106 Jurkats was washed once with phosphate buffered saline (PBS) supplemented
with 3% FBS (PBS/FBS). Between each rinsing step, the cells were pelleted by
centrifugation at 300xg and 4°C for 5 minutes. The pellet was resuspended in 20 μL
biotinylated mouse anti-human CD45 in 100 μL PBS/FBS per 106 cells, gently vortexed
and incubated at 4°C for 40 minutes. Then, the pellet was resuspended in 25 μg/mL
streptavidin-eosin isothiocyanate (SA-EITC) in PBS/FBS, gently vortexed and incubated
for 30 minutes at 4°C. The SA-EITC was synthesized and purified according to a
previously reported protocol [98]. After incubation and rinsing with PBS/FBS, the cells
were dispersed in 300 μL of a monomer precursor solution consisting of 420 mM
poly(ethylene glycol) diacrylate (Mn = 575) (PEGDA 575), 21 mM triethanolamine
(TEA), 35 mM 1-vinyl-2-pyrrolidinone (VP) in PBS. In fluorescent imaging studies, 0.05
wt % nile red 20 nanometer fluorescent NPs were also included in the precursor solution.
Just before introduction to cells, the monomer solution was bubbled with ultra-pure N2
for approximately 5 minutes to remove oxygen (polymerization inhibitor). The
monomer/cell solution was gently vortexed and then pipetted onto a standard microscope
slide in a Chip-clip chamber well (Whatman). The Chip-clip was then placed in a clear
plastic bag and purged with ultra-pure N2 for 5 minutes. Then, a photopolymerization
reaction was initiated with an LED lamp emitting collimated 530 nm light, adjusted to an
intensity of 30 mW/cm2 for 10 minutes. (See Appendix A-1 for example of general
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photopolymerization setup) The Chip-clip was then removed from the purged bag and the
cells were removed from the slide with a shearing stream of PBS and washed two times
to remove any unreacted monomer solution species and free nanoparticles.
4.2.3 Raman Microscopy Analysis
To probe the surface chemistry of coated cells, first a PEGDA coated Jurkat cell
sample was prepared as described, except that Jurkats were fixed in 1%
paraformaldehyde for 10 minutes and rinsed three times in PBS, and then incubated in
PBS + 3% FBS for 30 minutes before primary antibody incubation. After rinsing the
coated cells, the supernatant was removed and the cell pellet was pipetted onto a clean
microscope slide and allowed to dry for 2 h. For a native cell control, 106 cells were
centrifuged and rinsed once with cold PBS and then fixed in 1% paraformaldehyde for 10
minutes. The cells were then rinsed 3 times in cold PBS. After the final rinse, the
supernatant was removed and the pellet was gently pipetted onto a clean microscope
slide. A bulk polymer control was prepared by first reacting 25 μg/mL SA-EITC in PBS
on an epoxy-functionalized slide inserted in to a Chip-Clip for 1 hour. After rinsing, 300
μL of monomer solution was pipetted into the Chip-Clip well. The Chip-Clip slide was
purged and irradiated with an LED lamp for 10 minutes, emitting 530 nm light at an
intensity of 30 mW/cm2. The slide was then washed with deionized water and allowed to
dry overnight. The samples were analyzed using a Thermo Scientific DXR Raman
microscope. The 532 nm laser and 100X objective were used for all spectral
measurements. The pinhole aperture was set to 25 μm, corresponding to a focal spot of
approximately 1 μm diameter. Spectra were recorded between 300 and 3600 cm-1 at a 5
cm-1 spectral resolution. The system was calibrated to the spectral line of crystalline
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silicon at 520.7 cm-1. For a spectral measurement, the microscope was focused on the
surface of a sample and at least 8 scans at each spot were used to reduce the spectral
noise.
4.2.4 Scanning Electron Microscopy
For SEM analyses, a control Jurkat sample was fixed in 1% paraformaldehyde for
10 minutes, rinsed twice in PBS, and placed on a PLL coated microscopy slide for
electrostatic attachment. A coated sample was prepared with paraformaldehyde fixed
cells, as before. Samples were dried overnight before analysis. The sample slides were
then coated in gold/platinum by standard techniques and micrographs were taken with a
Hitachi S-4300 scanning electron microscope (Hitachi, Japan). The working distance was
set at 15 mm with an accelerating voltage of 5.0 kV.
4.2.5 Viability Assays
Cellular viability was measured by a calcein assay. Cells were rinsed once with
PBS, then the cell pellet was resuspended in cold PBS 1X with 50 nM calcein AM and
incubated at room temperature protected from light for 15 minutes. After incubation, the
cells were loaded into a BD Accuri C6 flow cytometer (Becton Dickinson), and run was
performed at a medium fluidics rate to a total event count of 100,000.
4.2.6 Surface-Initiated Polymer Microarrays
Epoxy-functionalized microscopy slides 25 x 75 mm (CEL-1) were rinsed once
with ethanol and dried with ultra-pure N2. Serial dilutions of biotinylated bovine serum
albumin (bBSA) from 0.11 to 1000 μg/mL were prepared in PBS plus one negative
control with 0 mg/mL bBSA (12 solutions total). bBSA solutions were then loaded into a
96 well plate and printed on the epoxy slides with an Affymetrix 417 Arrayer and
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allowed to dry overnight. Two replicate spots were printed for each biotin concentration
in an array, as shown in Appendix A-4. A biotin-functionalized slide was loaded into a
Whatman Chip-Clip, rinsed once with PBS supplemented with 0.1% BSA (PBSA) for 2
minutes, and then incubated with PBSA for 1 hr. After blocking, a 25 μg/mL SA-EITC
solution in PBSA was incubated in the array well for 30 minutes. The slide was then
rinsed once with PBSA for 2 minutes, then twice with PBS for 2 minutes each. For this
study, three polymerization conditions were investigated that mimicked live cell
encapsulation (Condition 1) and conditions used to coat fibroblast nuclei (Conditions 2 &
3). For live cell encapsulation, the monomer solution (1) consisted of: 420 mM PEGDA
575, 21 mM TEA, 35 mM VP, 0.05 wt% nile red NPs in PBS. For PEGDA-575 thin
films around nuclei (2), the monomer solution was: 420 mM PEGDA 575, 210 mM TEA,
35 mM VP, 0.05 wt% nile red NPs in deionized water. For PEGDA 3500 thin films (3):
25 wt% PEGDA-3500, 210 mM TEA, 35 mM VP, 0.05 wt% nile red NPs in deionized
water. Before polymerization, the solution was bubbled for 5 mins with ultra-pure N2.
After rinsing a slide, 300 μL of the corresponding monomer solution was pipetted into
the Chip-Clip array well, and placed in a clear plastic bag and purged with N2 for 5
minutes. The photoinitiation conditions were as follows: (1) 530 nm, 30 mW/cm2, 10
minutes; (2) 530 nm, 10.5 mW/cm2, 20 minutes; (3) 530 nm, 10.5 mW/cm2, 20 minutes.
After photopolymerization, the slides were rinsed twice with deionized water before
imaging. After drying overnight, profilometry measurements were performed on each
array set with a Dektak 6M profilometer to prevent scratching of the film, scan settings
were maintained at 4200 micron for 120 s, with a stylus force of 1 mg.
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4.2.7 Preparation of Encapsulated Subcellular Species by Polymer-Based
Amplification
Human dermal fibroblasts were cultured to ~80% confluency in DMEM
supplemented with 10% FBS and 1% penicillin/streptomycin at 37 °C and 5% CO2. Cells
were trypsinized, centrifuged, and seeded onto 35 mm cover glass-bottom culture dishes
(Mat-tek) in media. For encapsulation of nuclei, a recently published protocol was
adapted [104]. Cell dishes were washed twice with cold PBS, and then fixed with 1%
paraformaldehyde in PBS for 10 minutes. Cells were then washed 3 more times with cold
PBS. The fixed cells were then permeabilized with 0.01% Triton X-100 in PBS for 7
minutes, and washed 3 times with PBS. A blocking solution consisting of 2 mL of PBSA
with 2% FBS was pipetted into the dishes and incubated for 30 minutes at 4°C. Cells
were then immersed in a primary antibody solution of 1:1000 monoclonal mouse IgG
anti-human NPC in PBSA for 40 minutes at 4°C, followed by a secondary antibody
incubation of 1:400 biotinylated goat IgG anti-mouse IgG in PBSA for 40 minutes at
4°C. Cells were rinsed 3 times with PBSA, and then incubated with SA-EITC (25 μg/mL)
in PBSA for 30 min at 4°C. The cells were then washed 2 times with PBS and once with
deionized water. Two monomer solutions were prepared for polymer films of PEGDA575 (420 mM PEGDA-575, 210 mM TEA, 35 mM VP, 0.05 wt% nile red NPs in
deionized water) and PEGDA-3500 (25 wt% PEGDA-3500, 210 mM TEA, 35 mM VP,
0.05 wt% nile red NPs in deionized water). For each monomer molecular weight, 915 μL
of monomer solution was pipetted into a petri dish, and placed in a nitrogen-purged bag
as before. An LED lamp emitting green light (530 nm, 10.5 mW/cm2) was placed over
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the dish and the reaction was allowed to proceed for 20 minutes. The dishes were then
washed 3 times with deionized water.
4.2.8 Time-Dependent Confocal Microscopy Analysis of Diffusion
To probe macromolecular permeation through films formed by polymer-based
amplification, varying sizes of FITC-labeled dextrans (FD) (4kDa, 10kDa, 20kDa) were
prepared in transport buffer adapted from Mohr et al, consisting of 20mM HEPES-KOH
pH 7.4, 120 mM potassium acetate, 5mM magnesium acetate, and 250mM sucrose [106].
Solutions of 10 kDa and 20 kDa FD were prepared at 15 μM, however, the 4 kDa FD
required a higher concentration of 45 μM for quantifiable fluorescence signal. Human
dermal fibroblast cell samples were washed twice with transport buffer. Diffusion
kinetics were analyzed with a Leica AOBS/TCS SP5 confocal microscope (Leica
Microsystems, Wetzlar, Germany) equipped with a HyD photon-counting hybrid
detector. A 63x oil objective and an argon laser were used at 30% power. Just before a
confocal diffusion study, transport buffer was removed from a glass bottom petri dish and
it was loaded onto the microscope stage. The focus was adjusted and centered (zdirection) inside a coated nucleus. An automated timed scan was initiated, with an image
taken every 1.5 seconds. After approximately 3-4 scans, 100 μL of FD solution was
pipetted directly onto the scanning region and the automated scanning program was
allowed to run for at least 160 seconds. For statistical significance analysis Student’s ttest was calculated for all samples and in all the cases the p value obtained was lower
than 0.0001.
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4.3. Results and Discussion
4.3.1 Encapsulating Live Cells in Suspension by Surface Protein Recognition
The purpose of this study was to characterize the structure and permeability of
nanothin hydrogel coatings formed directly on cellular surfaces. These films are formed
by interfacial polymerization by binding the type-II photoinitiator eosin to surface marker
sites that enables excellent spatial control of polymer formation and ultra-thin coatings to
control molecular transport. (See Appendix A-5 for more details on protein specificity of
polymer formation) Photoinitiated systems are convenient for cell encapsulation, owing
to the delivery of uniform initiation energy to the system, rapid gelation, excellent
viability, and the ease of scale-up to large cell populations [70, 107, 108]. For our
suspension study we chose the T lymphoma Jurkat cell line because it is a robust
immortalized lineage with a high growth rate and abundant expression of CD45, an
antigen that is well understood and commonly targeted. The experimentally optimized
conditions of 21 mM TEA, a 10 minute reaction time, and an initiation light intensity of
30 mW/cm2 was used to encapsulate Jurkats with a crosslinked PEGDA film, shown in
Figure 4.2. To monitor film formation by microscopy and flow cytometry, fluorescent
NPs (nile red, 20nm, Fluospheres) were also introduced in the monomer mixture, and
have been shown to be physically entangled in the surface-initiated films in a similar
system [97]. High cell viability was preserved near 90% approximately 1 hour after
encapsulation, as measured by a flow cytometric calcein assay (Figure 4.3). Further,
cytometry experiments of coated cells showing low ethidium homodimer-1 fluorescence
compared to dead controls also suggest high viability of Jurkats through the coating
process. While longer time points are critical to the ultimate application of cell
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transplantation, this level of initial viability is consistent with that of similar eosin
photoinitiated PEGDA encapsulation systems with high long term cell viability [76, 80,
90].
4.3.2 Characterizing Film Surface Chemistry and Morphology
We used Raman microscopy to characterize the surface chemistry of the hydrogel
coating. Spectra were collected at the surface of an uncoated Jurkat, the surface of a
coated Jurkat, and at the surface of bulk cross-linked PEGDA-575 film (Figure 4.4). The
three spectra revealed the different chemical nature at the surface of each sample. We
expect the coated cells Raman spectrum to be the result of the superposition of both,
native cells and polymer film spectra. The coated Jurkat spectrum shows a peak at 2850
cm-1 associated with the symmetric stretching of CH2 groups from the lipid-rich cellular
organelles (lipid bodies) present in native Jurkats, but also displays signals from bulk
PEGDA at 2880 cm-1 and 2950 cm-1 corresponding to CH2 and CH3 vibrations,
respectively [109]. The presence of peaks associated with both the native cell and the
bulk polymer control in the polymer coated cell spectra further supports the presence of a
PEG-diacrylate coating observed at the cell surface by fluorescent labeling (Figure 4.1
and Figure 4.2).
Scanning electron microscopy was also used to analyze the surface morphology
of a polymer coated cell. A scanning electron micrograph of a paraformaldehyde-fixed
native Jurkat exhibits a smooth, flattened morphology (Figure 4.5.a), while a PEGDAencapsulated, fixed Jurkat cell (Figure 4.5.b) possesses a similar size as the uncoated cell
with a rough surface. The similarity in size between the coated and uncoated cells
supports our hypothesis that thin films on the order of nanometers thick and do not
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appear to alter the resulting coated cell size. The surface texture of coated cells is also
different from that of an uncoated cell and appears to have a rough yet consistent
topology. A magnified view of the coated cell surface (Figure 4.5.c) indicates a surface
texture similar to that of a surface-initiated PEG-diacrylate film (Figure 4.5.d). While
some variation in coating thickness is expected in surface mediated polymerization on the
order of tens of nanometers, the surface features in Figure 4.5.c are more consistent with
the underlying membrane folds common to Jurkats and other leukocytes [110]. Critically,
SEM observation clearly supports that coatings are uniform and complete across the
cell’s surface, without observable gaps or apparent changes in thickness. Further, the
covalent PEG crosslinking that forms these films is highly stable and to limit any
opportunity for cells to shed the films in the transplantation environment [111].
4.3.3 Estimation of Film Thickness
The overall goal of this work is to determine the size-dependent transport
properties of nanoscale hydrogels, and to relate them to the established bulk hydrogel
transport properties. For accurate scaling of nanoscale barrier films to bulk materials, it is
essential to attain an estimate of the coating thickness. The estimation of coating
thickness is particularly challenging at thicknesses below direct optical observation.
Measurement of coating thicknesses less than ~300 nm is typically accomplished by
ellipsometry, atomic force microscopy, profilometry, or electron microscopy. When
dealing with a poorly reproducible and non-uniform biological surfaces, it is difficult to
obtain accurate baseline data for thickness measurement by ellipsometry, atomic force
microscopy, and profilometry. Further, the solvent-dependent nature of hydrogel
thickness makes any measurement in a TEM embedding medium impossible to correlate
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without further understanding the solvent’s influence on the hydrogel thickness. As a
result, we estimated the thickness based on the fluorescent intensity of the polymer film
on a biological substrate by correlation to the fluorescent intensity of an easily measured
polymer film grown on a smooth glass substrate.
Biotinylated bovine serum albumin (bBSA) microarrays were prepared with
biotin concentrations between 0 and 1000 μg/ml bBSA, where these surfaces were meant
to replicate the chemical environment of the biotin-functionalized surface after a cell
surface is labeled with biotinylated antibodies. These surfaces were treated with
photopolymerization conditions that were identical to cellular coating procedures. As
expected, polymer thickness increased with printed bBSA concentration, as more eosin
molecules were bound to the array surface which increased radical formation during
photoinitiation (Figure 4.6). From image analysis, it was determined that each a.u. of
fluorescence intensity corresponded to 4.0 nm of thickness for the fluorescent
nanoparticle loaded PEGDA-575 hydrogel coatings (Table 4.1). The slope is comparable
for the PEGDA-3500 coatings (6.1 nm/a.u.), which suggests that the monomer size does
not have a significant impact on fluorescence per polymer volume, and that the PEGDA3500 films displayed reduced fluorescence simply because of lower polymer thickness.
Using this correlation, the fluorescent signal from nanoparticle-loaded coatings on cell
structures can be measured to then calculate a film thickness estimate. To obtain a
thickness estimate for the coatings used later to study transport kinetics, the fluorescent
signal from nanoparticle-loaded PEGDA-575 and PEGDA-3500 films encapsulating
dermal fibroblast nuclei was measured by epifluorescent microscopy similarly to the
microarray samples described above. To account for the signal contribution from the
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upper and lower layers of the spherical nuclei, the signal was divided by two to get a
representative estimate for the film coating. The thickness of PEGDA-575 and PEGDA3500 coatings was then estimated to be 158±16 nm 200±42, respectively (Table 4.1).
These estimates agree well with previous work with eosin-mediated growth of PEGDA
thin films and are used later for mass transfer modeling of the films in this work [92, 95].
4.3.4 Assessing Permeation Across Hydrogel Thin Films
To assess the transport kinetics of nanoscale hydrogel coatings on cellular
substrates, we use time dependent confocal microscopy to measure the transport of
fluorescently-labeled macromolecules across hydrogel membranes. There are several
advantages for studying diffusion through hydrogel coatings on adherent nuclei instead of
an encapsulated whole-cell in suspension. First, using nuclei offer a substrate that is
surface-anchored by cellular scaffolding without any further need for attachment factors
that could potentially alter cellular geometry or bias the import kinetics. Nuclei are also
much more rigidly spherical than other cellular species, including blood cells, that tend to
flatten when attached to a surface, which allows for more accuracy when collecting
confocal fluorescence data inside of the nucleus. Finally, the nuclear envelope can be
extensively permeabilized (with Triton X-100) without complete loss of structure unlike
most cell membranes, providing a scaffold for film coatings to be studied with minimal
influence on diffusion kinetics.
Numerous groups have used this time-dependent confocal microscopy technique
to study macromolecular permeation kinetics through nuclear pores of permeabilized
cells, yet the focus has been mechanistic and on the biological cues to passive or active
diffusion of different molecules [106, 112, 113]. We modify this established assay by
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first forming a PEGDA thin film coating around a nucleus of a permeabilized cell with
techniques described here and in prior work [104], and measuring passive diffusion of
large fluorescent biomolecules through the film by sampling the fluorescence signal (i.e.
concentration) inside the nucleus over time.
To establish that permeabilized fibroblast nuclei represented negligible resistance
to mass transfer across the nuclear envelope, control samples were fixed and
permeabilized with 0.1% Triton X-100. Solutions of fluorescein and various sizes (4, 10,
and 20 kDa) of FD were prepared in transport buffer, and the accumulation of fluorescent
material in nuclei was monitored by confocal microscopy (Figure 4.7). To account for
differences in absolute fluorescence between permeants, the fluorescent signal was
normalized by dividing the signal inside the nucleus by the signal outside the cell. For all
of the permeants studied, diffusion was virtually immediate into the permeabilized
control nuclei (>90% equilibrium concentration in nucleus at 3s).
In the uncoated permeation control study with 4 kDa FD, there is a clear affinity
of the FD for nuclear material seen in Figure 4.7.a. The higher fluorescence of the
nucleus versus the cytoplasm and surrounding regions at long timescales acts against the
expected concentration gradient at the nuclear membrane and is contrary to the expected
diffusive behavior. Further, the dynamics of the increase of fluorescence inside the
nucleus after 40 s is linear, rather than the first order decay expected in a diffusive
process. Importantly, the rate of this affinity process is less (0.2 change in relative
fluorescence over 160 s) than the diffusive behavior (~1.2 change in relative fluorescence
over 3 s).
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PEGDA (Mn 575 and 3500) coatings incorporating red NPs were grown on the
nuclear membrane by immunochemically localizing eosin to sites of nuclear pore
complex expression (Figure 4.7.b, 4.7.c), as described previously [97, 104]. Permeant
solutions were prepared as in the uncoated control experiments, and Figure 6 shows a
representative images at t=3 s and t=160 s after introduction of the fluorescent permeant
to the slide. For the PEGDA-575 coatings, fluorescein showed an immediate increase to a
high Fin/Fout as the relatively small molecule readily permeated the film. However, the
largest molecules investigated of 10 kDa and 20 kDa FD both showed essentially zero
increase in Fin/Fout during the entire ~170 s experiment, suggesting that both molecules
were completely excluded from the diffusing through the film. This exclusion of 10 kDa
FD indicates the PEGDA-575 coatings have a polymer mesh size smaller than 3.7 nm
(the hydrodynamic diameter of a 10kDa dextran) [114]. The trial of 4 kDa FD diffusion
showed a Fin/Fout signal that increased, supporting that the mesh size of the PEGDA-575
film is larger than 1.3 nm (the hydrodynamic diameter of a 4kDa dextran). This 1.3 – 3.7
nm mesh size is in agreement with a previous estimate of 2.0 – 5.0 nm for bulk PEGDA575 with the same mass fraction of monomer in water [97]. This prediction also agrees
well with the unimpeded diffusion of the fluorescein dye observed in PEGDA-575
coatings, a clear demonstration of molecular weight cutoff behavior in this coating.
In diffusion trials for PEGDA-3500, we hypothesized that because the molecular
weight between crosslinks was larger, the film would be more permissive to molecular
diffusion. For the largest biomolecules of 10 and 20 kDa, the PEGDA-3500 film showed
virtually no increase in Fin/Fout during the entire trial, demonstrating dextrans of
hydrodynamic diameter of > 3.7 nm are excluded by the PEGDA-3500 coatings. The 4
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kDa dextran (diameter ~1.3 nm) does permeate through the coating, indicating the
PEGDA 3500 coatings also have a mesh size between 1.3 and 3.7 nm. This estimate
agrees closely with the 2.2-2.7 nm mesh size reported for micron thick PEGDA-4000
coatings studied previously by Cruise, Scharp, and Hubbell [60]. To further support the
molecular weight cutoff behavior of these interfacial coatings, a trial of just fluorescein
showed that the film allowed instantaneous diffusion of the small molecule.
While the absolute cutoff behavior of the PEGDA-575 and PEGDA-3500 yields
an identical range of mesh size, the PEGDA-3500 film permitted the diffusion of 4 kDa
FD at a faster rate than PEGDA-575 (difference in Figure 6 slopes of over the first 10 s
are statistically significant with p = 1.76x10-25). The faster transport across the PEGDA3500 coating suggests a larger mesh size when compared to a PEGDA-575 coating. This
fundamentally agrees with bulk scale expectations, where a larger diacrylate will yield a
larger molecular weight between crosslinks, and faster diffusion than a smaller diacrylate
at an identical mass fraction. It is also observed that the PEGDA-575 or PEGDA-3500
coating did not alter the apparent affinity of the 4 kDa FD for nuclear material observed
in the uncoated control studies. At long time scales (t>90 s), there is an increase in
fluorescence in the nucleus which appears linear and does not follow the expected rate
decay of a diffusively driven process.
4.3.5 Estimation of Film Diffusion Coefficients
While these time-resolved images provide quantitative information about the size
exclusion properties of the films, the completeness of substrate coating, and the
molecular weight cut off for permeants, we also sought to extend our findings to estimate
the diffusion coefficients. Because bulk photopolymerization proceeds through
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drastically different initiation conditions than a typical surface-initiated system, the
crosslinking profiles generated are inherently different [115]. Further, polymer
diffusivities are typically measured with polymer geometries that are several micrometers
thick when hydrated, which is a much larger length scale than the thin films generated in
this work [60, 116]. Thus, direct measurement of diffusivities of films on cellular
substrates would result in a more representative characterization of transport in the
cellular microenvironment.
The diffusion constants for 4kDa FD through PEGDA coatings (D575 and D3500)
were the only analyzed, owing to clear change in nuclear fluorescence over an
experimentally-accessible time scale. In addition to permeation data, a coating thickness
was estimated (Table 4.1) using the relationship between film thickness and fluorescence
summarized in Figure 4.6. The coating thickness for the model was further expanded to
include a lower and bound approximately 50 nm above and below the calculated
estimates from our microarray study of film thicknesses to account for potential error in
our coating thickness estimate. Thus, a range was defined to be 100 to 200 nm for
PEGDA-575 film modeling and 150 to 250 nm for PEGDA-3500 film modeling. Coating
surface area and nuclear volume were calculated from confocal scans of the nucleus prior
to the assay. The nonlinear fluorescence increase during the first 15 s of the polymer
coated samples with 4 kDa FD appeared to be first order, and the fluorescence change in
this region is used to estimate passive diffusion across the polymer coatings. In all 4 kDa
FD samples, there was a consistent linear increase in nuclear fluorescence, and this nondiffusive behavior is attributed to an affinity of the dextran for the nuclear material. The
contribution from 4 kDa FD nuclear affinity was estimated to be 0.03 a.u. per 15 s time
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span. This contribution is <10% of the overall increase during the initial 15 s analyzed
and was not included in the model. This omission potentially introduces a small error in
the estimated diffusion constant, and future studies would benefit from identifying a low
affinity fluorescent probe in this molecular weight range.
Using these data, Fick’s Second law was numerically integrated, and diffusion
constants were fit to the data for each condition. Figure 4.8 shows plots representing a
model fit for the estimated film thickness studied for each monomer length. For the lower
and upper bounds of thicknesses modeled for PEGDA-575 (100-200 nm), the diffusivity
of 4kDa FD through the film was calculated as D575 = 9.5x10-10 – 2.0x10-9 cm2/s
Similarly, a diffusivity was fit to the Fin/Fout data for the PEGDA-3500 film at 150250nm, and was calculated to be D3500 = 5.9 – 9.8x10-9 cm2/s. These findings agree with
the expected higher diffusivity for the PEGDA-3500 film when compared to the PEGDA575 film, owing to a higher molecular weight between crosslinks [117].
Remarkably, the magnitudes of the diffusion constants for these hydrogel thin
films on fibroblast nuclei are consistent with that of bulk materials of similar macromer
molecular weights reported in literature. The most direct literature comparison is in
Cuchiara et al., where 3 and 10 kDa dextrans diffuse through PEGDA-6000 at a 10%
w/v, and the diffusivities were reported to be on the order of 10-7 and 10-9 cm2/s,
respectively [116]. Further, our diffusion results also follow the expected trend of
increasing diffusivity with increasing PEGDA length. Cruise et al. reported an increase in
diffusivity as the molecular weight of the PEGDA monomer increased from 2kDa to 20
kDa for vitamin B-12 (~1.3kDa) permeation across the PEGDA hydrogels [60]. These
diffusivities were on the order of 10-7 and 10-8 cm2/s for the diffusion of a permeant
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molecule considerably smaller than the 4 kDa FD studied here (Figure 4.8). This
observed agreement in diffusivity between thin film and bulk polymer materials suggest
that permeant diffusivity is largely decoupled from substrate encapsulation geometry. As
such, we expect the permeability analysis performed here on adherent fibroblast nuclei to
extend well to outer cell surfaces with minimal difference in diffusivities.
4.4 Conclusions
In this work we have demonstrated the encapsulation of both whole cell and subcellular species by photopolymerization of PEGDA films. By SEM and Raman
microscopy we have shown that complete and conformal films are targeted to cell
surfaces, and the coating surface is consistent in morphology to a surface-initiated PEG
diacrylate film. This technique is applicable to both adherent and suspended cell
configurations. By flow cytometric calcein assays we have shown that encapsulated cells
retain viability of ~90%. Time-dependent, photon-counting CSLM analysis demonstrates
that large 10- and 20 kDa fluorescein-functionalized dextran molecules are completely
excluded by films formed from both PEGDA-575 and PEGDA-3500 monomers, and
provides a polymer mesh size estimate of 1.3 - 3.7 nm. Microarray studies suggested
these films were 100 - 200 nm in thickness, which is consistent with previously reported
data on glass substrates [92]. Diffusion coefficients of 4 kDa FD permeation through
films calculated from a model of Fick’s second law were in good agreement with
reported trends and magnitudes in bulk crosslink hydrogel materials of similar precursor
monomer units. Notably, our results support that the technique described here can
encapsulate cells with biocompatible hydrogel coatings that achieve similar size selective
permeability behavior as previously studied cell encapsulation strategies, but with
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drastically lower thicknesses and minimal synthetic material. Further, these data suggest
that this surface initiated coating strategy will be capable of completely excluding SDS
surfactant micelles in ASL isolation, where micelles should be larger than the polymer
coating mesh size above the critical micellar concentration at ambient conditions [118].
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Table 4.1: Comparison of fluorescent signal for nanoparticle-loaded films encapsulating
dermal fibroblast nuclei.
Monomer
(Mn)

Fluorescence
Intensity From
Top and Bottom
(a.u.)

Fluorescence
Intensity From
Top (a.u.)

Intensity to
Thickness
Conversion
(nm/a.u.)

Film Thickness
Estimate (nm)

PEGDA (575)

71.9±8.2

35.9±4.1

4.0

158±16

PEGDA (3500)

63.8±13.8

31.9±6.9

6.1

200±42
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Figure 4.1: (a) Schematic of antigen-specific coating process to form nanothin films on
the surface of individual cells. (b) Fluorescent image of PEGDA encapsulated Jurkats by
recognition of CD45 antibody. Red fluorescence is from nile red 20 nm fluosphere
nanoparticles physically entangled in the polymer film. Scale bar = 20 micron.
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Figure 4.2: (a) Fluorescent image of PEGDA-575 encapsulated Jurkat cells. Red
fluorescence is from 20 nm nile red fluorescent nanoparticles loaded in film (0.05 wt%)
(b) Bright field phase image of PEGDA-575 encapsulated Jurkats. Scale bar = 50 μm.
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Figure 4.3: Flow cytometry analysis of coated cell viability by esterase activity. The live
control represents calcein stained Jurkat cells from culture and the dead control were
polymer coated cells incubated with 70% ethanol for 5 minutes before calcein staining.
Image inset shows a representative micrograph of calcein AM (green) and ethidium
homodimer-1 (red) staining of coated Jurkats. Student t-test for live control and polymer
coated populations yielded p=0.125, and for polymer coated and dead control populations
yielded p=6x10-8. Scale bar represents 100 μm.
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Figure 4.4: Confocal Raman microscopy surface analysis. Spectral comparison of
surface of native Jurkat, coated Jurkat, and bulk cross-linked PEG diacrylate (Mn 575).
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Figure 4.5: Scanning electron microscopy analysis of uncoated and coated cell surface
morphology. (a) Surface morphology of a native and uncoated Jurkat cell. (b) Surface
morphology of a PEG diacrylate coated Jurkat. (c) Higher magnification of coating
morphology. (d) Surface of an interfacial PEG diacrylate film formed on glass.
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Figure 4.6: Plot of microarray spot thickness vs. spot fluorescence for different monomer
molecular weights.
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Figure 4.7: Quantification of molecular diffusion through nanoscale coatings. Image
summary at t=3 s and t=160 s of passive macromolecular diffusion and time-dependent
analysis of fluorescent signal from free fluorescein and FITC-Dextrans through (a)
permeabilized dermal fibroblast nucleus controls, (b) PEGDA-575 and (c) PEGDA-3500
coated nuclei. Fin signal was from the inner domain of nuclei and Fout was the signal of
the FITC-dextran solution outside the cell. Error bars are shown only on every other time
point on plotted data for clarity.
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Figure 4.8: Analysis of diffusivity of 4 kDa FITC-labeled dextrans through nanoscale
coatings on cellular substrates. Permeation data was fitted with a time-dependent Fickian
diffusion model to calculate diffusion constants for lower and upper bounds of film
thicknesses for both PEGDA-575 and PEGDA-3500 films. (a) Model fit and calculated
diffusivity for diffusion of 4 kDa FITC-dextran though a PEGDA-575 film of an
estimated thickness of 150 nm. (b) Model fit and calculated diffusivity of 4 kDa FITCdextran through a PEGDA-3500 film of an estimated thickness of 200 nm. Initial
concentration and time parameters were adjusted to a reference point of zero for model
curve fitting.
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Chapter 5: Design and Development of Protective Polymer Coatings for Rapid
High-Purity Cancer Cell Isolation
In this chapter, we demonstrate the use of targeted, protective polymer coatings on
cells for the rapid enrichment of cancer cells. Antigen-positive cells are coated with a
biocompatible hydrogel which protects the cells, while uncoated cells are immediately
lysed. The polymer coating is later removed through orthogonal photochemistry. The
isolate yields viable cells which proliferate at rates comparable to control cells. Minority
cell populations are enriched from erythrocyte-depleted blood to >99% purity, while the
entire batch process requires one hour and <$2,000 in equipment. Batch scale-up is only
contingent on irradiation area for the coating photopolymerization, as surfactant based
lysis can be easily achieved on any scale. The information presented here is adapted with
minor modifications from previously published work. Jacob L. Lilly worked
collaboratively with Gabriela Romero as a primary contributor to protocol and assay
development, experimentation, and data preparation.
Gabriela Romero, Jacob L. Lilly, Nathan S. Abraham, Hainsworth Y. Shin,
Vivek Balasubramaniam, Tadahide Izumi, Brad J. Berron. Protective Polymer
Coatings for High-Throughput, High-Purity Cellular Isolation. ACS Applied
Materials & Interfaces. Aug 7;7(32):17598-602, 2015.
5.1 Introduction
From the first observation of tumor cells in the peripheral blood of cancer
patients, researchers have sought to develop a “fluid biopsy” in which patient-derived
peripheral blood could be analyzed for circulating tumor cells (CTCs) with the goal of
providing diagnostic and prognostic information with a minimally invasive procedure.
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While the observed presence of tumor cells in circulation has been correlated with
metastatic progression [6-8, 119], the current clinical utility of fluid biopsies remains
questionable due to a lack of reliability and versatility to detect heterogeneous cancer cell
types [4, 12].
Recent evidence suggests that multiple, distinct populations can arise from a
single tumor primary with drastically variable phenotypes [1, 15, 17]. While the
mechanisms that give rise to these populations remains an area of intense research, it has
been proposed that metastatic cells can be generally categorized as either: 1) primary
epithelial tumor cells spilling into circulation through leaky vasculature and 2) primary
tumor cells that have lost their epithelial nature and have actively migrated into the
peripheral blood in a mesenchymal state. Once in systemic circulation, little is known
about the biological functionality that leads to colonization of metastatic foci at distant
sites. Practically, functional characterization of CTCs has been encumbered by the
extreme rarity at which they seen of ~1 per 106. Further, many CTC isolation methods
currently available require fixation and intracellular staining to determine epithelial
identity, which prevents further examination of behavior and functionality after sorting.
In order to fully bridge our understanding of the mechanisms that allow an epithelial
cancer cell to survive in circulation an eventually spread the disease, viability of these
rare cell populations must be preserved during enrichment.
Researchers currently have a portfolio of technologies to meet many of their cell
sorting needs. Critically, there is a technology gap in isolating viable, rare cancer cells in
a rapid, highly-pure manner. Magnetic sorting excels in high-speed, low cost sorting, but
is hampered in purity by nonspecific adsorption in antigen-positive sorts [38].
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Fluorescence activated cellular sorting (FACS) delivers exceptional purity but at low
throughput and high cost [120]. Microfluidic approaches are promising, but purities for
populations adhered to antibody coated surfaces is typically low (<50%) [34], throughput
is limited (~10 mL or 108 cells per day) [121], and recovery of isolated cells from the
devices has proven difficult [122].

The most common approach for sorting large

numbers of antigen positive cells at high purity is a sequential approach where cells are
enriched with magnetic sorting, and purity is attained with FACS [41]. Even in this
debulked case, each antigen positive cell must pass through a FACS system, and
throughput for high purity sorts is typically ~107 cells/day, involving time-consuming
sterilization and gate adjustment operations. The stark contrast in magnitude between
rates achievable with FACS and the requirements of CTC isolation illustrates a critical
obstacle in the development of a reliable fluid biopsy.
Here, we present Antigen Specific Lysis (ASL) technique as a fundamentally new
approach to cellular sorting (Figure 5.1). Individual, antigen-positive cells are protected
with a biocompatible hydrogel coating. ASL utilizes an antibody covalently conjugated to
a photoinitiator, and upon incubation of cells in this conjugate, the initiator is localized to
only antigen positive cells. After further exposure in a macromer solution and irradiation,
polymer coatings are specifically formed around the targeted cells. The polymer coating
protects the cells from a surfactant solution, while uncoated cells can be immediately
lysed. Following lysis, the polymer coating is removed through orthogonal
photochemistry. Different cellular activity indicators were used to evaluate viability after
each step in ASL process. The isolate has >50% viability yield, negligible apoptotic
activity and regulated proliferation rate. ASL purity was evaluated by utilizing GFP as
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identity marker in a GFP-positive A549 cell line, where we detect >97% purity in the
isolate. Specificity of ASL was corroborated by sorting a particular cell population from
cell mixtures and further from leukocyte-enriched plasma from human blood samples.
The feasibility and adaptability of ASL technique promises unprecedented sorting rate
and throughput.
5.2. Materials and Methods
5.2.1 UV Degradable Monomer Synthesis
A poly(ethylene glycol) diacrylate macromer (Mn ~ 3500 Da) incorporating an
ortho-nitrobenzyl functionality (Figure 5.2) was synthesized according to a published
protocol by Kloxin et al. Structure and purity was confirmed by H-NMR [123].
5.2.2 PEG-diacrylate Monomer Synthesis
A poly(ethylene glycol) diacrylate macromer was synthesized with a similar
molecular length as UV degradable macromers. Poly(ethylene glycol) (PEG, Mn ~3350
Da, Sigma Aldrich) was added to the bottom of an additional funnel flask at a 10 gram
batch size and purged with ultra-pure N2 for 10 minutes. Anhydrous dichloromethane
(DCM, 30 mL) was added to the flask, and the PEG was allowed to dissolve under
magnetic stirring for 5 minutes. The flask was kept in a stirred room temperature water
bath (>500 mL) to serve as a heat sink for the exothermic reaction. For acrylation of the
PEG macromer, a molar ratio of 1:4:4 PEG:acryloyl chloride (AC, Sigma
Aldrich):triethylamine (TEA, Acros) was used. The calculated amount of TEA was added
directly to the bottom of the flask under continuous stirring. The calculated amount of
AC was mixed with 5mL of DCM and injected through a septum into the top of the
addition funnel, and the entire apparatus was then purged with N2 for 15 minutes. The
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AC/DCM solution was then added dropwise (~1 drop every 5 s) with the addition funnel
under continuous N2 purge and stirring. When the entire amount of AC/DCM solution
was added to the PEG/TEA/DCM solution, purging was stopped and the apparatus was
sealed, covered with aluminum foil and reacted overnight. The resulting pale yellow
mixture was then filtered through a Buchner funnel and washed with excess DCM to
remove the bulk of the TEA salts that formed during the reaction. Next, 10-fold molar
excess sodium carbonate was added to the solution, and the slurry was stirred vigorously
for 1 hour. The mixture was then again passed through a Buchner filter funnel and
washed with DCM to remove the insoluble sodium carbonate. A packed bed of alumina
(~3 cm thick) was then prepared in a glass frit column, and the solution was passed
through the bed and washed with DCM. The DCM was then evaporated off so that the
solution volume was ~40 mL, and cold diethyl ether (400 mL) was added to precipitate
the PEG diacrylate product. The mixture was kept at 4˚C for at least 1 hour to allow full
precipitation. The white precipitate was then collected with a Buchner filter funnel and
allowed to dry overnight in the dark. This process of dissolving in ~40 mL of DCM and
then precipitating the PEG diacrylate product in cold ether and filtering was repeated to
further remove any impurities. Structure and extent of acrylation (90%) were confirmed
with H-NMR.
5.2.3 Photopolymerization of Degradable Coatings on Cultured Jurkat Cells In
Suspension
Jurkat cells (ATCC) were cultured to ~60% confluency in RPMI-1640 (Cellgro)
supplemented with 10% fetal bovine serum (FBS, Gibco) and 100U Penicillin, 10 mg/mL
Streptomycin (Gibco). For each polymerization trial, 1.5 x 106 Jurkat cells were collected
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in culture media. In a 15 mL conical tube, the cells were centrifuged at 300xg for 5
minutes at 4 °C. The culture media was removed, and the cell pellet was resuspended by
gentle vortexing in 115 μL of DPBS (Gibco) with 3% FBS and 35 μL biotinylated mouse
anti-human CD45 (BD Biosciences), and incubated for 40 minutes at 4 °C. Following
incubation with primary antibody, the cell suspension was rinsed twice by centrifuging at
300xg for 5 minutes and then resuspending with cold DPBS with 3% FBS followed by
gentle vortexing. After the final rinse, the cell pellet was resuspended in 1 mL of cold
PBS with 3% FBS with 25 μg/mL streptavidin-eosin-5-isothiocyanate (SA-EITC), gently
vortexed and incubated at 4 °C for 30 minutes. Streptavidin (Thermo Scientific) and
eosin-5-isothiocyanate (Sigma Aldrich) were reacted and purified in-house by the method
described by Hansen et al. (2007) [98], The cell suspension was then rinsed once, as
before, with cold PBS with 3% FBS and then once with cold DPBS. The monomer
mixture was then prepared as follows: 25 wt% UV cleavable PEG diacrylate [123], 21
mM triethanolamine, 35 mM 1-vinyl-2-pyrrolidinone, and 0.05 wt% nile red 20
nanometer fluorescent nanoparticles (Fluospheres, Invitrogen) in 1x phosphate buffer.
The solution was bubbled with humidified ultra-pure N2 for approximately 3 minutes to
remove dissolved oxygen and reduce turbidity. The cell pellet was resuspended in 300 μL
monomer solution, gently vortexed, and placed in pre-cooled Chip-Clip well (Whatman)
with a standard microscopy slide (Fisherbrand). The Chip-Clip was then placed in a
sealed clear plastic bad and purged with humidified N2 for 3 minutes. While continuing
to purge, the reaction was initiated by turning on an LED lamp (Thor Labs) emitting 530
nm light at 30 mW/cm2 and centering the irradiation area on the well containing the cell
suspension. The photopolymerization was allowed to proceed for 10 minutes, at which
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time the Chip-Clip was removed from the bag and the cell suspension was removed
rinsed 3 times with room temperature DPBS.
5.2.4 Photopolymerization of Degradable Coatings on Cultured A549 Cells in
Suspension
Before a coating experiment, A549 cells (ATCC) were cultured to ~80%
confluency in RPMI-1640 with 10% FBS and 100U Penicillin, 10 mg mL-1 Streptomycin.
The culture flask was then rinsed with warm PBS 1x to remove media, and then
trypsin/EDTA solution was added for ~5 minutes to detach the adherent cells. After
detachment, cells were washed with 1 part trypsin neutralizing solution, pelleted and
resuspended in culture media. For each polymerization trial, 1.5 x 106 A549 cells in 1 mL
of media were used. Throughout the protocol, a rinsing solution consisting of DPBS 1x
(free of calcium and magnesium), 5mM EDTA, and 3% FBS was used to minimize A549
attachment during immunolabeling and polymerization. The cells in media from culture
were centrifuged at 300xg for 5 mins at 4 °C and resuspended in 100 μL rinsing solution
and 1 μL of stock mouse anti-human EpCAM (BioLegend) by gentle vortexing. The cell
suspension was incubated in primary antibody for 40 minutes at 4 °C. At the end of the
incubation the sample was centrifuged at 300xg for 5 mins at 4 °C and resuspended in 1
mL rinsing solution with 5 μL stock biotinylated goat anti-mouse IgG, gently vortexed
and incubated at 4 °C for 40 minutes. The cells were then again centrifuged as before,
rinsed twice by centrifuging and resuspending with rinsing solution. After the final rinse,
the cell pellet was resuspended in 1 mL of cold rinsing solution with 25 μg/mL
streptavidin-eosin isothiocyanate (SA-EITC), gently vortexed and incubated at 4 °C for
30 minutes. The cell suspension was then rinsed twice, as before, with cold rinsing
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solution. The monomer mixture was then prepared as described previously for Jurkat
coating: 25 wt% UV cleavable PEG diacrylate [123], 21 mM triethanolamine, 35 mM 1vinyl-2-pyrrolidinone, and 0.05 wt% nile red fluorescent nanoparticles in 1x phosphate
buffer. The solution was bubbled with humidified ultra-pure N2 for approximately 3
minutes to remove dissolved oxygen and reduce turbidity. The cell pellet was
resuspended in 300 μL monomer solution, gently vortexed, and placed in a pre-cooled
Chip-Clip well (Whatman) with a standard microscopy slide (Fisherbrand). The ChipClip was then placed in a sealed clear plastic bag and purged with humidified N2 for 3
minutes. While continuing to purge, the reaction was initiated by turning on an LED lamp
(Thor Labs) emitting 530 nm light at 30 mW/cm2 and centering the irradiation area on the
well containing the cell suspension. The photopolymerization was allowed to proceed for
10 minutes, at which time the Chip-Clip was removed from the bag and the cell
suspension was removed and rinsed 3 times with room temperature DPBS.
5.2.5 Polymerizing Cell Mixtures
In experiments with mixtures of Jurkat and A549 cells, each respective cell type
was cultured and collected as previously described and then combined at varying ratios.
The polymerization protocol used depended on the cell type targeted for isolation.
Because A549 cells were present in these experiments, 5 mM EDTA was included in all
rinsing solutions to prevent cell attachment.
5.2.6 Removal of Antigen-Negative Cells by Surfactant Lysis
Following photopolymerization and subsequent rinsing, cell mixtures were
resuspended in 500 µL PBS 1x and gently vortexed. To the cell suspension was added
500 µL of 10% sodium dodecyl sulfate (SDS) in PBS 1x and gently mixed by pipette to
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get final concentration of 5% SDS in PBS 1x. The suspension was then immediately
centrifuged at 300g for 5 minutes to collect the polymer coated, antigen-positive cells.
The surfactant solution was removed by pipette, and the pellet was rinsed twice more
with cold DPBS.
5.2.7 Coating Removal by UV Degradation
Polymer coated cells were suspended in 300 μL of 10 mM EDTA gently vortexed
and pipetted into a Chip Clip well. A UV LED lamp emitting 365 nm light was set up to
irradiate the entire well at 10 mW/cm2 for 15 minutes, as shown in Appendix A-1. The
cell solution was then removed from the well, and the well was rinsed twice and
combined with the removed solution. The cells were then pelleted by centrifugation at
300g for 5 minutes at 4 °C, and then resuspended in PBS 1x. The cells were rinsed twice
more in DPBS 1x similarly by pelleting and resuspending.
5.2.8 Cell Identity Assays
For cytometry experiments, an Accuri C6 flow cytometer was used. Gating
between coated and uncoated cells is based on nanoparticle fluorescence (535/575 nm)
and forward scatter. Each experiment was set to count 100,000 events and each run was
recorded using identical measurement parameters. Each condition tested was replicated
five times per experiment, and each experiment was repeated at least 3 times on different
days. To support the cell identity analyses above, a cytometry experiment was designed
to ASL sort GFP-transfected A549 cells (Cell Biolabs), where GFP signal serves as a
strong biochemical reporter for A549 identity. GFP positive A549 and Jurkats were
cultured in RPMI-1640 and collected as previously described above, and mixed at a ratio
of approximately 10% GFP positive A549 into 90% Jurkats, where gating was set on FL-
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1 vs forward scatter based on single cell population controls. GFP-A549 cells were
targeted with anti-EpCAM, and coated by photopolymerization of 25 wt% PEGdiacrylate macromer similarly to the coating protocol detailed previously. After SDS lysis
and rinsing with DPBS/FBS, cells were suspended in culture media and incubated
overnight to allow recovery of GFP signal that is partially photobleached during
photopolymerization. Cells were then resuspended in DPBS/FBS and analyzed again by
cytometry. The experiment was repeated 3 times on different days with 1,000 events per
replicate.
5.2.9 Viability and Proliferation Assays
Cell viability was determined by MTT, calcein, caspase-3/7, and SYTOX assays.
Measurements were taken after antibody incubations, polymerization, surfactant lysis,
and UV degradation. After the final rinse with cold PBS 1x at each step, cells were
centrifuged at 300g for 5 minutes and resuspended in 50 nM of calcein AM (Invitrogen)
in PBS and incubated for 15 minutes at 4 °C. Flow cytometric analysis was then
performed to measure calcein fluorescence. First, a threshold of fluorescence was
generated using uncoated and cells without exposure to calcein as control samples. All
events corresponding to uncoated cells without calcein were located at intensities below
this threshold for both green and red fluorescence, while events corresponding to polymer
coated cells without calcein were located at intensities below the threshold for the green
fluorescence channel. Each experiment was set to count 100,000 events per run and each
run was recorded using identical measurement parameters. Each condition tested was
replicated five times and each experiment was repeated at least 3 times in different days.
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The variation between each replicate was always less than 5% and between experiments
less than 10% in cell mixtures.
Cell viability after immunostaining, polymerization, lysis and polymer
degradation was also studied with the MTT assay. After each step, 100,000 cells in 200
µL of culture media were seeded into each well of 96-well plates. Thiazolyl Blue
Tetrazolium Bromide (Sigma Aldrich) was dissolved in PBS 1x at a concentration of 5
mg/mL. Then, 20 µL of MTT solution was added into each well and incubated for 3
hours. The absorbance was measured by means of a plate reader at 570 nm.
To further assay viability, a flow cytometry based caspase-3/7+SYTOX reporter
kit (Invitrogen) was used. Approximately 106 Jurkat cells were obtained from culture,
coated with polymer via anti-CD45, exposed to SDS lysis, then to degradation conditions
of UV light in 10 mM EDTA as described above. Apoptosis and membrane integrity
were probed after polymerization and degradation steps by incubating samples with both
500 nM caspase reporter reagent and 1 μM SYTOX reagent for 60 minutes at room
temperature in the dark. For analysis, flow cytometry gating was set from Jurkat controls
to 1,000 events per replicate. Fluorescence analysis was performed by excitation with a
488 nm laser with a 530/30 BP filter for the caspase channel and a 675/25 nm BP filter
for SYTOX. A dead control consisted of 70% ethanol fixed Jurkats, and an apoptotic
control was induced with a 3 hour incubation of Jurkat cells at 37 °C with 10 μM
camptothecin in RPMI-1640 culture media. Cell proliferation after polymer degradation
was studied with the MTT assay. 5,000 cells in 200 µL of culture media were plated into
each well of 96-well plate. During 5 days of co-incubation, 20 µL of MTT solution (5
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mg/mL in PBS 1x) was added into each well of the plates and incubated for 3 h. The
absorbance was measured by means of a plate reader at 570 nm.
5.2.10 ɣH2AX Foci Quantitation
A549 cells were plated on 12 mm coverslips and incubated in DMEM 10% FBS +
1% streptomycin/penicillin + 1 % L-Gln for 16 h. The coverslips were soaked in 2 ml
PBS in 6 cm dishes, and exposed to 10 mW/cm2, 365 nm irradiation for 10 or 20 min,
followed by incubation in a regular medium for 30 min, 1 h, or 3 h. Cells were then fixed
in 50% methanol followed by 100 % methanol, and then stained with anti-ɣH2AX
(Millipore) and probed with anti-mouse IgG-Alexa Fluor 488. Cells with foci were
counted to calculate mean %cells with foci from 10 independent observations. Foci
formation induced by 5 minutes of 0.2 mM H2O2 and measured after 30 minutes in
regular medium post exposure treatment is shown as a ɣH2AX positive control.
5.3 Results and Discussion
5.3.1 Antigen Specific Polymer Coating
Antigen Specific Lysis (ASL) consists of specific cellular protection by a
temporary polymer coating and the subsequent lysis of unprotected cells (Figure 5.1).
The formation of a polymer film requires a polymerization initiator [124], and ASL
utilizes antibodies to localize eosin (a type II photoinitiator) on the surface of only
antigen positive cells [97, 100, 125]. The monomer is prepared in a mixture composed by
25 wt% UV cleavable PEG diacrylate [123], 21 mM triethanolamine, 35 mM 1-vinyl-2pyrrolidinone, and 0.05 wt% fluorescent nanoparticles in 1x phosphate buffer. Coatings
are formed upon immersion in nitrogen purged monomer mix and 530 nm LED
irradiation (30 mW/cm2) for 10 minutes, where a red fluorescent polymer coating is
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formed on the outside of only targeted, initiator-labeled cells. When the photoinitiators
are targeted against protein tyrosine phosphatase (CD45 antigen), protective polymer
coatings are formed on the outside of Jurkat cells [97, 126]. Unprotected cells (Figure
5.3.a) are lysed and killed by a 10 minute exposure to 5% SDS (Figure 5.3.b) [127],
while we observe that cells encapsulated in fluorescent polymer coatings retain cellular
integrity (Figure 5.3.c, 5.3.d). Cellular integrity and activity was determined by caspase3/7 + SYTOX assay where a cell population of 81.7 ± 8 % is detected viable (Figure
5.4). Viability by cellular activity was determined at each step in the ASL process by
calcein esterase activity and capspase-3/7 + SYTOX assays. Calcein esterase assays
showed more than 80% viable Jurkat cells after polymer coating (Figure 5.3.e). The lack
of activation of caspase-3/7 apoptotic pathways by caspase-3/7 + SYTOX assay reveal
that after the polymer coating process, a negligible Jurkat cells population (0.2 ± 6 %)
was in the apoptotic stage and 14.5 ± 9 % of the cells were necrotic (Figure 5.4). The
high viability for these coating materials is to be expected given previous studies using
similar macromers and initiation chemistry [90, 126]. These same macromers were used
with >80% viability in tissue encapsulation studies by Kloxin et al. [123] and with >90%
viability by Griffin et al. [128] and by DeForest et al. [129]. Additionally, the
polymerization by a type II photoinitiation system (eosin with a tertiary amine coinitiator)
strategy has been extensively studied by the Hubbell [60, 80] and Lin [130, 131] groups
for pancreatic islet and pancreatic cancer tissue engineering studies.
This cellular protection by a targeted coating is the foundation of ASL sorting,
where complete elimination of the untargeted population is feasible through conventional
approaches of cell lysis. While enrichment based on the exclusion of SDS is a chemical
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means of selection, we have also evaluated the preservation of cellular function in
hypotonic solutions using similar coatings. Immersion of 105 uncoated Jurkat cells in 1
mL of pure water results in a large osmotic imbalance, leading to swelling and rupture of
the cell [132]. When Jurkat cells are coated with a PEG diacrylate polymer, the polymer
coating preserves cell membrane integrity and enzymatic function (Figure 5.3.d, 5.3.e).
In each mode of lysis, we have observed reductions in the numbers of uncoated cells.
Cell exposure to 5% SDS led to an undetectable lysed population, while the water
treatment results in a statistically insignificant (p=0.0517) number of viable cells.
Polymer coating protection from SDS or hypotonic lysis demonstrates the potential for
ASL to deliver 100% pure populations.
5.3.2 Specificity of ASL
The limiting factor for ASL purity is the specificity of polymerization afforded by
the antibody-targeted initiator species. To investigate the specificity of these polymer
coatings, we isolated A549 cells from a mixed population with Jurkat cells.
Approximately 104 A549 cells were mixed with 105 Jurkat cells. For the sake of
adaptability, we synthesized a streptavidin-eosin conjugate that can be targeted to A549
cells through the use of biotinylated antibodies and antibodies against epithelial cell
adhesion molecule antigen (anti-EpCAM). After photopolymerization (as described
above), the mixture of cells were analyzed by flow cytometry, and the two distinct
populations are consistent with control populations of coated A549 cells and uncoated
Jurkat cells. The fraction of each gated population (8% A549 to 90% Jurkat, Figure
5.5.a) is consistent with the fraction of starting populations. Upon addition of 5% SDS in
PBS to the pelleted cellular mixture, a purified population of polymer coated A549 cells
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is obtained through centrifugation (0.3 x g for 5 minutes) and rinsing in 3% FBS in PBS.
Flow cytometry shows >98% of the population to be consistent with coated A549 cells
(Figure 5.5.b).
To demonstrate that ASL specificity is feasible for other targeted populations, we
performed a similar experiment to isolate a minority of 104 Jurkat cells from a mixture
with 105 A549 cells. We labeled Jurkat cells with initiator by incubation in 1:5
biotinylated human anti-CD45 for 40 minutes in a solution of 3% FBS in 1x PBS,
followed by incubation in 10 µg/mL streptavidin-eosin for 30 minutes. After
photopolymerization with 530 nm light, the two distinct populations are consistent with
initial populations of coated 9% Jurkat cells and naïve 91% A549 cells (Figure 5.5.c).
Upon lysis with 5% SDS in PBS, ASL yielded a >96% pure Jurkat population as is
observed by flow cytometry (Figure 5.5.d).
Purity was further supported by fluorescence analysis when sorting a GFPtransfected A549 cell line. Polymer coating was performed in cell mixtures composed by
90% Jurkat cells and 10% GFP-positive A549 cells (Figure 5.6.a). The GFP fluorescence
signal serves as a strong biochemical reporter for A549 cell identity. GFP-positive A549
cell population is targeted using anti-EpCAM as described above for A549 cell sorting.
After polymerization, unprotected cells are lysed with 5% SDS. Prior to flow cytometer
analysis of the sorted population, cells are cultured overnight in media to allow the
recovery of GFP signal from photobleaching caused by the photopolymerization. ASL
yields a highly pure isolated fraction consisted of 97.1 ± 2.3 % GFP-positive A549 cells,
and only 2.9 ± 2.3 % GFP-negative cells per each 104 cell batch (Figure 5.6.b).
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5.3.3 Release of Sorted Cells From Polymer Coating
Removal of the polymer coating is essential for translation of ASL as a cell
isolation technology. We use a UV-degradable PEG-diacrylate monomer developed by
Kloxin et al. [123] to temporally control the presence of the crosslinked polymer coating.
Coated Jurkat cells were released from the polymer coating through 10 minute exposure
to 10 mW/cm2, 365 nm light in PBS and 10 mM EDTA. As photobleaching and particle
release possibilities weaken the certainty of direct observation of coating removal by
fluorescent means, the removal of the coatings was confirmed by proliferation assays of
the released cells and comparison to naive Jurkat cell. Released Jurkat cells proliferate at
rates comparable to naïve Jurkat cells (Figure 5.7.a), indicating the sufficient degradation
of the polymer coating to allow proliferation. We also evaluated the proliferation of
released A549 cells, which are anchorage dependent. The A549 cells had a 2 day lag in
proliferation (Figure 5.7.a). Discrepancies between the anchorage dependent A549 and
the anchorage independent Jurkat cells suggests residual polymer may interfere with
critical cell-substrate interactions. Observation of the cells in culture showed viable cell
spreading and residual red fluorescent polymer remaining after 1 day (Figure 5.7.c) and
although the fluorescent polymer can be observed still after 4 days of culturing (Figure
5.7.d), released A549 cells recover and proliferate at rates comparable to naive A549
cells. PEG hydrogels have been commonly used to prevent cell-substrate interactions,
and the screening of these interactions by residual polymer highlights an opportunity for
improvement of ASL through the more efficient removal of the polymer coating. Yield of
viable cells throughout the ASL process is 59 ± 1.2 % as determined by MTT assay,
(Figure 5.7.b) comparable to the viability achieved by FACS [133-135], which is
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promising for a newly-discovered technology. Cell viability was further supported by
caspase-3/7 + SYTOX (Figure 5.4). From the released cell population, more than the
72.6 ± 6.8 % of the cells remained alive, 19.5 ± 5 % were necrotic cells and the apoptotic
activity detected was negligible (0.5 ± 4 %).
The impact of UV light on the cell viability was studied by calcein assay and by
DNA damage quantification. There is a small impact (<10%) of UV light in the cell
viability after polymer degradation (Figure 5.8.a). DNA damage was quantified by
assessing the response of histone-2AX (H2AX) phosphorylation (ɣH2AX), a marker of
DNA double strand breaks [133-136]. ɣH2AX foci induction was monitored following
different time interval between UV light exposure and incubation in culture media
(Figure 5.8.b). Induction of ɣH2AX foci was negligible and not affected by the radiation
exposure time, suggesting no DNA damage in the cells after releasing them from polymer
coating upon UV irradiation.
5.3.4 ASL in Spiked Blood
Cellular isolation from actual biological samples is often more difficult than the
isolation of different cultured cell populations in buffers. Of these samples, blood is a
commonly targeted tissue for cells, and has many clinically relevant applications ranging
from progenitor cell isolation [137, 138] to cancer cell isolation [139, 140]. To support
the generalized use of ASL for isolations of rare cell populations beyond cultured cells,
we spiked A549 cells into the leukocyte-enriched plasma fraction harvested from
asymptomatic human blood subjected to cell sedimentation (Figure 5.9.a).
The mixed population was sequentially labeled with anti-EpCAM, biotin-antiMouse IgG, and streptavidin-eosin, prior to polymerization in the monomer formulation
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with 530 nm light at 30 mW/cm2 for 10 minutes. The polymer coated A549 cells are
distinguished from blood components by flow cytometry, constituting 16% of the
nucleated cells in the mixture (Figure 5.9.b). After exposure to 5% SDS, around 99% of
nucleated cells remaining correspond with A549 cells as quantified by flow cytometry
(Figure 5.9.c).
The scale-up of ASL promises the rapid processing of large quantities of cells.
ASL batch throughput is limited only by the lamp irradiation area. While our current
experiments are performed with inexpensive LEDs using a ~40 cm2 irradiation area, there
is a possibility of adaptation to commercially available irradiation chambers with bigger
irradiation areas (>850 cm2). By starting with a large sample, rare populations may be
isolated in appreciable numbers (~1010 cells per hour), allowing occult phenotypes to be
studied beyond single cell analytical techniques.
5.4 Conclusions
ASL constitutes a completely unique approach for cellular isolation. Even at this
early stage in development, the potential is clear for a high-purity, high-viability cell
isolation technique for both small and large batch isolations. As in the popular antibodycoated microfluidic systems, ASL is limited to single antigen sorts at a given sensitivity.
As such, it provides a high throughput alternative to microfluidic sorting which
complements existing antigen-negative magnetic sorting technology for high throughput,
high purity applications. Prior work has also shown the ease of tuning the sensitivity of
antibody-directed polymer coating system through antibody dilution or competitive
binding with non-labeled probes [141]. ASL’s reliance on common light sources (LEDs
from epifluorescent microscopes) allows capital costs to be >100x cheaper than a FACS
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system. Furthermore, all ASL processing can be performed in common disposable
labware, eliminating the expensive and time consuming sterilization procedures used in
most other sorting techniques. Additionally, others have shown fluorescein to be a
reasonable alternative to eosin-based initiation, where FITC-labeled antibodies could
potentially replace our custom eosin conjugates [141]. Further developments using
fluorescein-antibody conjugates for polymerization initiators would logically make ASL
even more accessible to a broad range of researchers.

81

Figure 5.1: Schematic figure of Antigen Specific Lysis. Cells are immunolabeled with
polymerization initiators, and protective coatings are formed only on initiator labeled
cells. Unprotected cells are lysed while coated cells remain viable.
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Figure 5.2: Structure and photocleavage route of ortho-nitrobenzyl-PEG-diacrylate
macromers. Adapted from Kloxin et al. (2009) [16].
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Figure 5.3: Protection of marker-positive cells through polymerization. a) Naive Jurkat
cells. b) Uncoated Jurkat cells are lysed in <10 seconds in 5% SDS. Only sparse cellular
debris remains in the viscous lysate. c) Polymer-coated Jurkats intact are after 10 minutes
in 5% SDS. d) Epifluorescent image of Jurkat cells coated with a red fluorescent
nanoparticle-loaded polymer in pure deionized water. Scale bars are 25 µm. e) Calcein
viability assay of Jurkat cells and polymer-coated Jurkat cells after 10 minutes in
indicated solution. Data are mean ± s.d.

84

Figure 5.4: Viability of Jurkat cells before and after polymer degradation measured by
Caspase and SYTOX assay. Data are mean ± standard error.
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Figure 5.5: Specific lysis of cultured cells. Representative flow cytometric analysis of
populations before and after exposure to SDS. a) Coating targeted to EpCAM+ cells from
an initial population of 9% Jurkat and 91% A549 after polymerization. b) Population
from (a) after 5 minute exposure to 5% SDS. c) Coating targeted to CD45+ cells from an
initial population of 9% A549 and 91% A549 after polymerization. d) Population from
(c) after 5 minute exposure to 5% SDS.
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Figure 5.6: Antigen Specific Lysis purity from a cell mixture composed by 90% Jurkat
cells + 10% GFP-positive A549 cells. a) Flow cytometric distribution from the cell
mixture before ASL and b) Flow cytometric data of GFP-positive cells after ASL.
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Figure 5.7: Proliferation and viability of processed cells. a) Proliferation rates of naive
(dashed line) or processed/released (solid line) cells. Jurkat cells (blue). A549 cells
(grey). b) Viability of Jurkat cells at critical steps in Antigen Specific Lysis processing.
Data are mean ± s.d. Calcein staining (green) images of released A549 cells after polymer
degradation after: c) 1 day and d) 4 days of culturing. The presence of red fluorescence
indicates regions of residual red fluorescent nanoparticle-loaded polymer.
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Figure 5.8: UV irradiation effect on cell viability. a) Cell viability determined by MTT
assay after 365 nm, 10 mW/cm2 light exposure over time. b) DNA repair activity in A549
cells after UV irradiation (365 nm, 10 mW/cm2). Activity correlated to fraction of cells
displaying ɣH2AX foci. X-axis indicates “[UV exposure time] => [recovery time prior to
analysis]”. Inset provides an expanded y-axis. H2O2 condition was 5 minutes of 0.2 mM
H2O2 and measured 30 minutes post exposure. Data are mean ± s.d.
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Figure 5.9: Isolation of EpCAM+ cells spiked into blood. a) Overview of approach. b)
Flow cytometric data of A549 cell spiked into erythrocyte-depleted blood after EpCAMspecific polymerization. Dashed line indicates distinction between polymer coated A549
cells and other blood components based on control studies of pure populations. c) Flow
cytometric data after lysis of EpCAM- components.
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Chapter 6: Quantitative Investigation of Surface Receptor Expression Density For
The Isolation of Tumor Cells
In this chapter, expression levels of common cancer markers are quantitated for
three breast cancer and two non-small cell lung cancer lineage models. These levels are
contrasted with that present on healthy peripheral blood mononuclear cells for
comparison to expected background levels in a fluid biopsy setting. A key feature of this
work is establishing a metric of markers per square micrometer. This describes an
average marker density on the cell membrane surface, which is a critical metric for
emerging isolation strategies. These results serve to extend expression of key tumor
markers in a sensitive and dynamic manner beyond traditional “positive”/”negative”
immunohistochemical staining to guide future fluid biopsy targeting strategies. The work
presented here is adapted with minor modifications from work previously published:
Calvin F. Cahall, Jacob L. Lilly, Edward A. Hirschowitz, Brad J. Berron. A
Quantitative Perspective on Surface Marker Selection for the Isolation of
Functional Tumor Cells. Breast cancer: Basic and Clinical Research. 9(Suppl
1):1, 2015.
6.1 Introduction
Much effort has gone into developing fluid biopsies of patient peripheral blood
for the monitoring of metastatic cancers. One common approach is to isolate and analyze
tumor cells in the peripheral blood [6, 8]. Widespread clinical implementation of this
approach has been hindered by the current choice of targeting epithelial markers known
to be highly variable in primary tumor sites [4]. Marker-targeting isolation strategies are
intrinsically dependent on the level of antigen expression presented on target cells. Low
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quantities, and more specifically low densities, of the target marker will decrease the net
binding recognition of antibodies to a marker positive cell surface, potentially leading to
poor discrimination between positive and negative events [4, 12]. Critically, the current
literature poorly describes the expression of even the best known tumor markers on the
most commonly studied tumor cell lines. Typically, the expression of a marker is
communicated as positive or negative. At best, papers will communicate relative levels in
terms of dim, moderate, bright, or variable. Alternatively, the level of receptor expression
is given as moles of receptor per mass of cell lysate. Techniques that have been used to
detect cell antigens qualitatively and quantitatively include enzyme immunoassay (EIA)
and enzyme-linked immunosorbent assay (ELISA) [142, 143]. However, these techniques
that quantify expression on a total mass basis are minimally useful in the development of
viable cell sorting, as they report antigens that may be present only intracellularly and
unavailable for targeting on an intact, viable cell [144, 145].
Herein, we seek to quantify the surface expression level of these critical markers
on common cell lines. This work represents a critical step in assessing the opportunities
and limitations of isolating functional tumor-associated cells from peripheral blood. We
have chosen tumor cell lines, as the majority of clinical research has centered on the
utility of finding epithelial cells in circulation. Finally, we discuss the significant
limitations of using these in vitro cell models for CTCs in the study of rare cancer cell
biology.
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6.2 Materials and Methods
6.2.1 Cell Culture
Three breast cancer cell lines and two non-small cell lung cancer (NSCLC) cell
lines were cultured. Breast cancer lines included MDA-MB-231 (mammary
adenocarcinoma), MCF-7 (mammary adenocarcinoma), and T-47D (mammary ductal
carcinoma), and NSCLC lines included A549 (alveolar adenocarcinoma) and H358
(bronchioalveolar carcinoma). All tumor lines were cultured in RPMI-1640 growth
medium (HyClone) supplemented with 2.05 mM L-glutamine, 10% fetal bovine serum
(FBS, Fisherbrand), and 1% penicillin-streptomycin (Sigma Aldrich), and maintained at
5% CO2 in air and 37 ˚C. Cells were cultured for 48 hours and were approximately 6080% confluent just before experimentation. Additionally, a peripheral blood control
sample was obtained with informed consent through University of Kentucky Medical
Center IRB protocols and processed within an hour of collection. Briefly, whole blood
was mixed with a dextran/NaCl solution to a working concentration of 2 wt% dextran and
0.3 wt% NaCl and was allowed to separate by 1xg sedimentation at room temperature for
1 hour. The buffy coat containing peripheral blood mononuclear cells (PBMC) was then
pipetted off and exposed to red blood cell lysis buffer (155mM NH4Cl, 10mM KHCO3,
0.1mM EDTA) for 5 minutes to further remove red blood cells from the sample. The
nucleated cells were collected by centrifugation at 300xg for 5 minutes and washed twice
with cold 1X PBS.
6.2.2 Cell Imaging
Representative bright field, phase contrast images of all tumor cell lines were taken with
a Nikon Ti-U inverted microscope.
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6.2.3 Surface Marker Immunostaining
Tumor cells were incubated with trypsin/EDTA (0.25%) solution for 3 minutes to
allow for detachment, rinsed with growth medium and centrifuged. Cell concentration
and cell diameter was determined optically with a Cellometer Automated Cell counter
(Nexelcom). Each data replicate sample consisted of 1x105 cells in a microcentrifuge
tube. For experimentation, a rinsing buffer of 1X PBS with 3% FBS was prepared and
used for all rinsing steps. All materials and cell samples were kept on ice throughout the
staining procedure. For immunolabeling, cell samples were first rinsed once with rinsing
buffer and centrifuged (400xg, 1.5 minutes). Subsequently, samples were incubated with
primary antibodies at ~0.5 μg in 150 μl of rinsing buffer for 40 minutes. For all cell lines,
markers were targeted with primary monoclonal mouse IgG antibodies with
corresponding isotype controls that consisted of: CD326/EpCAM (IgG2b, clone 9C4,
BioLegend, San Diego, CA), HER1/EGFR (IgG1, clone AY13, BioLegend), CD44
(IgG1, clone BJ18, BioLegend), E-cadherin (IgG1, clone 67A4, BioLegend),
erbB2/HER2 (IgG1, clone 24D2, BioLegend), N-cadherin (IgG1, clone8C11,
BioLegend), alphaV-beta3 integrin (IgG1, clone 23C6, BioLegend), ICAM-1 (IgG1,
clone HA58, eBiosciences, San Diego, CA), ER-α (IgG2a, clone F-10, Santa Cruz
Biotechnology, Dallas, TX). Samples were then rinsed twice with rinsing buffer on ice,
with centrifugation between rinses. Cells were then labeled with biotinylated goat antimouse IgG antibody (Vector Labs, Burlingame, CA) at a 1:400 dilution in rinsing buffer
on ice for 40 minutes. Cells were rinsed twice with rinsing buffer and incubated with
streptavidin-phycoerythrin at ~1 μg in 200 μl on ice for 20 minutes. Samples were rinsed
three times and resuspended in ~200 μl rinsing buffer for immediate analysis.
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6.2.4 Flow Cytometry
Cell sample immunofluorescence was assessed with an Accuri C6 flow
cytometer. Samples were kept on ice, then gently vortexed before a cytometry run. For
each replicate, 5000 cell events were collected based on initial cell culture control gating.
Phycoerythrin fluorescence data was collected for each sample in the FL2 channel
configured for excitation with a 488 nm laser and emission detected through a 585/40
bandpass filter.
6.2.5 Data Analysis
Data is calculated as mean ± standard error of the geometric means of event
populations (N=3) for all marker quantification assays and cell diameter calculations.
Standard deviation within individual replicates of cytometry data is also reported.
Quantibrite PE bead calibration was performed during cell immunofluorescence data
collection and fluorescence calibration values are collected in channel FL2. Statistical
analysis consisted of a two-tailed student t-test performed in Matlab to calculate p-values.
6.3 Results and Discussion
6.3.1 Imaging Analysis
A summary of cell types and corresponding cell sizes is shown in Table 6.1.
From a regression analysis relating mean forward scatter and mean Cellometer cell size
(Figure 6.1), cell diameters of individual populations of lymphocytes, monocytes, and
granulocytes were extrapolated. As expected, these PBMC showed diameters smaller
than epithelial cancer cells. To estimate cell surface area, a spherical model was assumed
for each cell. While some cell types can possess membrane folds that can alter diameter
and surface area in certain scenarios (e.g. activation of white blood cells) [146], we posit

95

this simple model is sufficient to generally show accessible marker densities on the
surface of the cells studied here. For morphological comparison, representative bright
field images of tumor cell lines are shown in Figure 6.2. The basal-like breast line MDAMB-231 [147] show morphology quite distinct from any other investigated in the study,
with elongated, multi-polar behavior and favoring minimal cell-cell contact consistent
with basal subtypes. Luminal breast lines MCF-7 and T-47D [148] and NSCLC line
H358 show morphology more consistent with an epithelial phenotype favoring extensive
cell-cell contact and colonization. NSCLC line A549 appears to exhibit behavior
somewhere between these extremes with less organized cell junctions.
6.3.2 Quantitation of Marker Expression by Flow Cytometry
The results of marker quantitation using the flow cytometric Quantibrite assay are
presented in Figures 6.3 and 6.4, where Phycoerythrin fluorescence signal serves a
reporter for antigen quantity. Expression data is presented here both as expression fold
over isotype controls as well as normalized to the calculated mean surface area for each
cell type. Because we employed an indirect immunostaining approach, some labeling
amplification inherent in antibody binding interactions was seen. A biotin anti-EpCAM
primary was labeled in parallel to biotin-anti-mouse secondary staining, with only a ~1.3fold amplification seen for secondary immunolabeling. Further, we also expect some
amplification at the biotin/SA-PE labeling interaction. Although this may skew the
representation of the actual number of biological copies of these surface proteins, the
focus of our study was to provide a methodology engineering perspective on the
maximum level of antigen affinity recognition afforded by traditional immunolabeling for
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viable CTC isolation, where some amplification is not only acceptable but desired.
Moreover, as all markers were tagged with identical indirect staining approaches, relative
expression across cell lines and between markers should be consistent regardless of any
labeling amplification.
Overall, marker expression levels often varied drastically between cell lines with
some correlation seen between cell morphology, behavior, and marker profiles.
Specifically, MDA-MB-231 showed significantly decreased PE labeling density for
EpCAM and E-cadherin compared to MCF-7, T-47D, and H358 (p-values<0.001), while
showing higher levels of labeling density for CD44, EGFR and ICAM-1 (p-values≤0.01,
Figure 6.4). A549 also showed decreased EpCAM and E-cadherin density (pvalues<0.001) and increased CD44 density over MCF-7, T-47D, and H358 (pvalues<0.01). EGFR and ICAM-1 expression seemed to be consistently high, resulting in
PE label densities equal to or greater than 100 per μm2 for all cell lines except MCF-7.
EGFR has been linked to a basal-like molecular signature [149], and elevated levels of
EGFR and ICAM-1 have been linked to metastatic disease [150, 151]. The αV-β3
integrin is elevated 10-fold in MDA-MB-231 cells compared to the other tumor lines
investigated (p-values<0.001), with ~30 PE molecules per μm2. Of particular interest for
breast cancer lines was ERα and HER2 expression because of their prominent clinical
role in breast cancer classification, prognosis and therapy selection. The antibody chosen
(clone F-10, Santa Cruz) targeted the c-terminus ligand binding domain. All three breast
cancer lines showed a slight increase in ERα expression over isotype controls (pvalues<0.05, Figure 6.3.a-6.3.c), and a statistical elevation in expression over NSCLC
lines (p-values<0.05) which showed virtually no ERα expression, with the exception of
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MCF-7 compared to A549 (p=0.15, Figure 6.3.d, 6.3.e). HER2 expression was expressed
at relatively high levels in all three breast cancer lines as well as NSCLC lines, resulting
in roughly 50-100 PE molecules per μm2 (Figure 6.4).
Our study also sought to provide background expression levels on PBMC for
comparison, as it is ultimately a determining factor in marker selection for isolating CTCs
from peripheral blood. Figure 6.3.f shows marker expression fold over IgG for separately
gated lymphocyte, monocyte, and granulocyte populations. Notably, relatively elevated
levels of both CD44 and ICAM-1 are seen. In Figure 6.4.f, the PE binding density is
reported for PBMC, showing high non-specific noise in isotype controls, especially for
monocytes. This immunolabeling noise can reduce the biorecognition contrast between
the target tumor cells for capture and the majority PBMC, so here we further demonstrate
the PE labeling density fold vs peripheral blood monocyte expression, which represent
the most likely culprits for false-positive capture (Figure 6.5). First, MDA-MB-231
showed drastically attenuated EpCAM (p=0.0038) and E-cadherin (p=0.90) elevation
over monocytes due to low expression seen in Figure 6.4.a. EGFR contrast remains high
for MDA-MB-231 and NSCLC lines (p-values<0.01). Although CD44 and ICAM-1 were
highly expressed across all cancer lines in the study, the contrast over blood cells is
reduced because of corresponding high expression in PBMC. MDA-MB-231 have a
slight CD44 contrast over monocytes, and MDA-MB-231 and A549 both retain high
contrast for ICAM-1 expression (p-values<0.01). Finally, N-cadherin and αV-β3 integrin
expression on all five cancer lines investigated shows little to no elevation over that of
peripheral monocytes.
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Here, we have reported quantitative results of levels of antibody-mediated
recognition attained for several commonly investigated markers associated with
metastasis on both breast cancer and NSCLC lines. To our knowledge, very little
information is reported on the numbers of marker proteins present on cancer cell
membrane surfaces. While many fundamental biology questions can be answered with
immunohistochemical and blotting assays that yield binned “positive” or “negative”
information, these approaches generally fail to represent the highly dynamic and variable
expression patterns seen for many tumor cells [31, 145, 152]. Particularly for antibodybased cell isolation methodologies, the ability to capture a marker-presenting cell
amongst a majority of marker-negative cells is critically dependent on the amount of
marker proteins available on the cell surface for labeling. In this light, we propose these
findings represent a significant step toward providing the tumor cell isolation community
with quantitative antigenic expression information.
Notably, our results show distinct expression signatures for basal and luminal
breast cancer subtypes consistent with the characteristics commonly associated with each.
Basal-like cells are often seen to be more highly invasive and de-differentiated, while
luminal-type cells are often considered epithelial-like [148, 149]. MDA-MB-231 are
classified as basal, whereas MCF-7 and T-47D are luminal A subtypes. We found that
MDA-MB-231 showed elevated levels of mesenchymal and/or metastatic markers CD44,
N-cadherin, αV-β3 integrin, ICAM-1, as well as upregulation of EGFR commonly seen
for basal subtypes (Figure 6.3.a) [149]. Further, the basal-like MDA-MB-231 also
showed lower expression of epithelial markers EpCAM and E-cadherin compared to
MCF-7 and T-47D (Figure 6.3.a-6.3.c). Elevated levels of mesenchymal markers have
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been linked to a more metastatic phenotype, as these proteins play key functional roles as
tools for migration and invasion [18]. In the context of CTC isolation that currently is
predominantly based on EpCAM+ sorting, these results highlight a disconnect between
marker targeting strategy and the biologic tendencies of highly invasive cells.
Specifically, a detection threshold of EpCAM expression exists for any antibody-based
isolation methodology, and highly-invasive cells downregulate EpCAM and have a
higher potential to go “unseen” as false negatives.
A surprising result was also seen for ERα expression in comparing the basal
(MDA-MB-231) and luminal A (MCF-7 and T-47D) subtypes in the study. All three cell
lines showed a similar expression of HER2, which was not unexpected for basal and
luminal A subtypes that generally do not have overexpression of HER2 [148]. However,
we found that MDA-MB-231 cells also expressed similar surface densities of ERα
compared to MCF-7 and T-47D. One possible explanation could be that because our
focus was to determine antigen densities on intact tumor cell surfaces, the antibody
chosen for ERα targeting (clone F-10, Santa Cruz Biotech) targeted the C-terminal ligand
binding

domain;

however,

these

nuclear

receptors

are

often

trafficked

intracellularly.[153] Therefore, these results do not account for intracellular ERα where
differences in expression between basal and luminal A subtypes could arise.
Our study also sought to offer some order-of-magnitude perspective on expression
levels of surface markers CD44, N-cadherin, αV-β3 integrin and ICAM-1 implicated in
metastatic progression [150, 154, 155], as these could potentially serve as promising new
targets for sorting clinically relevant cells. A poorly expressed molecule may play an
important role biologically, but would be of minimal utility as a target for live cell
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isolation. Furthermore, a molecule may even be highly expressed, but if it is also highly
expressed on peripheral blood cells, it would no longer serve to distinguish epithelial
identity from the background blood cells. PBMC marker expression was normalized to
cell size similarly to epithelial cells, and PBMC size estimates were found to be in fair
agreement with literature [156, 157]. We found that although both N-cadherin and αV-β3
integrin were upregulated on some lines (MDA-MB-231 and A549), their inherent
expression density was still approximately equal to or below the expression found on
peripheral monocytes, which consistently showed the highest background staining
levels(Figures 6.4.f and 6.5). Additionally, while CD44 was relatively high for all cancer
lines (Figure 6.4) it was also highly expressed in PBMC which reduced the expression
ratio over monocytes to nearly 1 or below for all lines except MDA-MB-231 that retained
a 7-fold ratio over monocytes (Figure 6.5). Therefore, because our results show minimal
differences in expression of these markers over blood cells, they are not recommended
for targeting intact tumor cells. It is worth noting though that more work is warranted in
quantitating the extent of elevation of markers like N-cadherin shown to undergo a
“cadherin switch” from stromal cytokine stimulation in vivo [158, 159]. This phenotypic
transition is correlated with a more invasive cell and could conceivably potentiate Ncadherin as a target for tumor cell isolation. ICAM-1 expression density was seen to be
approximately 30- to 60-fold higher than monocytes for T-47D and MDA-MB-231,
respectively (Figure 6.5). ICAM-1 is involved in cell adhesion interactions, migration,
and has been recently been classified as a mesenchymal cell marker [160-162]. Further,
one recent study has shown that increased populations of ICAM-1high CTCs correlated to
poorer prognosis in hepatocellular carcinoma patients [150]. Coupled with these findings,
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our results point toward ICAM-1 as a potential target for isolation of clinically relevant
tumor cells.
6.4 Conclusions
We have reported surface marker densities on several model tumor cell linages to
guide the development of isolation methodologies for live and functional CTC
populations. The surface density of targeted markers is a critical parameter for any
antigen-based CTC capture platform, and likely represents a key oversight that has led to
poor performance of many previously developed technologies. Our results also indicate
extreme variability in expression between markers and cancer cell lines, and illustrate the
need for greater appreciation of heterogeneity at the surface marker level across different
cancer subsets. While Figure 6.3 and Figure 6.4 are presented as mean with standard
error of mean, Figure 6.6 also shows that the variance in immunofluorescence for cell
events within each replicate was often considerably higher. This could be due in part to
the inherent variability within the cultured cell population, as well as due to deviations
from a mean Kd for each antibody used. As with any antibody based assay, the variance
in antibody binding affinity from different suppliers should be carefully considered when
interpreting these data as well as in designing an antibody-based isolation strategy.
Further, cancer heterogeneity has also been widely reported for in vivo settings [152,
163]. Cytokine signaling and tumor-stromal interactions can cause certain subsets of
malignant cells to display drastically altered marker profiles, some resembling stem-like
phenotypes in what is referred to as epithelial-mesenchymal transition [1]. These highly
potent subsets have been reported to go largely unnoticed in EpCAM+ based CTC
isolation strategies, leading many to suggest that perhaps EpCAM alone is not sufficient
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to capture any and all CTCs [12, 164]. Our findings further support that EpCAM surface
presentation cannot be assumed to be similar for all tumor lines, and more comprehensive
targeting strategies that account for expression level variability is warranted. One
possible strategy would be to use panels of antibodies to target several tumor markers to
ensure successful capture in instances where certain markers are downregulated. For
example, Yu et al. targeted patient-derived breast CTCs with a cocktail of EpCAM,
EGFR, and HER2 antibodies in a microchip device approach, where subsequent
fluorescent immunostaining of captured cells revealed they possessed highly variable and
dynamic phenotypes with both epithelial and mesenchymal markers [31]. Building upon
these types of robust targeting strategies will be vital for developing future generations of
more clinically relevant fluid biopsy technologies.
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Table 6.1: Summary of cell types analyzed in the study. Diameter and surface area
calculations are reported as mean ± s.e.m.
2

Cell Type

Description

Diameter (μm)

Surface Area (μm )

MDA-MB-231

mammary
adenocarcinoma

11.5 ± 0.3

415 ± 19

MCF-7

mammary
adenocarcinoma

17.1 ± 0.4

922 ± 43

T-47D

mammary ductal
carcinoma

14.5 ± 0.3

663 ± 34

A549

alveolar adenocarcinoma

15.0 ± 0.4

710 ± 38

H358

bronchioalveolar
carcinoma

16.8 ± 0.5

890 ± 47

Peripheral
Lymphocytes

Healthy PBMC

6.7 ± 0.1

142 ± 1

Peripheral
Monocytes

Healthy PBMC

7.9 ± 0.1

197 ± 2

Peripheral
Granulocytes

Healthy PBMC

8.2 ± 0.1

209 ± 1
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Figure 6.1: Plot of regression analysis relating mean forward scatter vs. mean Cellometer
cell diameter for all five cancer lines.
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Figure 6.2: Representative bright field micrograph images of cultured breast cancer lines
(MDA-MB-231, MCF-7, T-47D) and non-small cell lung cancer lines (A549, H358).
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Chapter 7: The Role of Surface Receptor Density in Surface-Initiated
Polymerizations for Cancer Cell Isolation
In this chapter, we demonstrate the labeling density of photoinitiators is strongly
correlated with the yield of intact cells during ASL by flow cytometry analysis. Results
suggest ASL is fundamentally capable of delivering approximately 50-60% of targeted
cells after isolation, which rivals competing methodologies. The gelation response during
ASL polymerization is also investigated via protein microarray analogs on planar glass.
Finally, a density threshold of photoinitiator labeling required for protection during lysis
is determined for both monomer formulations. These results indicate ASL is a promising
technology for high yield CTC isolation for rare-cell function assays and fluid biopsies.
The chapter presented here is adapted with minor modifications from the following work
currently in review:
Jacob L. Lilly, Brad J. Berron. The Role of Surface Receptor Density in SurfaceInitiated Polymerizations for Cancer Cell Isolation. Langmuir, In Review.
7.1 Introduction
Fluid biopsies potentially offer a minimally invasive alternative to traditional
tissue biopsies for the continual monitoring of metastatic cancer [33, 165]. Current
established technologies for isolating circulating tumor cells (CTCs) suffer from poor
purity, yield, and require fixatives that preclude the collection of viable cells for
longitudinal analyses of biological function. Antigen Specific Lysis (ASL) is a rapid,
high-purity method of cell isolation based on targeted protective coatings on antigenpresenting cells and lysis depletion of unprotected antigen-negative cells. In ASL,
photoinitiators are specifically labeled on cell surfaces that enable subsequent surface-
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initiated polymerization. (See Appendix A-5 for details on cell protein specificity) While
we have shown ASL delivers viable (~90%) and highly pure (>97%) populations of
marker-presenting cells, cell yield has yet to be fully investigated for this process. For
CTC sorting, target cells exist in extreme rarity (~1 per 106 nucleated cells). Increasing
isolation yield will minimize the occurrence of false negatives and potentially provide the
key difference for an accurate diagnosis. Further, for any antigen-based isolation
platform, successful positive capture of cells is inherently dependent on the density of
surface markers available for targeting. For ASL, the surface density of markers dictates
the concentration of eosin photoinitiators present at the cell surface. A distinct threshold
eosin density has been previously reported for surface-mediated polymer amplification
assays, below which radical generation is not sufficient for gelation [92, 125]. Therefore,
we hypothesize a minimum density of antibody-photoinitiator binding is required to form
complete protective coatings.
Herein, we investigate the effect of photoinitiator loading on polymerization and
lysis-based negative depletion of cells. (Figure 7.1) A non-small cell lung cancer line
(A549) serves as a model CTC. To eliminate heterogeneity in surface marker clustering,
our investigation first nonspecifically biotinylates the cell surfaces for polymer protection
studies. This approach allows for more consistent biotin functionalization and limits the
potential for signaling activation that targeting a specific marker might enact, which
could influence our results. We then shift to the more clinically relevant antibody-based
strategies, targeting either EpCAM or a panel of metastatic markers for comparison to our
covalent labeling approach. Finally, we relate the density dependent protection to thin
film polymerization behavior on an analogous system of biotin-functionalized protein
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microarrays. These glass microarrays afford a controlled environment to quantitatively
determine the gelation response to the photopolymerization conditions used in the cell
studies.
The impact of this study extends beyond our new lysis isolation process to the
field of immunoprotective coatings on cells. Immunoprotection requires a complete
polymer barrier to isolate the non-native cellular material from a host’s immune response.
Several groups are utilizing nano- and micro-scale polymers to isolate individual cells
from immune response [54, 166-170]. As the thickness of these materials decreases, the
diffusive flux of oxygen and low molecular weight nutrients increases. Critically, as the
coating thickness approaches the diffraction limit of light, it is increasingly challenging to
visually verify the completeness of the coating. This study uses surfactant lysis as a new
approach to cheaply and quickly verify the completeness of the coating.
7.2. Materials and Methods
7.2.1 Reagents and Materials
The A549 cell line (non-small cell lung cancer) was purchased from American
Type Culture Collection. RPMI-1640 culture media, penicillin/streptomycin (1%), and
trypsin/EDTA (0.25%) were supplied by Gibco™. Advantage-grade fetal bovine serum
(FBS) was purchased from Atlanta Biologicals. Lyophilized streptavidin, streptavidinCy3 conjugate, biotinylated bovine serum albumin (b-BSA), sulfo-NHS-LC-biotin,
CellTracker™-Deep Red dye, Hoechst 33342 stain, and yellow-green FluoSpheres™
nanoparticles (0.02μm, carboxylate-terminated, 505/515nm excitation/emission) were
purchased through Thermo Fisher Scientific. Bovine serum albumin (BSA), Polyethylene
glycol diacrylate (Mn~575), Polyethylene glycol (Mn~3400), monomer MEHQ dehibiting
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columns,

1-vinyl-2-pyrrolidinone,

acryloyl

chloride,

triethylamine,

Eosin-5-

isothiocyanate (EITC), sodium dodecyl sulfate (SDS) were all supplied from Sigma
Aldrich. Triethanolamine (TEA), dichloromethane (DCM), and diethyl ether were
supplied by Fisher Chemical. DNase I (>500U/mg, from bovine pancreas) was supplied
by Biomatik. Monoclonal antibodies against EpCAM (IgG2b, clone 9C4), CD44 (IgG1,
clone BJ18), and HER1/EGFR (IgG1, clone AY13) were purchased from BioLegend, and
anti-ICAM-1 (IgG1, clone HA58) was purchased from eBiosciences. Biotinylated goat
anti-mouse IgG antibody was purchased from Vector Labs. Streptavidin R-phycoerythrin
conjugate was purchased from Anaspec. The QuantiBRITE phycoerythrin (PE)
fluorescence flow cytometry quantitation kit was supplied by BD Pharmingen.
7.2.2 Monomer Synthesis and Preparation
Polyethylene glycol diacrylate (Mn~575, PEGDA-575) was twice flowed by
gravity through a dehibiting column to remove the polymerization inhibitor monomethyl
ether hydroquinone, and stored for use protected from light at room temperature.
Polyethylene glycol (Mn~3400) was dissolved in DCM and reacted with acryloyl chloride
and triethylamine according a previously published protocol [171]. Monomer product
purity (~90% acrylation yield) was confirmed by 1H-NMR and was stored at 80% (w/v)
in water protected from light. Co-monomer 1-vinyl-2-pyrrolidinone was used as received.
7.2.3 Photoinitiator-Protein Conjugation
The conjugation reaction to label eosin-5-isothiocyanate to streptavidin primary
amines was adapted from a previous protocol with only a minor protocol modification of
reacting at pH 10 in 0.1 M carbonate/bicarbonate buffer [98]. Conjugates were purified
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with a 5 mL 7 KDa MWCO Zeba desalting column and the molar ratio confirmed with
UV-vis analysis of absorbances at 280nm and 530nm. (see Appendix A-2 and A-3)
7.2.4 Cell Culture and Fluorescent Labeling
A549 cells were cultured in RPMI-1640 supplemented with 10% FBS and 1%
penicillin/streptomycin at 37˚C and 5% CO2 for approximately 48 hours. Cell flasks were
75-90% confluent at the time of experimentation. To harvest the A549 cells, the culture
media was removed and the cells were washed with 37˚C sterile phosphate buffered
saline (PBS 1X). Trypsin/EDTA (0.25%) was added to each flask and incubated for 3-5
minutes. Fresh culture media was added to the flask and gently rinsed by pipetting to
detach cells. The cell suspension was then centrifuged at ~500g for 3 minutes and the
supernatant discarded. The cell pellet was resuspended in fresh media and immediately
stored on ice. To begin fluorescent labeling cell samples, cells were first centrifuged at
500g for 1.5 minutes at 4˚C and resuspended in cold PBS by gentle vortexing. Initial cell
counts from culture were obtained by flow cytometry using an Accuri C6 cytometer and
adjusted to 1x106 per sample tube. Cells were rinsed in cold PBS twice more, then
resuspended by vortexing in 0.5 μM CellTracker™-Deep Red in cold PBS and incubated
for 30 minutes on ice. Samples were then rinsed three times with cold PBS as before.
Experiments investigated two groups: covalently biotinylated cell samples and antibody
immunolabeled samples.
For covalent biotinylation, cells were incubated with 1 mM sulfo-NHS-LC-biotin
prepared in cold PBS for 30 minutes then rinsed three times with cold PBS. Cells were
then rinsed once more with PBS supplemented with 3% FBS in PBS (PBS/FBS) and
incubated for 10 minutes on ice. To predictably and incrementally vary photoinitiator
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loading while keep covalent biotinylation conditions constant, streptavidin-EITC was
combined with unconjugated streptavidin at known and varied ratios with a total
streptavidin concentration of 25 μg/mL. Upon contacting with cells for 30 minutes, the
proteins competitively bound to biotin sites, allowing for photoinitiator (eosin) to be
reliably loaded at desired levels. After rinsing twice with cold PBS, cell count was
obtained by cytometry and adjusted to 3x105 cells per sample tube to ensure consistent
cell density during cell photopolymerization.
For antibody labeling of samples, cells were incubated with primary antibodies
(anti-EpCAM or a “metastatic” cocktail of anti-CD44, anti-ICAM-1, and anti-EGFR)
consisting of 0.5 μg of each antibody in 100 μL PBS/FBS for 40 minutes, then rinsed
three times in PBS/FBS. Cells were then resuspended in 1:400 dilution of biotinylated
goat anti-mouse IgG antibody in PBS/FBS for 40 minutes, and rinsed again three times
with PBS/FBS. After the biotinylation by immunolabeling, samples were incubated with
25 μg/mL SA-EITC for 30 minutes protected from light. After rinsing twice with cold
PBS, cell count was obtained by cytometry and adjusted to 3x105 cells per sample tube to
ensure consistent cell density during cell photopolymerization. A negative labeling
control was also performed for each monomer formulation that consisted of A549 cells
incubated with 25 μg/mL SA-EITC for 30 minutes without prior incubation with
biotinylating agents, followed by the polymerization and lysis procedures detailed for
biotinylated samples.
7.2.5 Cell Suspension Photopolymerization and Lysis
Polymerization formulations were prepared in PBS consisting of 21 mM TEA, 35
mM VP, with 25% (w/v) of either PEGDA-575 or PEGDA-3500, and 0.05% (w/v)
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Fluosphere nanoparticles. All formulations were adjusted to pH~7.5 with 1.2 M HCl and
purged with humidified, ultra-pure N2 for 15 minutes just prior to combining with cells.
Each sample was polymerized in a sterile cover glass-bottom 35 mm culture dish placed
inside a 150 mm culture dish outfitted with purging inlet and outlet ports. (See Appendix
Figure A-1) The entire system was purged with N2 for 5 minutes, at which point
irradiation light was introduced while continuing to purge, consisting of 30 mW/cm2
collimated 530 nm light (ThorLabs LED lamp) for 10 minutes. Lysing solutions were
prepared in two parts: (1) DNase I solution of 5 mM MgCl2, 1 mM CaCl2 and 500 U
DNase I in PBS, (2) 10% SDS in PBS. Lysing in the presence of DNase minimizes cell
clumping due to free DNA in solution. After polymerization and rinsing, each cell pellet
was gently resuspended in 500 μL of solution (1) and incubated for 5 minutes at room
temperature, followed by addition of 500 μL of solution (2).
7.2.6 Flow Cytometry and Cell Fluorescence Analysis
Cell samples were analyzed during the isolation process just before addition of
polymerization solution and after the lysis procedure to calculate the percent yield. To
obtain a cell count before polymerization, each sample was redistributed evenly in 10 mL
of cold PBS, and then 150 μL of the suspension was pipetted off for analysis. Cytometer
fluidics were set to analyze 100 μL of the sample volume. “Positive” cell counts were
defined from controls as FL4+ (CellTracker-Deep Red) and FSC≥2x106 (intact cell). (see
Figure 7.2) Additionally, the FL1 channel was monitored in this gated population to
determine the SA-EITC loading corresponding to each sample. Identical run constraints
and gating were imposed after lysis to monitor yield. In parallel experiments,
streptavidin-PE conjugates were also reacted with covalently biotinylated A549
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populations at identical conditions to streptavidin-EITC binding experiments at various
loading levels to calibrate FL2 of streptavidin-PE loaded samples vs. FL1 of SA-EITC
loaded samples. Samples of 10,000 events were analyzed by flow cytometry and the FL2
mean fluorescence of SA-PE tagged samples was plotted vs. FL1 of identically
biotinylated SA-EITC samples, shown in Figure 7.3.a. BD QuantiBRITE PE quantitation
beads were then used to quantify PE fluorescence by vortexing in 500 μL PBS and
analyzing in the FL2 channel to calibrate PE binding on biotinylated A549 cells, as
shown in Figure 7.3.b. The degree of substitution (DOS) of SA-PE and SA-EITC was
also determined for fluorescent analysis. The mean DOS of SA-PE was provided by the
manufacturer (Anaspec) to be 1.07 phycoerythrin per streptavidin. The DOS of the SAEITC conjugate was determined by UV-Vis analysis. Standard curves of unconjugated
streptavidin and EITC were prepared, allowing for Equation A-2.1 to be generated that
outputs the molar ratio of EITC to SA. The UV-vis of the conjugate used in this study is
shown in Figure A-2, and the absorbance values at 280 nm and 530 nm were used to
calculate a mean DOS of 4.05 eosin groups per streptavidin. Finally, an average cell
diameter of 17 μm was determined through automated bright field image analysis with a
Cellometer cell counter (Nexelcom) and was used to calculate average cell surface area
of 908 μm2, assuming a perfect spherical cell geometry. Using these data with the
fluorescence cytometry calibrations listed above, Equation 7.1 was developed to
determine eosin molecule density from the mean FL1 obtained for each yield
experimental trial.
7.2.7 Cell Fluorescent Imaging
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A549 cells were imaged after exposure to lysing conditions with a Nikon Ti-U
inverted epifluorescent microscope. Cells were incubated with 5 μg/ml Hoechst 33342
stain for 10 minutes, rinsed once with cold PBS and pipetted onto a coverslipped
microscopy slide for imaging with a 20x objective. Hoechst DNA staining was imaged
with UV excitation, followed by an overlay image of blue excitation to visualize the
yellow-green imaging nanoparticles loaded in polymer coatings.
7.2.8 Microarray Fabrication and Hydrogel Film Formation
Epoxy-functionalized slides were washed with ethanol and loaded into an
Affymetrix 417 Arrayer. Serial dilutions of bio-BSA and BSA were prepared in PBS,
keeping the total protein concentration in solution constant at 1 mg/ml. Biotinylated-BSA
concentration was varied to print 12 concentrations (1000, 400, 160, 64, 25.6, 10.2, 4.1,
1.64, 0.66, 0.26, 0.1, 0 μg/ml). Each slide was printed with an array of 24 spots with each
concentration duplicated as shown in Appendix A-4. Slides were allowed to dry
overnight before experimentation. Each array slide was loaded into a Whatman Chip Clip
slide incubation apparatus, and blocked for 1 hour with 1 mg/ml BSA in PBS. Slides
were then incubated for 30 minutes in 25 μg/ml SA-EITC in 1 mg/ml BSA in PBS.
During incubation, the slides were protected from light to prevent photobleaching during
photoinitiator loading at biotinylated sites. Slides were then rinsed 3 times with PBS, and
photopolymerized with either PEGDA-575 or PEGDA-3500 monomer formulations at
identical conditions as detailed above for live cell coatings. Slides were then washed once
with PBS, 3 times with deionized water, and allowed to dry for 1 hour. To measure
thickness response, a Dektak 6M stylus profilometer was used with a 1 mg stylus force
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and a scan rate of 120 μm/s. Average height of each spot was measured, with n=6 spots
for each measurement.
7.2.9 Cy3 Calibration of Slide Fluorescent Labeling
Array fluorescence was measured using an Affymetrix 428 Array Scanner.
Streptavidin-Cy3 conjugates were contacted with array slides at identical conditions as
for SA-EITC conjugates detailed above (n=6 spots at each concentration analyzed for
Cy3 binding). Both SA-Cy3 and SA-EITC fluorescence was then measured with 532 nm
laser excitation, detection with a PMT with a bandpass filter centered at 570 nm, and the
gain set at 30 db. Array spot binding density was then calculated by calibrating at 30 db
gain with a Cy3 scanner calibration slide from Full Moon Biosystems. Calibration slides
contain 12 replicate spots of 28 different concentrations arranged at a 2-fold dilution. By
UV-Vis spectroscopy analysis of SA-Cy3 and SA-EITC conjugates (Figure A-2.4,
Equation A-2.1, Figure 7.4, Equation 7.2), the ratio of EITC to Cy3 functionalization
was calculated to be ~2.1, which allowed for photoinitiator surface density to be
calculated for each printed array spot.
7.3 Results and Discussion
The overall goal of this work was to determine to effect of photoinitiator labeling
density on the gelation response and cell protection efficiency (i.e. yield) in lysing
conditions. A549 lung cancer cells are biotinylated either covalently or with antibody
targeting, then coated by visible light photopolymerization. The protection afforded by
the coating was determined by exposing the coated cells to lysing conditions and
interrogating the remaining cells by both fluorescent microscopy and flow cytometry. In
parallel, an analogous planar microarray system is biotinylated and exposed to identical
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photopolymerization conditions to provide hydrogel film thickness information about our
system by profilometry analysis. Photoinitiator binding density is quantified
fluorometrically in both experimental scenarios for comparison.
We first confirm the structural integrity of polymer coated cells in a 5% SDS lysis
solution. Figure 7.5 shows an overlay of fluorescent micrograph images of A549 cells
encapsulated with crosslinked PEGDA-3500 just after exposure to 5% SDS lysis
solution. Here, cells were biotinylated with the “metastatic” antibody cocktail (antiCD44, Ant-ICAM-1, anti-EGFR). Panel (a) shows a fluorescent image of yellow-green
fluorescent imaging nanoparticles previously shown to be physically entangled in the
crosslinked film mesh in similar systems [97], showing visible fluorescent signal
completely surrounding the cell perimeter. Panel (b), taken at the same stage position, is
Hoechst 33342 DNA staining, which exhibits fluorescence confined to a smaller region
than the polymer coating. The smaller localization of the DNA is consistent with a
structurally-intact nuclear envelope. Frame (c) shows the blue and green channel
overlaid, suggesting the cells have remained protected and intact and nuclear DNA
localization has remained largely unaltered. We were unable to image any distinct
structures in the cellular lysate of unprotected cells. Further, we have previously shown
polymer coated cells are viable and proliferate after removal of the coating. In all,
fluorescent imaging of the polymer supports the formation of a conformal coating, while
nuclear staining supports the integrity of polymer coated cells in lysis conditions.
7.3.1 Relationship Between Initiator Density and Cellular Protection
Our seminal work in ASL work describes a binary relationship between specific
photoinitiator labeling with antibodies and protection from surfactant lysis. On a
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fundamental level, any antibody-based labeling is a contrast between specific and
nonspecific labeling. As a result, our prior work implies that the specific labeling is
sufficient to form a protective coating and nonspecific labeling is insufficient. In reality,
the marker density of different surface receptors varies by several orders of magnitude
within a single cell type. As such, even for a single cell type and a single marker, one
would expect some cells to have high marker density and some to have low marker
density. We hypothesize that this heterogeneity in marker density will translate to a
comparable heterogeneity in photoinitiator density on the surface. In this same
population, only a given fraction of cells will have sufficient photoinitiator density to
completely form a protective coating on the given cell. Thus, only a fraction of the cells
are expected to remain intact after surfactant exposure. The fraction of intact cells
following surfactant exposure is expected to increase with an increase in the mean
photoinitiator density for the population. In antigen labeling experiments, this equates to
higher yields for higher surface densities of the targeted marker.
Figure 7.6 shows the results of the flow cytometry analysis of process yield
dependence on mean photoinitiator labeling density of each sample. The presence of an
intact cell was defined by both size and fluorescent intensity. A549 cells were labeled
intracellularly with CellTracker Deep Red at the outset of each experiment to enable flow
detection with the 630 nm laser and 675/25 nm filter combination in the FL4 channel.
The excitation-emission spectra for this dye was specifically chosen because of the
spectral separation at higher wavelengths from the photoinitiator, imaging nanoparticles,
and irradiation lamp used in this study to provide a distinct and reliable fluorescent
indicator of an intact cell event. Additionally, intact A549 populations consistently show
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forward scatter above ~2,000,000 for our instrument. Thus, a “positive” intact cell event
was defined based on live stained A549 controls by quadrant gating FSC vs FL4 as FSC
> 2,000,000 a.u. and FL4 > 30,000 a.u. (Figure 7.2). The yield of intact cells was
calculated as the cell count per 1 mL after lysis divided by the cell count per 1 mL just
before polymerization. The mean photoinitiator density (fluorophores/μm2) for each data
point was determined by calibrating overall streptavidin-photoinitiator binding to A549
with a QuantiBRITE fluorescence quantitation assay, and then normalizing with the
calculated spherical model surface area.
Figure 7.6.a shows a summary plot of A549 yield versus photoinitiator density
for polymer coating with 25 wt% PEGDA-575. Each data point represents an
independent isolation experiment. Covalently biotinylated samples were incrementally
loaded by competitive binding of varied ratios of streptavidin-photoinitiator and
unconjugated streptavidin. As expected, the yield of intact cells after lysis depletion was
strongly and directly dependent on photoinitiator surface density. At the lowest loading
density investigated (~1,600 eosin molecules per μm2), the yield was <1%, while at the
highest bound of our PEGDA-575 study of above 54,000 eosin molecules per μm2
showed nearly 50% yield of intact cells. Figure 7.6.b shows a similar summary plot of
isolation

yield

dependence

on

photoinitiator

loading

for

PEGDA-3500

photopolymerization. As before, A549 cell samples were biotinylated covalently by
succinimide-amine chemistry indiscriminately on surface proteins, then loaded with
streptavidin eosin at incrementally varied levels by competitive binding with
unconjugated streptavidin. At the lowest level of eosin loading of ~1,300 molecules per
μm2, yield was again below 1%, while for the highest bound of eosin functionalization at
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~43,000 molecules per μm2, the yield here for PEGDA-3500 coated samples was as high
as 68%. For both monomer formulations, there is a distinct trend for a larger fraction of
cells remaining intact when protected by a coating formed with a higher mean surface
density of the eosin photoinitiator. This qualitatively agrees with our hypothesis that
more cells in the population are above a threshold photoinitiator density required for
protection.
With a protection trend established with nonspecific biotin functionalization of
cell surfaces, we sought to verify this trend in an antibody labeling system. In separate
experiments, cancer cell targeting scenarios were also investigated using antibodies. We
have previously shown that A549 exhibit significantly lower surface density of epithelial
markers (EpCAM and E-cadherin) than stem-like markers such as CD44 and metastasis
markers like EGFR and ICAM-1 [172]. Figure 7.6.a shows that EpCAM targeting
resulted in low photoinitiator loading density in agreement with our previous findings of
below 1,200 eosin molecules per μm2. The low eosin surface concentration using
EpCAM resulted in low isolation yield near 1% for a PEGDA-575 monomer solution.
For PEGDA-3500 in Figure 7.6.b, eosin loading was also below 1,200 molecules per
μm2 and delivered correspondingly yield of intact cells at around 1%. The yield of intact
cells for both monomers are in close agreement with predictions based on the covalent
labeling studies.
In separate experiments, A549 cell samples were also biotinylated by targeting a
panel of markers implicated in metastasis, which included CD44, ICAM-1, and EGFR. In
Figure 7.6.a, this antibody targeting strategy allowed for much higher surface densities
of between 10,000 and 20,000 eosins per μm2, and resulted in higher yield of intact cells
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of approximately 20% for the PEGDA-575. Similarly, the metastatic marker targeting
resulted in ~10% yield of intact cells for the PEGDA-3500. The qualitative trend of
higher yields was in fairly good agreement with the percent yield of corresponding
covalent biotinylated samples of similar photoinitiator loading. Further, Figure 7.7 shows
a negative control representing nonspecific labeling of streptavidin-photoinitiator without
biotinylation by antibodies or covalent grafting. For both monomer formulations,
photoinitiator loading densities were in the range of 100-200 eosin molecules per μm2
and yielded <0.1% intact events, indicating that protection during lysis is predominantly
due to the specific labeling of streptavidin-photoinitiator at biotinylated sites.
7.3.2 Analysis of Photopolymerization Gelation Response
Quantitative comparison of the lysis protection by PEGDA-575 and PEGDA3500 indicates a higher yield of intact cells for the PEGDA-3500. Specifically, a PEGDA
575 coating from a photoinitiator density of 35,000 molecules per μm2 results in ~35%
yield, while the same photoinitiator density provides ~60% yield using the PEGDA-3500
monomer. To determine if this discrepancy originates in the sensitivity of polymer
formation, we studied the polymerization of each monomer system on protein
microarrays. Because of the inherent variability in cell geometry and morphology, direct
measurement of nanothin film coating thickness on suspended cell substrates is
prohibitively challenging. Protein microarrays on glass offer a reproducible platform to
analyze these thicknesses (Figure 7.8.a-c). Photoinitiator surface densities can be tuned
to recapitulate the range seen on cancer cell surfaces during ASL (0 to 20,000 eosin
molecules per μm2). Figures 7.8.d and Figure 7.8.e show plots of measured profilometry
thickness

of

polymerized

microarrays
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Photopolymerization conditions were identical to those used for cell suspensions for both
PEGDA-575 and PEGDA-3500 formulations. Plot 7.8.d shows the gelation response for
PEGDA-575 reaches average thickness of 85 nm at the high bound of the array
experiment at approximately 17,000 eosin molecules per μm2. Plot 7.8.e shows the
gelation response for PEGDA-3500 which exhibits a lower gel thickness response,
reaching approximately 40 nm at the highest eosin density investigated.
Figure 7.8 also indicates that polymer forms at photoinitiator densities of ~100
and ~1,000 for PEGDA 575 and 3500, respectively. This observation is contrasted with
the cell yield data, where comparable densities offers negligible protection (~1% yield,
Figure 7.6). This underscores the requirement of a complete coating for protection
against lysis. This has dramatic implications for the purity of ASL isolation, where cell
with low levels of nonspecific adsorption is unlikely to protect a cell against lysis.
Similarly, if large antibody aggregates adhere to a cell surface, it is unlikely to form a
complete protective coating around the cell. The higher threshold of the PEGDA-3500
over PEGDA-575 suggests the 3500 system requires a higher antigen density for
protection over the PEGDA-575 system. The distinction between the 575 and 3500
systems is not definitively observed in the yield data in Figure 7.6. Critically, the data in
Figure 7.6 is an analysis based on population means, where cell-level data is obscured.
7.3.3 Determining Photoinitiator Loading Threshold Required for Isolation
The calculated mean photoinitiator density is not a sufficient parameter to
determine a required photoinitiator density for the protection of a given cell. To
determine a minimum threshold density for protection, we must further examine the
distribution of eosin-label density for each population. If an exact threshold exists, we
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would expect every cell of higher eosin density than the threshold to remain intact
through the lysis. As such, we expect a population with X % of events having greater
eosin density than the threshold to have a yield of X %. To evaluate this we calculated the
yield of each population and drew a line on the surface density histogram where the
fraction of events with higher eosin density than the line is equal to that sample’s yield.
Further, we would expect this threshold to be the same for every trial. For example, if a
hypothetical isolation run resulted in 60% yield intact cells, the histogram of eosin
labeling for that experiment would be labeled at a density corresponding to 60% of events
above the threshold. We then analyzed the surface density corresponding to that line for
each population.
Figure 7.9 shows representative “low”, “mid”, and “high” photoinitiator labeling
examples from our study for both PEGDA-575 and PEGDA-3500 polymer formulations.
In Figure 7.10, we plot this threshold gate for all data trials for both PEGDA-575 and
PEGDA-3500. There is a general upward trend in threshold photoinitiator density for the
PEGDA-575. In the PEGDA-3500 system, the calculated threshold density value is
independent of process yield. While the mean photoinitiator density shifts drastically in
these systems (~50 fold change), the hypothetical density threshold corresponding to the
yield only varies by 4 fold. This suggests that the eventual yield delivered is a strong
function of the population distribution of initiator labeling in relation to this threshold.
Based on our cytometry labeling calibration analysis described above, these threshold
photoinitiator densities are roughly 27,000 eosin molecules per μm2 and 21,000 eosin
molecules per μm2 for PEGDA-575 and PEGDA-3500 formulations, respectively.
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7.4 Conclusions
In this work we have investigated the relationship between marker expression
density on cancer cells and the yield of intact cells during ASL. A lung cancer cell line
(A549) was used as a model CTC and cells were incrementally biotinylated via
covalently functionalization and subsequent competitive binding with PI-conjugated and
unconjugated streptavidin, which provided a predictable prototypic system to
methodically study labeling density effects on yield. We have shown a strong, direct
correlation between photoinitiator surface density and yield of protected, intact cells.
Based on previous work [171], we expect these results to translate to heterogeneous cell
suspensions and represents a critical first step in validating ASL as versatile platform for
CTC isolation.
Further, there was no appreciable difference between covalent eosin
functionalization and the antibody targeting strategies examined here. Mammalian cell
membranes are a complex, dynamic composition of cell proteins and other biomolecules
that are distributed over the cell surface into discrete locations, often non-randomly. We
realized caution should be taken when selecting biomarkers for photoinitiator targeting
because some have been shown to cluster into “islands” [173], which could exaggerate
non-uniformity in expression and lead to incomplete coating formation. Because little
difference was seen between covalent biotinylation and the markers selected here, we
conclude that any surface protein clustering phenomena were not significant enough to
preclude successful isolation of the cell/antigen systems studied.
Finally, we purposely chose to investigate an expanded photoinitiator loading
range through covalent targeting that far exceeded conventional antibody targeting, and
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showed elevated yield response at higher photoinitiator loading levels. These results
suggest ASL would potentially benefit from the design and implementation of
streptavidin-macrophotoinitiators that have been shown to direct several fold greater
quantities of photoinitiator molecules to each site of biotin recognition and increase
polymer amplification response [141]. Moving forward, development of such routes to
increased gelation response to biorecognition could conceivably enable robust positive
isolation based on targeting poorly expressed proteins that may be of high clinical
relevance.
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Figure 7.1: Schematic of surface polymerization approach for cancer cell isolation.
Photoinitiator loading dictates yield of polymerized cells in surfactant lysis conditions.
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Figure 7.2: Flow cytometry control plot of forward scatter vs. FL4 showing gating
definition of an intact cell in upper right quadrant.
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Figure 7.3: (a) Linear regression of FL2 vs. FL1 for calibration of SA-PE and SA-EITC
labeling at varied biotinylation. (b) Cytometry standard curve of FL2 for R-phycoerythrin
functionalized beads.
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Equation 7.1: Calibration equation to relate photoinitiator cell surface density to mean
FL1 of individual cell samples.
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Figure 7.4: UV-vis absorbance spectra of streptavidin-Cy3 conjugate.

Equation 7.2: Equation to calculate the DOS of Cy3:SA by regression analysis of UVvis analysis of absorbance values at 280 nm and 550 nm.
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Figure 7.5: Fluorescent micrograph overlays of PEGDA coated A549 cells after
exposure to 5% SDS lysing conditions. (a) Fluorescent signal from 20 nm yellow-green
imaging nanoparticles physically entangled in polymer mesh. (b) Hoechst 33342 blue
DNA staining. (c) Overlay of yellow-green nanoparticle and Hoechst 33342 images.
Scale bars represent 50μm.
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Figure 7.6: Plots of ASL isolation experiments showing yield intact yells attained after
lysis vs. corresponding mean photoinitiator density via either covalent or antibody
biotinylation for (a) PEGDA-575 and (b) PEGDA-3500 monomers during
photopolymerization.
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Figure 7.7: ASL negative control of A549 targeting. % Yield of intact cells for nonspecific SA-EITC labeling for (a) PEGDA-575 and (b) PEGDA-3500 monomer
formulations.
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Figure 7.8: (a) Schematic of polymer microarrays to analyze gelation response vs.
photoinitiator density. Biotin-BSA protein arrays are printed at serial dilution, contacted
with SA-EITC and photopolymerized with cell encapsulation conditions. Panel (b) shows
fluorescent array scanner image showing specific SA-EITC binding and fluorescence. (c)
Fluorescent microscopy image after photopolymerization showing fluorescent
nanoparticle loaded polymer film formation. Scale bar represents 500 μm. Contact
profilometry thickness analysis vs. photoinitiator surface density of (d) PEGDA-575 and
(e) PEGDA-3500 monomer formulations. Errors bars represent standard error for n=6
spot concentrations.
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Figure 7.9: Photoinitiator density threshold analysis. Representative histograms for
“low”, “mid”, and “high” photoinitiator loading trials and the FL1 intensity of the gating
corresponding to the % yield of each individual experiment for both (a) PEGDA-575 (b)
PEGDA-3500.
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Figure 7.10: The threshold photoinitiator density corresponding to each individual
isolation % yield shown for (a) PEGDA-575 and (b) PEGDA-3500 formulations.
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Chapter 8: Conclusions and Future Perspectives
In this work, we explored the development of cell surface coatings formed by
interfacial polymerization for protection during a lysis-based isolation method. This
dissertation demonstrated several key findings for this novel technique. First in Chapter
4, individual cells were encapsulated with complete and conformal PEG crosslinked
coatings, and are shown to remain highly viable through this biocompatible process.
Polymer coatings are specifically formed from photoinitiator-tagged cell surface
receptors through polymer-based amplification. Further, these film coatings exhibit size
selective permeability, completely excluding fluorescent dextran molecules above a
molecular weight of approximately 10 kDa. We then further explored this coating
technique to specifically target and sort marker-presenting cells in heterogeneous
mixtures in Chapter 5. Notably, model CTCs were sorted with exceptional purity (~99%)
from spiked human buffy coat by targeting the EpCAM surface marker. Designed orthonitrobenzyl groups between crosslinks allows for photodegradation of positively-sorted
cell to release pure populations for further analysis. Viability and proliferation assays
showed these sorted and released cells are highly viable and proliferative compared to
controls of cultured cells. While this study demonstrated ASL has great promise for high
performance cell sorting of viable cells, we then focused on further examining marker
availability and the feasibility of potential targeting scenarios. Chapter 6 examined the
available densities of a panel of metastatic markers on commonly studied breast and lung
cancer lines, revealing extreme variability between markers and cell lines. This showed
that greater appreciation for biological heterogeneity is warranted when designing
isolation targeting strategies, particularly for CTCs which have been shown to
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downregulate epithelial markers. Finally in Chapter 7, our last study related the marker
density for targeting to the eventual ASL process yield, and showed that targeting
metastatic markers on A549 cells resulted in significantly higher process yield, as
expected from the prior marker density analysis. In this work, we also determined a
density threshold of photoinitiator functionalization on A549 for complete gelation and
successful positive isolation that we expect to be generally applicable to other cell
targeting scenarios.
Uniquely, we have demonstrated high performance for this sorting technique with
components that are inexpensive and generally commercially available. The LED lamps
to initiate polymerization are approximately $1000 each, and the costs for antibodies used
in photoinitiator tagging are continuing to decrease as immunolabeling becomes more
commonplace for virtually all biological research fields. The processing containers are
pre-sterilized polystyrene or polypropylene cell culture products that are disposable,
eliminating the need for lengthy and costly cleaning as required for fluorescent sorting.
These low costs of processing could conceivably make ASL more accessible to a broader
range of researchers that are generally not able to use other high cost competing
technologies.
8.1 Future Perspectives
The results presented in this dissertation suggest ASL is a promising technology
for the rapid sorting of tumor cells. However, there are several barriers to development
and clinical implementation. The following sections detail these challenges and the future
goals of this research direction.
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8.1.1 Correlating Marker Targeting Scenarios with Invasive Functionality of CTCs
This work previously demonstrated the proliferative capacity and viability of cells
after sorting. However, in the context of CTCs the most definitive assessment of
functionality is direct measurement of invasiveness and motility. Therefore, we will
evaluate the functionality of CTCs toward metastatic potential using a Matrigel basement
membrane invasion assay. We expect that cells possessing the appropriate repertoire of
migratory proteins and signaling will be able to dissolve the basement membrane
mimicking 3D culture and will invade the farthest into the gel. The model CTCs with the
high metastatic relevance will be generated by TGF-β stimulation, whereas tumor lines
directly from normal epithelial culture will display lower metastatic potential. We
hypothesize that sorting EMT stimulated model CTCs with stem cell markers will yield
cells with the highest invasive potential in the Matrigel assay, given that the markers
targeting allow sufficient eosin priming above the coating isolation threshold.
Conversely, sorting tumor cells with epithelial markers that have not been stimulated
toward a mesenchymal phenotype will yield cells with a lower invasive phenotype. All
sorted scenarios will be compared to the parallel controls of cultured tumor lines seeded
at matching cell densities into the Matrigel invasion wells. We expect that sorted cells to
behave similarly to unsorted controls, in that they will proliferate and invade similarly.
Additionally, migratory potential will also be confirmed with a wound healing scratch
assay. As in the Matrigel assay, we expect that EMT stimulated model CTCs to migrate
at a faster rate than non-stimulated counterparts. We again hypothesize that sorting by
stem markers will yield populations with higher migratory potential than sorting by
epithelial markers, and that sorted cells will migrate comparably to pre-sorted controls.
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These assays will serve to both validate the metastatic functionality of CTCs sorted by
ASL as well as further link a stem-like phenotype to higher invasive potential. We expect
that these validations will inform the development of ASL as a more clinically relevant
CTC isolation technology capable of delivering pure populations of biologically
functional metastatic cells for analysis.
8.1.2 Developing ASL for Clinical Translation
Several challenges must be overcome to enable the translation of ASL as a
clinically useful fluid biopsy technology. First, because these tumor cells circulate in
metastatic patients at extreme rarity, the process yield for antibody targeting scenarios
must be improved. In Chapter 7, we have shown that even with targeting several markers
that are shown to be overexpressed in the model cell line used in the study, we were only
able to achieve approximately 25% cell yield. However, the study also showed that by
greatly increasing the photoinitiator labeling density with covalent tagging over what is
capable with traditional immunolabeling, process yield was improved to approximately
50-60%. In these studies, we functionalized 4-5 eosin molecules per streptavidin;
however, to achieve significantly higher levels of photoinitiator labeling we aim to design
streptavidin-macrophotoinitiator conjugates that are capable of directing tens to hundreds
of photoinitiator molecules per biotin binding event [141]. Macrophotoinitiators will be
synthesized by coupling an excess of eosin isothiocyanate to primary amines of
poly(acrylamide-co-acrylic acid) macromers of varying lengths. To conjugate
photoinitiator macromers to avidin groups, carboxyl moeities contributed by acrylic acid
monomer units will be activated by EDC/sulfo-NHS, quenched with 2-mercaptoethanol,
and then reacted with streptavidin. Similarly, fluorescein macrophotoinitiators will be
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investigated for feasibility with ASL. In preliminary studies, our group has shown the
polymerized gel thickness of fluorescein surface initiation systems can rival eosin
systems, but the fluorescein fluorophore is more widely assimilated in the scientific
community and is approximately 20 times cheaper per milligram. Using these types of
macrophotoinitiators systems, we expect significantly higher levels of photoinitiator
surface densities can be achieved that will improve process yield.
After process yield is improved and carefully validated with model systems
developed in vitro, the feasibility of ASL sorting patient-derived samples can be
examined. The key advantage of ASL over other CTC isolation methodologies is the
potential to rapidly collect functional cells. Conceivably, this technology is uniquely
positioned to enable the researcher to correlate cancer cell phenotype and functional
characteristics at both the tumor primary, at metastatic lesions, as well as in circulation
from a single patient. While this correlative study is an exciting future possibility, there
are challenges to achieving that goal particularly due to the rarity and uncertainty of cell
occurrences in circulation. A practical starting point is at the primary, where there are
simply more cells for experimentation. Fresh primary tissue punch biopsies can be
collected, then enzymatically and mechanically dispersed into a cell suspension for ASL
processing. A preliminary study of interest at the primary would be to first separate
different regions associated with the primary (i.e. necrotic core, invasive front, stromal
tissue) and sort in parallel. Here, one could examine the frequency of cells that are
obtained at each region by positively sorting with a panel of markers, but also compare
the functional characteristics of those populations post-sorting. After the ASL system is
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well established with primary tissue, matched primary, secondary, and peripheral blood
samples can be examined for similarities in cell phenotype and behavior.
Other challenges for clinical translation center around the logistics of processing
the sheer magnitude of cells one would see in a fluid biopsy setting. A red blood cell
depletion step with ammonium chloride is widely used for an initial debulking step;
however, removing that large quantity of material from the system while preserving and
separating all nucleated cells becomes a challenge. The incorporation of EDTA and
DNase I is expected to be beneficial in preventing large cell clumping of nucleated cells.
Practical adaptations must also be made for material handling, as density based
centrifugation in culture tubes may cause the unintentional removal of large proportions
of CTCs from the sample. Further, to photopolymerize these large cell samples, larger
collimated LED lamps must be designed that can accommodate the large irradiation areas
needed for adequate photoinitiation.
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Appendix

A-1 Cell Photopolymerization and Degradation Experimental Set-Up

Figure A-1.1: Photograph of purging and photopolymerization set up. Cells are
suspended in monomer solution in recessed well of cover glass bottom 35mm dish, and
purged with ultra-pure N2 in a 150mm clear culture dish outfitted with inlet and outlet
ports. Irradiation light is supplied by collimated LED lamp (ThorLabs) outputting 530nm
light.
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Figure A-1.2: Photograph of the UV photodegradation apparatus. Collimated LED
outputting 365 nm light with a ChipClip / FAST-slide assembly.
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A-2 UV-Vis Analysis and Calculation of Degree of Substitution (DOS) for
Streptavidin-eosin-isothiocyanate Conjugation

Figure A-2.1: UV-Vis standard curve of streptavidin prepared in PBS. Absorbances are
at 280 nm.
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Figure A-2.2: UV-Vis standard curve of eosin-isothiocyanate prepared in PBS.
Absorbances are at 530 nm.
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Figure A-2.3: Standard curve relating concentration and UV-Vis absorbance at 280 nm
of eosin isothiocyanate prepared in PBS.

Equation A-2.1: Calculation of degree of substitution (DOS) of conjugation of eosin
isothiocyanate (EITC) to streptavidin from UV-vis standard curve regression analysis.
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Figure A-2.4: Example of UV-Vis spectra of SA-EITC conjugate showing absorbance
peaks at 280 nm and 530 nm.
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A-3 Study of Significant Reaction Parameters Affecting Degree of Substitution of
Streptavidin-eosin-isothiocyanate Conjugation
Polymerization experiments in this dissertation involve the specific labeling of
biotinylated sites with streptavidin (SA) which is covalently conjugated with eosin
istothiocyanate (EITC). The isothiocyanate group reacts with the primary amine of lysine
residues at pH ~ 8 to 10. Previous studies report the use of general reaction protocol
which involves dissolving lyophilized streptavidin at 10 mg/ml in 0.1 M carbonate buffer
at pH 9, and reacting with EITC at a 140:1 molar ratio (EITC:SA) for 8 to 9 hours at 4 ˚C
in the dark [98]. This protocol yields conjugates with a calculated DOS of approximately
2-3. We hypothesized that higher photoinitiator loading for cell labeling could be
obtained by increasing the DOS of the EITC to SA reaction. Therefore, and investigation
of the significant reaction parameters dictating the extent of labeling was warranted. We
examined pH, reaction time, and the reactant molar ratio in the study, while the total
buffer salt concentration and reaction temperature were kept constant. First, the molar
ratio was kept constant at 140:1, while the pH was varied (9, 10, and 10.5) as well as
reaction itme (9, 12, and 15 h). The EITC:SA ratio was calculated from UV-Vis analysis
after conjugation of absorbance values at 280 and 530 nm. Figure A-3.1 shows the
results of the varied pH and reaction time experiment. This figure suggests that the
reaction time in the range examined is not a significant parameter affecting DOS.
However, the reaction pH did significantly affect the DOS, as increasing the pH from 9 to
10 almost doubled the DOS. The data suggests that increasing the reaction above 10 to
10.5 does not have a significant effect on the DOS, as here the increase only yielded
~10% increase in the DOS. Another experiment examined the reactant molar ratio as it
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was increased above the original ratio of ~140:1 from the protocol originally reported by
Hansen et al. (2007). Figure A-3.2 shows the results of this experiment, and indicates
that molar ratio does increase the reaction DOS. When the molar ratio is doubled, the
DOS increases by approximately 1.5-fold. From these studies, it was concluded that a
reaction time of 9 hours, a reaction pH of 10, and a reactant molar ratio of 140:1 would
be sufficiently to yield a SA-EITC conjugate for cell labeling in ASL experiments.
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Figure A-3.1 The effect of reaction time and reaction pH on the DOS of EITC:SA
conjugates. Data points are presented as mean, with error bars representing standard error
for N=3.
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Figure A-3.2 Effect of reactant (free EITC to SA) molar ratio on DOS at pH 9 and 10 for
a constant reaction time of 12 hours. “Fold Molar Ratio” refers to the fold increase in
molar ratio over the original protocol that was adapted for this work found in Hansen et
al. (2007) [98]. Data points are presented as mean, with error bars representing standard
error for N=3.
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A-4 General Orientation of Printed Protein Microarrays
Printed protein microarrays are used in the preceding chapters to investigate the
gelation response to varied monomer formulations and photoinitiator surface densities. A
general layout for these microarrays is shown below in Figure A-4.1. Pre-functionalized
epoxy microscopy slides are purchased and washed once with 100% ethanol. Slides are
loaded into an Affymetrix 417 Array Printer, where serial dilutions of biotinylated bovine
serum albumin (bBSA) are printed identically on each slide. As shown below, each of the
12 concentrations are printed in duplicate on each array, with 4 replicate arrays printed on
each slide. Figure A-4.2 shows the bBSA print concetration corresponding to the array
spotting configuration. In all printing scenarios, the total protein concentration is kept
constant at 1000 μg/ml, with proportions of bBSA and BSA being prepared at varied
ratios to serially modify the eventual biotin surface density on printed microarrays.
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Figure A-4.1 General setup of biotinylated BSA protein microarrays. Array spot color
indicates different concentrations.

Figure A-4.2 Concentrations of biotinylated BSA corresponding to the designed
microarray configuration.
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A-5: Interfacial Polymerization for Colorimetric Labeling of Protein Expression in
Cells
The following section is adapted with minor changes from work previously published:
Jacob L. Lilly, Philip R. Sheldon, Liv J. Hoversten, Gabriela Romero, Vivek
Balasubramaniam, Brad J. Berron. Interfacial Polymerization for Colorimetric
Labeling of Protein Expression in Cells. PLOS ONE. 9(12): e115630, 2014.
A-5.1 Introduction
The determination of spatial patterns of protein expression in biological samples
is a cornerstone of modern clinical diagnostic and biological research. Protein
identification and localization is typically achieved through incubation of the sample with
labeled antibodies against the protein of interest. While direct labeling of the target
antibody is sufficient for localization of abundant proteins in fluorescent imaging,
amplification of the signal is typically required to label proteins for brightfield
observation of samples where dilute proteins can be difficult to observe colorimetrically.
Horseradish peroxidase (HRP) amplification is a common method for amplifying the
label of a poorly expressed protein in cells and tissues. The basic concept uses the
incubation of HRP enzyme coupled to antibody location, typically through biotinylated
antibodies and HRP-avidin conjugates [174]. The specificity of the antibody binds the
enzyme to regions expressing the protein of interest. When the sample is subsequently
immersed in a solution of hydrogen peroxide and diaminobenzidine, the HRP rapidly
converts the diaminobenzidine to yield an insoluble brown product. Under ideal
conditions, the presence of the brown product is isolated to regions of expression of the
target protein. Unfortunately, nonspecific HRP signal is common from endogenous
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peroxidases naturally residing in the tissue [175]. The presence of these active enzymes
in the sample tissue requires additional sample processing to quench their activity [176].
Incomplete quenching can lead to false positives or inconclusive staining. Further, fine
localization of HRP staining is an empirical process, where over-amplification commonly
results in significant diffusion of the signal away from the targeted protein expression.
Polymerization based amplification (PBA) recently emerged as a signal
amplification approach which does not suffer from diffusional loss of localization or
endogenous signal [96, 177]. PBA uses interfacial polymerization as the basis for
depositing a large amount of label at the site of a biological recognition event (e.g.
antibody/antigen) [141, 178-180]. Both the presence of a polymerization initiator and
reactive monomers are required for the formation of polymer. The PBA approach couples
the spatial localization of the polymerization initiator to that of a specific protein
recognition event (Figure A-5.1). Wherever the antibody recognizes the target protein, a
polymerization initiator is immobilized. Upon addition of monomer and the appropriate
excitation energy, a polymer coating is formed through the deposition of many monomers
at the site of an initiation event. The process has been previously demonstrated on
microarrays to specifically form polymer films from as few as 3 binding events per
square micron allowing great sensitivity and specificity at antibody concentrations that
will limit non-specific background staining [97]. PBA has limitations with respect to
sample archival. On cells, PBA has exclusively utilized fluorescent visualization of
polymerization events [97, 100]. While PBA has shown strong stability of fluorescent
signal during standard imaging conditions, a colorimetric stain would be advantageous
for long-term sample storage and archiving.
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Here, we seek to adapt PBA to serve as a colorimetric, signal-amplification
scheme. Our general approach, termed Polymer Dye Labeling involves the specific
loading of the interfacial polymer with dyes. The interfacial polymer typically used in
PBA is Polyethylene glycol diacrylate (PEG diacrylate), which has been demonstrated to
have specific staining with common dyes [80, 124, 141, 181]. Literature shows both
Evans Blue[80] and eosin[180] to be effective in staining PEG diacrylate polymers. In
particular, the Sikes group has established the use of eosin stained microarrays for
colorimetric assays of oligonucleotide and protein expression, with strong signal to noise
[141, 180, 182]. Critically, the ability of eosin to non-specifically stain many cellular
components present in biological samples[183] precludes its use in Polymer Dye
Labeling to detect specific targeted cellular substrates. We seek to develop a dye system
of comparable staining intensity to the eosin dye, but with reduced affinity for common
cellular components in biological cells. In all, Polymer Dye Labeling is expected to draw
from the advantages of PBA (large signal, excellent localization, and specificity of
action) while adding colorimetric capability to allow improved sample archiving.
Our evaluation of Polymer Dye Labeling builds on prior PBA technology [94, 96,
97, 99, 100, 124, 178, 179, 184-186]. We first confirm the expected process of PBA
through quantifying the deposition of initiator and polymer on control glass surfaces. We
then examine the loading of eosin and Evans Blue dyes into these interfacial coatings
through quantification of color change. We then extend this work to the labeling of cells
by Polymer Dye Labeling. On a culture of human dermal fibroblast samples, we confirm
the stability of the Polymer Dye Labeling signal over 200 days, and also demonstrate the
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compatibility of the Polymer Dye Labeling technology with conventional mounting
media used in sample archiving.
A-5.2 Materials and Methods
A-5.2.1 Materials
Epoxy functionalized slides were purchased from CEL Associates. Biotinylated
bovine

serum

albumin

(bio-BSA),

streptavidin,

eosin-isothiocyanate,

eosin-y,

Monoclonal mouse IgG1 anti-vimentin (V9; catalogue #V6389), 10× phosphate-buffered
saline (PBS), Triton-X 100, trypsin, hydrogen peroxide (30 wt% solution), PEG
diacrylate (Mn = 575), triethanol amine, and 1-vinyl-2-pyrrolidinone were purchased
from Sigma Aldrich (St Louis, MO). Monoclonal mouse IgG1 anti-NPC (MAb414) was
purchased from Covance (Princeton, NJ; catalogue #MMS-120P). Biotinylated
polyclonal goat IgG anti-mouse IgG (H+L; catalogue #BA-9200) and Vectashield hardset
mounting medium was purchased from Vector Laboratories (Burlingame, CA). Bovine
serum albumin (BSA), methanol, and ethanol (absolute) were purchased from Fisher
Scientific (Waltham, MA). Paraformaldehyde was purchased from Electron Microscopy
Sciences (Hatfield, PA). Streptavidin-Alexa488 conjugates were purchased from Life
Technologies (Grand Island, NY). Rabbit antibodies against mouse pro-surfactant protein
C was purchased from Seven Hills Bioreagents (Cincinnati, OH). Donkey antibodies
against rabbit IgG were purchased from Invitrogen (Carlsbad, CA).
RPMI-1640 cell culture media was purchased from Cellgro and supplemented
with 10% fetal bovine serum (FBS, Gibco, Carlsbad, CA), 100U/mL Penicillin, 10
mg/mL Streptomycin (Gibco) prior to use. Normal human dermal fibroblasts (#CC-2511)
were purchased from Lonza (Basel, Switzerland). Streptavidin-eosin (SA-initiator) was
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prepared as described previously [178]. PBSA was prepared by adding 1 mg/mL bovine
serum albumin 1x PBS. Monomer mix was prepared immediately prior to use and
consists of 25 wt% PEG diacrylate, 21 mM triethanolamine, 35 mM 1-vinyl-2pyrrolidinone, and 0.05 wt% Nile red fluorescent nanoparticles in deionized water.
A-5.2.2 Biotin Microarray Printing
Epoxy functionalized glass slides were rinsed with ethanol, dried under a stream
of nitrogen, and placed on the stage of the Affymetrix (Santa Clara, CA) GMS 417
Arrayer. BSA solutions were prepared keeping a constant 1 mg/mL concentration of BSA
in PBS, and varying the fraction of BSA that is biotinylated . Twelve solutions were
prepared at the following concentrations of biotinylated BSA: 1 mg/mL, 400 µg/mL, 160
µg/mL, 64 µg/mL, 26 µg/mL, 10 µg/mL, 4 µg/mL, 1.6 µg/mL, 650ng/mL, 260 ng/mL,
100 ng/mL, 0 ng/mL. Arrays consisted of 24 spots, where each solution was duplicated
on each array, and four identical arrays were printed on each glass slide. Only the two
centermost arrays were used, as the polymerization light source can only irradiate two
arrays at a time. Slides were printed under 60% relative humidity in a single batch of 25
slides.
A-5.2.3 Microarray Polymerization, Staining, and Imaging
Slides were blocked in PBSA for 10 minutes, incubated in 1.0 µg/mL SA-initiator
in PBSA for 20 minutes, and rinsed with PBSA. These initiator-labeled arrays were then
scanned in an Affymetrix Microarray Scanner (Model 428) using 532 nm laser excitation
and a 551 ± 7 nm band pass emission filter. Files were exported to ImageJ for analysis of
array spot intensity. Fluorescent data are reported as the mean and standard deviation of
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16 measurements (two duplicates spots per array, two arrays per slide, four independent
preparations of a single slide).
Slides were then immediately placed in a Chip Clip (Whatman, Little Chalfont,
UK) with a two well FAST slide (Whatman) with 400 µL of monomer mix in each well.
Samples were purged with humidified nitrogen in a clear plastic bag for 5 minutes. Then,
the slide was irradiated for 20 minutes with collimated, 10 mW/cm2, 530 nm LED light
(Thorlabs, Newton NJ, model M530L3) under a constant stream of humidified nitrogen.
After irradiation, samples were rinsed with water. The samples were then incubated in a 1
mg/mL solution of the indicated dye for 20 minutes. Evans Blue was prepared in PBS,
while eosin was prepared in an aqueous solution of 50% methanol to promote solubility.
Slides were dried under a stream of nitrogen, and imaged using an Epson Perfection 4490
Photo flat-bed document scanner at a resolution of 2400 dpi. Only the two arrays mostcentered under the LED irradiation were analyzed owing to radial non-uniformities in the
irradiation intensity. Greyscale values of the fractional darkness of each spot were
collected for each spot using ImageJ. Fractional darkness is defined as 1.00 minus the
fractional greyscale value of spot brightness. The thickness of each polymer spot was
measured with a Dektak 6M stylus profilometer. Limit of detection is defined as the
lowest concentration of biotinylated BSA of a different mean when compared to the
lower concentrations with at least 95% confidence by student t-test. The saturation range
is defined as the high concentration range of biotinylated-BSA where the mean
measurement is not different from each other with at least 95% confidence by a student ttest. The dynamic range is defined as the concentration range between the limit of
detection to the saturation region.
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A-5.2.4 Immunolabeling of Cells
Dermal fibroblasts were cultured on 8 well chamber slides in media at 37 C in 5%
CO2 until ~80% confluent. The cells were rinsed with cold PBS, and fixed in 4%
paraformaldehyde in PBS for 10 minutes. Fixed cells on chamber slides were stored in
PBS at 4 ºC for up to 30 days prior to use with no observed change in staining intensity.
Cells were permeablized with 0.1% Triton X-100 in PBS for 5 minutes and blocked with
PBSA for 10 minutes. Then, slides were incubated in the appropriate primary antibody at
the appropriate dilution in PBSA (anti-NPC at 1:1,000 or anti-vimentin at a 1:5,000) for
40 minutes and rinsed with PBSA. The cells were contacted with biotinylated antibodies
against mouse IgG at 1:400 dilution in PBSA for 4 minutes and rinsed with PBSA. These
samples were then ready for either Polymer Dye Labeling or control labeling with
Alexa488.
For Polymer Dye Labeling, the cells were incubated in a 25 µg/mL solution of
SA-initiator in PBSA for 20 minutes and rinsed with PBS. 80 µL of monomer mix was
added to each well, and the slides were polymerized for 20 minutes with collimated, 10
mW/cm2, 530 nm LED light (Thorlabs model M530L3) under a constant stream of
humidified nitrogen. After irradiation, samples were rinsed with water, and incubated in a
1 mg/mL solution of Evans Blue dye in PBS for 20 minutes. Samples were briefly rinsed
with PBS, and then imaged on a Nikon (Tokyo, Japan) Ti-U inverted microscope using a
60x oil immersion objective with a Nikon DS-Ri1 12 MP cooled color CCD camera.
For control experiments, cells labeled with biotinylated secondary antibodies were
contacted with 1 µg/mL streptavidin-Alexa488 in PBSA for 20 minutes and were
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immediately imaged on a Nikon Ti-U inverted microscope as before except with
epifluorescent imaging in the FITC channel.
Greyscale values of the fractional darkness of each spot were collected for each
spot using ImageJ. Fractional darkness is defined as 1.00 minus the fractional greyscale
value of spot brightness. Background (non-cell region) darkness was subtracted from
both the signal (nucleus region) and noise (cytoplasm region). Signal to noise is defined
by the division of the signal value by the noise value.
A-5.3 Results and Discussion
Our goal is to develop a colorimetric alternative to enzymatic amplification which
is not hampered by non-specific amplification by endogenous enzymes or through
diffusional loss of signal localization. Our approach, “Polymer Dye Labeling,” is a multistep process where 1) polymerization initiator is localized to the site of antigen
expression, 2) an interfacial polymer coating is grown from the surface-grafted initiator,
and 3) dye is loaded into the polymer. Our approach is to first study the fundamental
relationship between initiator binding and the intensity of Polymer Dye Labeling. Then,
we investigate the comprehensive Polymer Dye Labeling process when applied to the
labeling of protein expression in cultured human dermal fibroblasts.
A-5.3.1 Characterization of Recognition, Polymerization, and Dye Association
Bio-BSA was printed into microarrays on an epoxy coated slide, and blocked with
PBSA. Recognition of the SA-initiator with the biotin of the bio-BSA, was quantified
through measuring the fluorescence of the eosin initiator in biotin-expressing regions. A
solution of the SA-initiator conjugate at 1 μg/mL in PBSA was contacted with each
microarray for 20 minutes, and excess conjugate was rinsed briefly with PBSA prior to
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capturing a fluorescent image with a microarray scanner (Figure A-5.2.a). The
fluorescence of each spot was measured using ImageJ, and plotted against the
corresponding concentration of Bio-BSA in the printing solution (Figure A-5.2.b). The
relative initiator concentration is indistinguishable from the background at printed
solution concentrations less than 10-3 g/L of Bio-BSA (limit of detection, p=10-14). There
is a two log fluorescent dynamic range, and saturation above 10-1 g/L of Bio-BSA
(p=.043). Initiator binding is restricted to printed regions, and printed spots containing
only BSA did not exhibit fluorescence greater than that of non-printed regions. The
specificity of binding in this study is consistent with previous reports of initiator binding
based on antibody-antigen [97, 100, 185] or Streptavidin-biotin interactions [178, 184].
Interfacial polymerization is accomplished through the immersion of an initiatorprimed surface in a PEG diacrylate monomer solution. Polymerization proceeded with a
20 minute exposure to 10 mW/cm2, 530 nm irradiation under a nitrogen atmosphere. The
resulting arrays of polymer spots were measured by profilometry to determine the
sensitivity and magnitude of the polymerization reaction (Figure A-5.2.c). As expected,
polymer growth was restricted to regions of initiator-labeling, supporting the specificity
of the polymerization process. The limit of detection was identical to that of the
fluorescence arrays (10-3 g/L of Bio-BSA, p= .001). The dynamic range of polymer
thickness extended to 10-1 g/L of Bio-BSA (p=.01), and was identical to that of the
dynamic range of initiator concentration on the surface, supporting prior reports of the
polymerization reaction being limited by the initiator concentration [141].
Incubation of the PEG diacrylate hydrogels in a dye is expected to alter the color
of the polymer. We are investigating Evans Blue as a candidate dye for strong specific
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staining of the polymer with minimal nonspecific staining of cellular material. Arrays of
PEG diacrylate polymer films were incubated in 1 mg/mL Evans Blue for 20 minutes,
and upon removal, the polymer spots were darkened, while the surrounding glass slide
remained unstained (Figure A-5.3.a). The darkness of the spots was quantified and
plotted against the printed concentration of bio-BSA (Figure A-5.3.c). Again, the limit of
detection was identical to that of the polymer thickness and the initiator concentration
(10-3 g/L of Bio-BSA, p=0.0004). Critically, the dynamic range of the staining was
negligible, and saturation range began at the next data point (4x10-3 g/L of Bio-BSA, p=
0.008). As a result, the colorimetric response was largely binary. When compared to the
use of 1 mg/mL eosin as the polymer dye (Figure A-5.3.b, A-5.3.d), Evans Blue has a
greater magnitude of colorimetric labeling (p= 10-63) of the polymer stained regions but
different levels of background staining (p= 10-5). The limit of detection (10-3 g/L of BioBSA, p= 0.0008) and beginning of the saturation range (10-2 g/L of Bio-BSA, p= 0.0008)
for eosin are similar to the Evans Blue labeling. This indicates Evans Blue is a potential
alternative to eosin in colorimetric staining of PEG diacrylate hydrogels in microarray
settings. The use of eosin dyes on hydrogel microarrays has already demonstrated
effectiveness in a colorimetric detection of biological species [141], and the use of a blue
dye may improve ease of use over the pink color associated with eosin-dyed hydrogels.
To directly compare the effectiveness of the dye-labeling step, we related the
darkness of each spot to the thickness of the hydrogel at that location, providing a
relationship of how much dye is absorbed per unit thickness by the PEG diacrylate
hydrogels. Applying a linear relationship (slope =1.78x10-4 darkness units per nm) to the
Evans Blue data is consistent with the expected increase in spot darkness with a longer
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path length through the dyed polymer (Figure A-5.4.a), yet this fit is statistically
different than the data (p=.01), indicating a poor fit. A linear relationship (2.7x10-4
darkness units per nm) is observed for the eosin-dyed polymer spots (Figure 4b), without
a statistical difference between the data and the linear fit (p=0.06). Additionally, the eosin
associated with the initiator is not perceptible through visual observation prior to
immersion of the hydrogel in eosin. All darkness of the spot is attributed to the postpolymerization dying. While the magnitude of the spot darkness is higher for the eosin
dyed spots than the Evans Blue dyed spots, there is a comparable difference in
nonspecific darkness on the glass slide. Here, we show the eosin labeling of the polymer
is specific. In previous studies, greater signal to noise has been reported by others through
the use of 20-fold higher concentrations of eosin [180]. Higher concentrations of eosin or
Evans Blue were not used in the present study, in an effort to limit nonspecific staining in
subsequent cell studies.
The diameter of the dye labeled polymer spots was determined by optical
microscopy to be 340 ± 20 µm (Figure A-5.3.a, A-5.3.b), and this value was within
measurement error of the spot size of the original initiator labeled arrays of 350 ± 20µm
(Figure A-5.2.a). The lack of detectible polymer overgrowth is promising for the
localization of the polymer to the site of protein expression.
A-5.3.2 Labeling of Protein Expression in Cells
The transition from a controlled microarray environment to a biological substrate
introduces additional challenges to label specificity. Every step in the amplification
process must be specific to the region of antibody/antigen recognition. For the
localization of the initiator, the specificity is dictated by specific binding of the antibodies
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and the SA-initiator complex [96]. When antibodies against nuclear pore complex (NPC)
are used on a fixed, permeabilized, and blocked dermal fibroblast, the initiator
fluorescence is isolated to the nuclear membrane (Figure A-5.5.c). When the NPC
primary antibodies are replaced with antibodies against vimentin, the initiator
fluorescence is localized to vimentin, a fibrous structural component which stretches
across the cytoplasm (Figure A-5.5.d). Control experiments using standard streptavidinAlexa488 instead of the SA-initiator show identical patterns of expression (Figure A5.5.a, A-5.5.b), supporting the appropriate protein specificity of the initiator localization.
The signal intensity from labeling with SA-initiator (signal to noise 4.53 ± 0.36) and
streptavidin-Alexa488 (signal to noise 4.23 ± 0.80) are fully described in Table A-5.2.
These findings are consistent with prior work in polymerization amplification [100, 178].
Upon addition of the PEG diacrylate monomer mix to the initiator-labeled cells
and irradiation with 10 mW/cm2, 530 nm (green) light, an interfacial polymer is formed
on only surfaces expressing the target protein. Unreacted monomer is rinsed away with
PBS, and the polymer-labeled cells are immersed in 1 mg/ mL Evans Blue in PBS. While
both eosin and Evans Blue are capable of specific staining in a microarray setting, the
non-specific staining of eosin for cytoplasmic proteins and collagen precludes its use for
Polymer Dye Labeling on most biological substrates [183]. As such, only Evans Blue
was used in the cell staining studies. In the case of NPC labeled cells, the blue staining of
the Polymer Dye Labeling (Figure A-5.5.e) is consistent with the fluorescent control
NPC staining, where the nuclear membrane is labeled. Similarly, the Polymer Dye
Labeling of vimentin is specific to these cytoskeletal components, with appropriate
alignment of fibers towards cellular extensions (Figure A-5.5.f). Taken together, the
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cellular labeling studies are supportive of the specificity of Polymer Dye Labeling in
biological environments. Further, the intensity of staining is consistent with the expected
amplification resulting from the reaction of many monomers at the site of initiation.
In the context of biological research, colorimetric staining allows independence
from fluorescent analysis and associated costs. Colorimetric staining is almost
exclusively accomplished with enzymatic amplification of the label and enzymatic
labeling has the fundamental challenge of nonspecific labeling from endogenous enzymes
and diffusion. Importantly, our work was performed in the absence of any additional
steps to quench endogenous enzyme activity, as the routes for nonspecific polymerization
initiation are currently undetected. A limitation of the current embodiment of polymer
dye labeling is the need for a photopolymerization light source. The light source utilized
here (Thorlabs LED, <$1000 US) is significantly less expensive than a fluorescent
microscope which requires additional filters and optics. Further, other modes of
polymerization based amplification are based on non-light driven polymerizations [124,
177, 186-190]. The future incorporation of ATRP or other modes of polymerization
would further reduce the capital cost of polymer dye labeling.
A-5.3.3 Suitability for Sample Archiving
Signal stability is a major advantage of a colorimetric staining over a fluorescent
approach. We challenged the stability of cells polymer dye labeled cells with storage at
ambient conditions. Specifically, the samples were imaged immediately after Polymer
Dye Labeling for nuclear pore complex and again after being stored in a drawer for 208
days (Figure A-5.6). The darkness of the nucleus when stained (0.363 ± 0.088) is
comparable to the darkness of the nucleus 208 days after the staining (0.343 ± 0.091).
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The only observable differences between the images were a slight reorientation of the
frame and an increase in small optical aberrations attributed to environmental
contaminants (dust, bacteria, etc.). The storage had no significant impact on the intensity
or localization of staining, indicating promise for the application of Polymer Dye
Labeling to long term sample archiving.
We also evaluated the stability of Polymer Dye Labeling signal when using a
mounting medium. Prior studies using fluorescent PBA to label proteins has been
exclusively executed in the absence of mounting medium, as the fluorescence is
completely quenched in the presence of mounting media [100]. This is a significant
limitation, as mounting medium is commonly integrated into conventional imaging and
archiving protocols to improve image quality and to preserve signal.
NPC expression was stained through four variants of Polymer Dye Labeling: dry
with Evans Blue, mounted with Evans Blue, dry without Evans Blue, and mounted
without Evans Blue. Images are presented in Figure A-5.7, while the darkness of the
stain in these images was measured with ImageJ and compiled in Table A-5.1. For dry
imaging of Polymer Dye Labeling, a blue nucleus is clearly observed (signal / noise ~7)
in contrast to minimal nonspecific signal in the cytoplasm (Figure A-5.7.a). Vectashield
hardset mounting medium was added to the sample according to manufacturer’s
instructions, coverslipped and imaged (Figure A-5.7.b). While the overall darkness of
the stain decreased, the signal/noise almost tripled that of the dry Polymer Dye Labeling.
This is attributed to a large decrease in the nonspecific staining of the cytoplasm.
The most striking change with sample mounting was the change in color of the
Polymer Dye Labeling from blue to violet. To verify this different color of labeling is
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attributed to the use of the Evans Blue dye, we polymerized in response to NPC with the
omission of the Evans Blue dye (Figure A-5.7.c). This dry, undyed sample shows
negligible signal yet did impart some contrast in the image, owing to the change in
refractive index between the polymerized nucleus and the background. Upon addition of
mounting medium to this sample, a slight violet tint is imparted on the interfacial
polymer covering the nucleus (Figure A-5.7.d). The magnitude of the mounting
medium’s contribution to the signal is low (signal/noise ~1), supporting the Evans Blue
dye as the dominant mechanism for staining. As the dark violet color of the polymer is
only observed when both Evans Blue and mounting medium are used, it is likely the
change in the chemical environment of the dye is altering the absorption characteristics.
Similar shifts in absorption peak position are commonly observed in many lightabsorbing molecules (photoinitiators [191], fluorophores [192, 193], etc.) with a change
in solvent.
While enzymatic amplification methods are also stable over prolonged times and
are compatible with modern sample archiving methods, polymerization based methods
have greater site-specificity than enzymatic amplification [100]. The present findings
clearly address the prior limitations in archiving of polymerization amplification samples,
delivering a plausible path forward for a new colorimetric technique with all of the
positive attributes of both enzymatic and polymerization techniques.
A-5.4 Conclusions
Polymer Dye Labeling is based on interfacial polymerization which is specific to
the site of the targeted protein, and these target-specific polymer coatings are then stained
with Evans Blue dye. As a result, a dye-loaded polymer is isolated to regions of protein
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expression. In microarray studies, the use of Evans Blue provides a comparable contrast
to an unstained background as eosin dyes. Application of Polymer Dye Labeling to
immunostaining of cultured cells allowed bright field observation of both the spatial
protein expression and cell morphology. The labeling of protein expression is stable over
several months. Prior polymerization labeling approaches were incompatible with
mounting medium, but Polymer Dye Labeling maintains signal intensity and localization
in common mounting media. We conclude that Polymer Dye Labeling will allow
colorimetric visualization of the spatial localization of targets within a cell to leverage the
highly sensitive and specific aspects of Polymerization Based Amplification.
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Table A-5.1: Staining intensity for Polymer Dye Labeling of nuclear pore complex.
Sample

Signal a,c
Noise b,c
Mean
Standard Mean
Deviation
0.333
0.009
0.049

Signal / Noise
Standard Mean
Standard
Deviation
Deviation
0.004
6.9
0.7

Polymer Dye
Labeling dry
Polymer Dye
0.191
0.016
0.010
0.003
Labeling Mounted
Polymer Dry
-0.001
0.001
-0.004
0.002
Polymer Mounted
0.016
0.006
0.005
0.014
a
- Signal is defined as the darkness of the nucleus.
b
- Noise is defined as the darkness of the cytoplasm.
c
- Values are relative increase over empty region of slide.
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20.9

8.2

0.2
1.2

0.6
2.3

Table A-5.2: Staining intensity for immunofluorescent labeling of nuclear pore complex.
Sample

Noise b,c
Signal a,c
Mean
Standard Mean
Deviation
0.146
0.028
0.035

Signal / Noise
Standard Mean
Standard
Deviation
Deviation
0.006
4.23
0.80

Streptavidin-488
Labeling
Streptavidin-eosin
0.101
0.008
0.022
0.007
Labeling
a
- Signal is defined as the brightness of the nucleus.
b
- Noise is defined as the brightness of the cytoplasm.
c
- Values are relative increase over empty region of slide.

175

4.53

0.36

Figure A-5.1: Polymer Dye Labeling concept at the (a) cellular level and (b) molecular
level. A polymerization initiator is localized to site of antigen through antibody and
biotin-streptavidin labeling. Interfacial hydrogel polymerization occurs only at regions
labeled with initiator. The hydrogel is colorimetrically labeled through an affinity dye.
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Figure A-5.2: Imaging of initiator concentration for microarray. a) Fluorescent
microarray scanner measuring relative abundance of initiator prior to polymerization
labeling. Scale bar = 1 mm. b) Relative initiator concentration on surface for spots printed
from the indicated concentration of biotinylated-BSA and reacted with the SA-initiator
complex. Measurements based on initiator fluorescence (ex/em = 525/545 nm). c)
Thickness of spots of indicated Bio-BSA concentration. Data are mean ± standard
deviation. n=16.
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Figure A-5.3: Colorimetric imaging of Polymer Dye Labeling. a) Greyscale image from
optical document scanner after Polymer Dye Labeling with Evans Blue dye. b) Greyscale
image from optical document scanner after Polymer Dye Labeling with eosin dye. Scale
bars = 1 mm. c) darkness of Evans Blue dyed spots of indicated Bio-BSA concentration.
d) Darkness of eosin dyed spots of indicated Bio-BSA concentration. Data in c) and d)
are mean ± standard deviation. n=12.
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Figure A-5.4: Relationship between polymer spot thickness and spot darkness after
Polymer Dye Labeling. a) Polymer Dye Labeling with Evans Blue dye. b) Polymer Dye
Labeling with eosin dye. Each data set includes at least 6 microarrays from 3 independent
experiments. Black squares indicate array data. Grey squares indicate mean value of nonspecific regions for each experiment.

179

Figure A-5.5: Comparison of Polymer Dye Labeling with immunofluorescent labeling in
human dermal fibroblasts. Control fluorescent staining of nuclear pore complex (a) and
vimentin (b) using Streptavidin-Alexa488. Initiator localization when using antibodies
against nuclear pore complex (c) and vimentin (d). Dyed Polymer localization when
using antibodies against nuclear pore complex (e) and vimentin (f). Scale bars are 50 µm.
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Figure A-5.6: Labeling Stability of Polymer Dye Labeling. Polymer Dye Labeling of
nuclear pore complex immediately after staining (a) and 208 days after staining (b). Scale
bars are 50 µm.
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Figure A-5.7: Compatibility of Polymer Dye Labeling with Vectashield mounting
medium. Polymer Dye Labeling of nuclear pore complex imaged (a) dry or (b) in
Vectashield hardset mounting medium. Polymer coated nuclei without Evans Blue dye
imaged (c) dry or (d) in Vectashield hardset mounting medium. Scale bars are 50 µm.
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List of Abbreviations

AC
ASL
bBSA
BP
BSA
CK
CTC
DAPI
DCM
DNA
DOS
DPBS
ECM
EDC
EDTA
EGF
EGFR
EIA
EITC
ELISA
EMT
EpCAM
ER-α
FACS
FBS
FD
FITC
GFP
1H-NMR
HEPES
HER1
HER2
HGF
ICAM-1
IgG
IHC
LAP
LED
MACS
MEHQ
MW

Acryloyl chloride
Antigen specific lysis
Biotinylated bovine serum albumin
Bandpass
Bovine serum albumin
Cytokeratin
Circulating tumor cell
4',6-diamidino-2-phenylindole
Dichloromethane
Deoxyribonucleic acid
Degree of substitution
Dulbecco’s phosphate buffered saline
Extracellular matrix
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
Ethylenediaminetetraacetic acid
Epidermal growth factor
Epidermal growth factor receptor
Enzyme immunoassay
Eosin-5-isothiocyanate
Ezymed-linked immunosorbent assay
Epithelial-mesenchymal transition
Epithelial cell adhesion molecule
Estrogen receptor-α
Fluorescence activated cell sorting
Fetal bovine serum
Fluorescein-5-isothiocyanate labeled dextran
Fluorescein-5-isothiocyanate
Green fluorescent protein
Proton nuclear magnetic resonance
2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid
Human epidermal growth factor receptor 1
Human epidermal growth factor receptor 2
Hepatocyte growth factor
Inflammatory cell adhesion molecule 1
Immunoglobulin
Immunohistochemical
Lithium acylphosphinate
Light emitting diode
Magnetic activated cell sorting
Monomethyl ether hydroquinone
Molecular weight
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MWBC
NHS
NPC
NSCLC
PBA
PBMC
PBS
PBSA
PCL
PDGF
PE
PEG
PEGDA
PLA
PLGA
PLL
PVA
SA
SDS
SEM
TEA
TEM
TGF-β
UV
VP
ZEB

molecular weight between crosslinks
N-hydroxysuccinimide
Nuclear pore complex
Non-small cell lung cancer
Polymer-based amplification
Peripheral blood mononuclear cell
Phosphate buffered saline
Phosphate buffered saline with 1 mg/ml bovine serum albumin
Poly(caprolactone)
Platelet derived growth factor
Phycoerythrin
Poly(ethylene glycol)
Poly(ethylene glycol) diacrylate
Poly(lactic acid)
Poly(lactic-co-glycolic acid)
Poly(L-lysine)
Poly(vinyl alcohol)
Streptavidin
Sodium dodecyl sulfate
Scanning electron microscopy
Triethanolamine
Transmission electron microscopy
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